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1 INTRODUCTION   
 
1.1 The Mitochondrial Respiratory Chain 
 
The mitochondrial respiratory chain transfers electrons through a redox potential span of 1.14 
V (Em,7), from the NAD
+ / NADH couple to the O2 / 2H2O couple (Nicholls and Ferguson, 
2001). Four enzymes (complexes) are responsible for the electron transfer: 
•  NADH:Ubiquinone Oxidoreductase (complex I) 
•  Succinate:Ubiquinone Oxidoreductase (complex II) 
•  Ubiquinol:Cytochrome c-Oxidoreductase (complex III) 
•  Cytochrome c-Oxidase (complex IV) 
and two types of electron carriers 
•  Ubiquinone (UQ) 
•  Cytochrome c. 
The respiratory chain and the ATP-synthase constitute the oxidative phosphorylation system 
(OXPHOS), that produces most of the ATP in aerobic organisms. The ATP production begins 
with the oxidation of NADH (produced mostly in the citric acid cycle and β-oxidation of fatty 
acids) in the mitochondrial matrix. The resulting electrons are transported to oxygen through 
the respiratory chain in the mitochondrial inner membrane. During this transfer protons are 
translocated across the membrane producing an electrochemical potential. This protonmotive 
force is used for the synthesis of ATP from ADP and inorganic phosphate by the ATP-
synthase, as first proposed by Mitchell (1961). 
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1.2 Complex I 
 
1.2.1 General Overview  
 
Proton-translocating NADH:ubiquinone oxidoreductase (complex I, EC 1.6.99.3) transports 
two electrons from NADH to membrane bound ubiquinone: in this process four protons are 
translocated across the membrane, producing 40% of the total proton gradient between matrix 
side and intermembrane space (Wikström, 1984). 
Complex I is present in many eucaryotes and procaryotes. Bacterial enzymes have a 
molecular mass of around 500 kDa and consist of 14 subunits (Yagi et al., 1998; Dupuis et al., 
1998). Mitochondrial complex I has a molecular weight of around 1000 kDa (Hirst et al., 
2003), contains more than 35 subunits in fungi and plants (Leif et al., 1993) and at least 46 in 
mammals. Most of the genes for mammalian complex I are located in the nuclear genome and 
seven in the mitochondrial genome. This dual coding system and the size of this multi-protein 
enzyme cause a number of difficulties in studying function and mechanism. Furthermore, an 
X-ray structure is not available. 
On the other hand, complex I raises interest not only in the bioenergetic field as the least 
understood enzyme of the OXPHOS system (X-ray structures are available for the other 
complexes), but also in the medical field  and as target for insecticides and acaricides (see 1.4 
and 1.5). 
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1.2.2 Complex I Structure 
 
The subunits that form the bacterial proton-translocating NADH-quinone oxidoreductase 
(NDH-1) in organisms like Escherichia coli, Thermus thermophilus, Paracoccus denitrificans 
and Rhodobacter capsulatus, have homologous subunits in mitochondrial complex I (Yagi et 
al., 1998). Therefore, the bacterial enzyme is considered as the „minimal form“ of complex I 
with regard to eucaryotic enzyme, and the bacterial subunits are defined as “core” subunits.  
For simplicity, in this work the nomenclature of E. coli NDH-1 and of Bos taurus NADH-
ubiquinone oxidoreductase are used for bacterial and mitochondrial complex I, respectively. 
Table 1.1 compares nomenclatures of homologous subunits between bacterial and 
mitochondrial enzymes. A comparison between nomenclatures and subunit composition of 
complex I from different organisms is shown in appendix 9.1. 
The bacterial enzyme from E. coli and the eucaryotic enzyme from the filamentous fungus 
Neurospora crassa, the mammal B. taurus and from the yeast Yarrowia lipolytica were 
investigated by electronic microscopy. They showed an L-form, which consists of two 
domains: a peripheral “arm” (hydrophilic domain) and a membrane “arm” (hydrophobic 
domain) (Djafarzadeh et al., 2000). 
Treatment with the non-denaturing detergent N,N-dimethyl-dodecylamine N-oxide allowed 
the dissociation of the bovine enzyme into two subcomplexes called Iα and Iβ (Finel et al., 
1992). Characterization of these subcomplexes revealed that Iα consists of mostly hydrophilic 
subunits and contains all the known redox centres and has NADH:ferricyanide oxidoreductase 
activity. Most likely this fragment constitutes the peripheral and part of the membrane arm 
(Walker et al., 1995). The peripheral arm, which is the hydrophilic part of the protein and 
protrudes into the matrix, is constituted of seven subunits (NUOB, C-D, E, F, G, I) in 
bacteria. The same domain in eucaryotes contains the 7 nuclear coded subunits 20 kDa (or 
TYKY), 23 kDa (or PSST), 24 kDa, 30 kDa, 49 kDa, 51 kDa, and 75 kDa that are 
homologous to the bacterial ones. The Iβ fragment contains hydrophobic subunits, does not 
have prosthetic groups and did not show NADH:ferricyanide oxidoreductase activity 
(Sazanov et al., 2000). This domain constitutes the membrane arm and is embedded in the 
lipid bilayer of the membrane by virtue of its hydrophobicity: NUOA, NUOK, NUOL, NUOJ, 
NUOH, NUOM, NUON are the seven subunits which form this domain in E. coli. ND1-6 and 
ND4L, encoded by the mitochondrial genome, are their homologous in eukaryotes. 
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Little is known about the function of the remaining subunits in the eucaryotic complex I: in 
this work only the core subunits are considered. 
 
 
Mitochondrial Complex I 
(B. taurus) 
Bacterial Complex I 
(E. coli) 
Subunit Location 
(L-shaped form) 
Name of the Subunit  Gene Localization  Name of the Subunit Domain 
NUAM or 75 kDa  Nucleus  Nuo B  Peripheral domain 
NUBM or 51 kDa  Nucleus   Nuo C
* Peripheral domain 
NUCM or 49 kDa  Nucleus   Nuo D
* Peripheral domain 
NUGM or 30 kDa  Nucleus  Nuo E  Peripheral domain 
NUHM or 24 kDa  Nucleus  Nuo F  Peripheral domain 
NUIM or TYKY  Nucleus  Nuo G  Peripheral domain 
NUKM or PSST  Nucleus  Nuo I  Peripheral domain 
ND1  Mitochondria  Nuo H  Membrane domain
ND2  Mitochondria  Nuo N  Membrane domain
ND3  Mitochondria  Nuo A  Membrane domain
ND4  Mitochondria  Nuo M  Membrane domain
ND4L  Mitochondria  Nuo K  Membrane domain
ND5  Mitochondria  Nuo L  Membrane domain
ND6  Mitochondria  Nuo J  Membrane domain
 
 
Table 1.1      B. taurus (bovine) and E. coli nomenclatures of the 14 core subunits of complex I 
*In E. coli, Nuo C and D are fused 
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1.2.3 Complex I Redox Groups 
 
Complex I contains one non-covalently bound flavin mononucleotide (FMN) and many iron-
sulfur clusters as redox active groups. They transport electrons from NADH to ubiquinone. 
FMN oxidises NADH by uptake of two electrons and acts as a converter between the two-
electron donor NADH and the one-electron acceptors, the iron-sulfur clusters. There are bi- 
and tetra–nuclear clusters in complex I. Binuclear clusters are composed of two iron ions, 
which are bridged by two inorganic sulfides and ligated to four cysteinyl sulfurs that belong 
to the polypeptide chain of the protein. Tetranuclear clusters contain four iron and four 
inorganic sulfur ions arranged in a distorted cube structure in which the iron ions are bound to 
the polypeptide chain via four cysteine sulfur ligands (Ohnishi, 1998). The number of iron-
sulfur clusters in complex I is still unclear and depends on the origin of the enzyme under 
study (Meinhardt et al., 1990). In bovine complex I (the best characterised mammalian 
enzyme) six iron-sulfur clusters were identified by EPR spectroscopy: N1a, N1b, N2, N3, N4 
and N5 (Walker, 1992). Cluster N1a and N1b are binuclear and N2, N3, N4 and N5 are 
tetranuclear. Controversial and still discussed is the subunit location of the redox centers 
(Ohnishi, 1998). The latest commonly accepted hypotheses about type and location of the 
EPR detectable redox centers has been summarised in Fig. 1.1. The first event is the oxidation 
of NADH by FMN. Successively, electrons are transported through the clusters N1a, N1b, N3, 
N4 and N5. The exact order of electron transport trough the iron-sulfur clusters is still 
unknown. Cluster N2, having a pH dependent redox midpoint potential, is most likely the last 
step to ubiquinone. 
 
NADH
2e-
FMN
[4Fe-4S]
N2 (PSST
or TYKY)
UQ
(51 KDa)
[2Fe-2S]
N1a (24 KDa)
N1b (75 KDa)
N4 (75 KDa)
N5 (75 KDa)
N3 (51 KDa)
[4Fe-4S]
1e- 1e- 2e-
 
 
Figure 1.1    -Electron transport in complex I- 
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For simplicity, the bovine nomenclature has been used. Ubiquinone (UQ) is the final 
electron acceptor. 
 
 
 
Cluster N2 
Cluster N2 is supposed to be the immediate electron donor to ubiquinone by virtue of its 
highest and pH dependent redox midpoint potential (Em,7 –150 mV), which distinguishes it 
from the other clusters. Ohnishi and coworkers showed an EPR detectable magnetic 
interaction between cluster N2 and semiquinone radicals and predicted their distance to be 8-
11 Å, suggesting cluster N2 as immediate electron donor to ubiquinone (Ohnishi et al., 1999). 
Since in bovine complex I the redox midpoint potential of N2 was found to be dependent on 
the pH value (Ingledew and Ohnishi, 1980), cluster N2 has been considered to be involved in 
the proton translocation mechanism (Brandt and Trumpower, 1994). 
The exact location of the tetra-nuclear cluster N2 is still a matter of debate. The TYKY 
subunit contains two canonical binding motifs for tetranuclear clusters (CxxCxxCxxxCP –
(x)27 – CxxCxxCxxxCP) that contain eight cysteins as possible ligands. The PSST subunit 
contains one non canonical motif CC(x)63 - C(x)28 - GCPP in which two cysteins are 
contiguous in the amino acids sequence. For steric reasons it seems unlikely that both of them 
ligate cluster N2, posing the question about the fourth ligand. Site directed mutagenesis in the 
PSST homologous subunits from E. coli (Friedrich, 1998), N. crassa (Dupuis et al., 1998), 
and Yarrowia lipolytica (see 1.3.4) did not solve this question unequivocally. 
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1.2.4 Functional Modules of Complex I 
 
As previously described, 14 genes constitute the “minimal form” of a proton-pumping 
respiratory NADH:ubiquinone oxidoreductase in bacteria. This “minimal form” can be 
functionally sub-divided into three modules (Friedrich and Scheide, 2000): 
1.  An electron transfer module, formed by the 24, 51 and 75 kDa subunits that oxidizes 
NADH via FMN. 
2.  A proton translocation module, constituted by ND4/5 and ND2 subunits. 
3.  A ubiquinone reduction module, formed by the 49 kDa, PSST and TYKY subunits.  
Complex I evolved from the above described pre-existing modules:  
1.  The ability to transfer electrons by FMN and Fe-S clusters has been found in many 
bacterial hydrogenases: they oxidize hydrogen, reduce NAD
+ and contain non-
covalently bound FMN and several Fe-S clusters. These hydrogenases show 
homology to parts of the 24, 51 and 75 kDa subunits from complex I (Friedrich and 
Weiss, 1997). 
2.  The ability to pump protons seems to be related to a module present in bacterial K
+ / 
H
+ or Na
+ / H
+ antiporters (Pinner et al., 1992). Genes coding for this module show 
homology to ND4 and ND5 in complex I, (Friedrich and Weiss, 1997; Mathiesen and 
Hägerhäll, 2002). 
3.  A common evolutionary origin of complex I and [Ni-Fe] hydrogenases was suggested 
(Friedrich and Scheide, 2000; Böhm et al., 1990). Assuming a similar mechanism for 
the electron transport in the two enzyme classes, knowledge about hydrogenases could 
be a help for understanding the ubiquinone reduction module of complex I (see 
below). 
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1.2.5 [Ni-Fe] Hydrogenases: a Model for the Ubiquinone Reduction Module in Complex 
I 
 
Hydrogenases catalyse either cleavage or production of molecular hydrogen, following the 
reaction: H2   2H
+ + 2e
-. For ours purposes we distinguish between water-soluble and 
membrane-bound hydrogenases. 
The water soluble [Ni-Fe] hydrogenases from Desulfovibrio gigas (Volbeda et al., 1995) and 
Desulfovibrio fructosovorans (Montet et al., 1997) are composed of a large subunit which 
contains the [Ni-Fe] cluster coordinated by four cysteines and a small subunit which contains 
three iron-sulfur clusters, one [3Fe-4S] and two [4Fe-4S] in a linear arrangement. Sequence 
comparison suggests that the large subunit corresponds to the 49 kDa and that the small one 
corresponds to the PSST subunit of mitochondrial complex I (Fig. 1.2A-C). According to this 
theory, the proximal tetranuclear cluster in the small subunit corresponds to cluster N2 in 
complex I (Kashani-Poor et al., 2001b). Three of the four cystein ligands of the proximal 
cluster, which form a conserved motif CxxCnnGxCxxxGxmCPP, have corresponding 
cysteines in the PSST subunit, but the first cysteine of this motif is missing in complex I (see 
1.2.3). The proximal cluster is close to the interface between small and large subunit (Fig. 
1.2A). The [Ni-Fe] cluster is the active site, in which hydrogen production takes place, and 
donates electrons to the proximal cluster. Four cysteines are ligands for the [Ni-Fe] cluster: 
C72, C75, C543 and C546 (D. fructosovorans). These positions are not conserved in complex 
I and the [Ni-Fe] cluster is missing. It has been proposed that the catalytic centre of complex I 
evolved from the hydrogenases catalytic centre and that the [Ni-Fe] site became the 
ubiquinone-binding site (Kashani-Poor et al., 2001b). With respect to this model, it is 
predicted that the fold around cluster N2 is partially conserved, that the PSST and the 49 kDa 
subunits in complex I are close to each other like the small and large subunits in 
hydrogenases, and that cluster N2 is located near the interface between these two subunits 
(Kerscher et al., 2001b). Figure 1.2C represents schematically complex I subunits that are 
homologous to subunits in [Ni-Fe] hydrogenases from D. fructosovorans and M. barkeri. 
Interestingly, a random mutagenesis study in the 49 kDa homologous subunit in complex I 
from Rhodobacter capsulatus revealed that exchange of valine 407 into methionine causes 
resistance against quinone-analogous complex I inhibitors (Darrouzet et al., 1998). This 
residue corresponds to the [Ni-Fe] cluster ligand C543 in D. fructosovorans, indicating that 
inhibitor resistance is caused by a mutation in the region of the 49 kDa subunit that originated 
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from the [Ni-Fe] site of hydrogenases. These observations are in line with the results of a site 
directed mutagenesis study in Y. lipolytica. Aspartate 458, corresponding to position D541 in 
the large subunit from D. fructosovorans (located about 8 Å away from the [Ni-Fe] site and 
only two residues upstream from the ligand C453) was changed into alanine. Strain D458A 
showed I50 values for quinone-analogous inhibitors up to 30 times higher than the parental 
one. In addition, site directed mutagenesis of each residue that corresponds to the cysteine 
ligands of the hydrogenase [Ni-Fe] cluster has been carried out in Y. lipolytica. These 
mutations had dramatic effects on complex I NADH:ubiquinone oxidoreductase activity. 
Overall, there is substantial evidence that the fold around the [Ni-Fe] site in hydrogenases has 
been conserved and evolved into part of the quinone binding region of complex I (Kashani-
Poor et al., 2001b). 
The membrane-bound [Ni-Fe] hydrogenase from Methanosarcina barkeri consists of five 
subunits: EchA, EchB, EchC, EchE and EchF. The [Ni-Fe] cluster is located in EchE, which 
is homologous to the 49 kDa subunit, EchC corresponds to PSST and EchF corresponds to 
TYKY (Fig. 1.2B-C). Two four-cysteine motifs for the binding of two [4Fe-4S] clusters were 
identified in the amino acid sequence of the EchF subunit and one four-cysteines motif in the 
EchC subunit, as illustrated in figure 1.2B. EPR analysis indicated the presence of a 
tetranuclear cluster in the EchC subunit, which by virtue of its magnetic interaction with the 
[Ni-Fe] site is supposed to be close to the interface between the two subunits. Both other 
clusters were consequently assigned to EchF (Kurkin et al., 2002). In membrane-bound [Ni-
Fe] hydrogenases, the homologue of the small subunit of water-soluble enzymes has suffered 
a C-terminal deletion, removing the binding motifs of two iron-sulfur clusters. Apparently, 
these have been replaced by a novel, ferrodoxin-like subunit in membrane bound 
hydrogenases. Both EchA and EchB are supposed to be involved in the transfer of proton 
across the membrane, similarly to ND2/5/4 and ND1 in complex I. 
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ND2
ND4
ND5
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Figure 1.2    -Homology between [Ni-Fe] hydrogenases and complex I- 
A. X-ray representation of the [Ni-Fe] hydrogenase from Desulfovibrio fructosovorans; 
B. [Ni-Fe] hydrogenase from Methanosarcina barkeri; C. Schematic representation of 
NADH:ubiquinone oxidoreductase (Complex I). Subunits that are homologous between 
the three classes of enzymes are indicated by the same colour. The direction of the 
proton transport is indicated by arrows.  
 
 
1.3 Yarrowia lipolytica 
 
1.3.1 Yarrowia lipolytica as a Model Organism for Studying Complex I 
 
Y. lipolytica is a strictly aerobic yeast which grows on different carbon sources like alkanes, 
fatty acids, ethanol and acetate (Barth and Gaillardin, 1996). Its growth-temperature optimum 
is at 28°C and its biomass yield is up to 100 g/l (wet weight). 
Y. lipolytica offers the advantage of an eucaryotic organism containing complex I, which is 
amenable to straightforward genetic manipulation (Kerscher et al., 2001b). This organism has 
a simple haplo/diplontic life cycle, two naturally stable mating types (Mat A and B), a high 
frequency of homologous recombination and a relatively small genome for which a draft 
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sequence has been completed (Casaregola et al., 2000). These features have allowed the 
cloning, sequencing, and generation of point mutations in the seven nuclear genes NUAM, 
NUBM, NUCM, NUGM, NUHM, NUIM, NUKM (corresponding to the 75, 51, 49, 30, 24 kDa, 
TYKY and PSST subunits from bovine complex I, respectively) that encode the seven highly 
conserved subunits of complex I of the peripheral arm (Djafarzadeh et al., 2000). 
As an obligate aerobic organism, Y. lipolytica expresses complex I even when mutations 
compromise its enzyme activity, allowing study of defective complex I. 
 
1.3.2 The Respiratory Chain of Yarrowia lipolytica 
 
The respiratory chain of Y. lipolytica contains all complexes that make up the respiratory 
chain in mammals. In addition, the yeast Y. lipolytica has one NADH:ubiquinone 
oxidoreductase (NDH2 or alternative dehydrogenase) that is also able to oxidise NADH and 
transfer electrons to ubiquinone, but without translocating protons.  
 
NDH2 
NDH2, being located at the external side of the inner mitochondrial membrane, cannot 
contribute to the oxidation of NADH in the mitochondrial matrix. This enzyme, whose 
physiological function is unclear, consists of a single water soluble subunit that carries a non-
covalently bound flavin dinucleotide (FAD) as unique prosthetic group (de Vries and Marres, 
1987). The gene for the alternative NADH dehydrogenase of Y. lipolytica was identified 
(Kerscher et al., 1999) and fused with the sequence which is responsible for the import of the 
75 kDa subunit of complex I into the mitochondrial matrix. This fusion allows the redirection 
of NDH2 to the internal face of the mitochondrial inner membrane (NDH2i) (Kerscher et al., 
2001a). NDH2i, by virtue of its ability to transfer electrons from NADH in the mitochondrial 
matrix to the ubiquinone pool of the respiratory chain, rescues complex I deficiency making 
complex I dispensable for cell survival. In fact, complex I defects causing loss of catalytic 
activity higher than ~70% are not compatible with survival of Y. lipolytica without NDH2i 
(Ahlers, data not published). NDH2i allows the study of complex I defects even if complex I 
activity is strongly compromised or completely absent, as in the case of complex I assembly 
defects. Taking advantage of NDH2i, each of the genes for the seven highly conserved and 
nuclear coded subunits of complex I was deleted from the Y. lipolytica genome, allowing a 
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simple, direct mutagenesis of every single subunit via complementation on a replicative 
plasmid (Kerscher et al., 2001b). The introduction of NDH2i represented a key contribution to 
the development of Y. lipolytica as a genetic system for studying complex I. 
 
1.3.3 Complex I from Yarrowia lipolytica 
 
In terms of function, structure, number and type of redox centres, the features of complex I 
from  Y. lipolytica are very similar to the features of the traditionally well characterised 
complexes I from E. coli, N. crassa and bovine heart mitochondria (Djafarzadeh et al., 2000). 
In addition, complex I from Y. lipolytica is very stable and purification can be achieved by 
affinity chromatography (for more details see 2.3.10). Attaching a six histidine tag to the C-
terminus of the 30 kDa subunit allowed a His-tag affinity purification (Kashani-Poor et al., 
2001a). This method produces enzyme with a purity of around 95% and a yield of 38% for the 
parental strain. Two-dimensional electron microscopic analysis of single particles showed that 
complex I from Y. lipolytica has an L-shaped structure with a membrane and a peripheral 
domain perpendicular to each other, similar to the enzymes from E. coli and N. crassa 
(Djafarzadeh et al., 2000).  
 
1.3.4 Mutants in the NUKM Subunit of Complex I from Yarrowia lipolytica 
 
Site directed mutagenesis of the PSST homologous subunit (NUKM) in complex I from Y. 
lipolytica had been carried out in this laboratory previously, in an effort to investigate the role 
of this key subunit and the position of cluster N2 (Ahlers et al., 2000b). 
It had been speculated that the conserved glutamic acid in position 89 in the NUKM subunit 
of Y. lipolytica might act as fourth ligand for cluster N2 (Ohnishi, 1993). In fact, this position 
is in proximity to cysteines 85-86 that belong to the non canonical binding motif (see 1.2.3). 
Glutamic acid 89 was mutagenised into glutamine, cysteine and alanine. EPR spectra from 
isolated complex I of mutants had excluded the hypothesis that this glutamate could act as 
ligand for cluster N2. On the other hand, the slight shift to lower values of the N2 EPR 
specific gz signal observed in all three mutant complexes strongly suggested that position 89 
is located in the proximity of N2 cluster (Ahlers et al., 2000b). 
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Other conserved acidic residues had been mutagenised in the NUKM subunit from Y. 
lipolytica: D136, E140 and D168 (Ahlers et al., 2000b). When positions D136 and E140 were 
changed into their corresponding amides, ubiquinone reductase activity of complex I was 
found to be moderately decreased and hypersensitivity to rotenone and slight resistance to 
DQA were observed. These data strongly suggested that the conserved acidic residues in the 
NUKM subunit play a role in complex I catalytic activity. Differently, mutant D168N showed 
essentially the same properties as the parental strain. Data from EPR spectra revealed that 
none of these mutagenised amino acids could be identified as the fourth ligand for N2 cluster, 
leaving this question open. 
 
1.4 Complex I in Disease 
 
In general, dysfunction of complex I can cause three different kinds of problems: 
1.  Reduced ability to oxidise NADH, which results in lactic acidosis; 
2.  Reduced ability to pump protons, which decreases the rate of ATP synthesis; 
3.  Enhanced production of superoxide radicals, which could cause DNA mutations, lipid 
peroxidation and protein denaturation (Kitajima-Ihara and Yagi, 1998). 
Actually, the reduced proton pumping capacity as such does not appear to be a serious health 
issue: complex III and IV could rescue this complex I defect (Seo et al., 1998). In contrast, the 
inability of mitochondria to oxidize NADH and damages provoked by superoxide radical 
production cause severe health problems. It has been hypothesized that oxygen radical 
production is increased when complex I activity is compromised (Robinson, 1998). Different 
studies suggest a direct correlation between myopathies (Bentlage et al., 1995), familial 
cardiomyopathy (Pitkanen et al., 1996), neurodegenerative disorders (Schapira, 1998), 
Parkinson´s disease (Hartley et al., 1994), and complex I defects. 
Due to the above described dual coding system of complex I, human diseases connected with 
complex I defects can be caused by mutations in the mitochondrial or in the nuclear DNA. 
While the role of mutations in mtDNA has been recognised as a major contributor to complex 
I deficiency (Wallace, 1999), recent findings have shown that mutations in nuclear encoded 
subunits of complex I can also result in diverse pathologies. Among these, a severe 
progressive neurodegenerative disorder called “Leigh syndrome”, is the most common 
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clinical manifestation. Mutations in two nuclear coded complex I subunits that result in Leigh 
syndrome are described below.  
 
Leigh Syndrome 
Recently, three missense mutations in two nuclear coded subunits of mitochondrial complex I 
have been identified as the causative genetic defects in two cases of neuropathologically 
proven Leigh syndrome (MIM 25600), that resulted in death in early infancy. Homozygosity 
for a V122M substitution in the human NDUFS7 (PSST homologous) subunit has been found 
in two siblings (Triepels et al., 1999); and heterozygosity for mutations P79L and R102H in 
the human NDUFS8 (TYKY homologous) subunit has been found in another patient (Loeffen 
et al., 1998). 
NADH:ubiquinone oxidoreductase activity was low in all tissues examined, suggesting that a 
reduction in the electron transfer activity of complex I could be one cause of the Leigh 
syndrome. 
 
1.5 Complex I as a Target for Insecticides and Acaricides 
 
Complex I is also a target for certain insecticides and acaricides: same of them have been 
shown to inhibit its catalytic activity (Hollingworth and Ahammadsahib, 1995; Hollingworth 
et al., 1994). The natural compound piericidin A was isolated from cultures of Streptomyces 
mobaraensis (S.Yoshida, 1978) and rotenone is the active component in the insecticidal and 
fish-poisonous extract of Derris (Leguminosae) roots. Both compounds are known as high 
affinity inhibitors for complex I. Synthetic insecticides and acaricides that inhibit complex I 
can be grouped in two main classes: pyrazoles and substituted pyrimidines in the first class, 
pyridines and quinazolines in the second class (Lümmen, 1998). Both classes of compounds 
are of commercial interest. 
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1.6 Aims 
 
1.6.1 Site Directed Mutagenesis of NUIM (TYKY) and NUKM (PSST) Subunits from 
Yarrowia lipolytica 
 
In an effort to investigate the “ubiquinone reduction module” of complex I, in the first part of 
this work site directed mutagenesis of the NUIM (TYKY) and NUKM (PSST) subunits has 
been carried out. 
 
Mutagenesis of Conserved Cysteine Residues 
The bovine TYKY and PSST subunits have been discussed as candidates for carrying cluster 
N2 by virtue of their three conserved binding motifs for tetra-nuclear iron sulfur clusters (see 
1.2.3). 
The first goal of this work was to carry out a systematic mutagenesis of all cysteines that 
belong to these motifs in the NUIM (TYKY) and NUKM (PSST) subunits of Y. lipolytica.  
 
Mutagenesis of Conserved Acidic Residues in the PSST Subunit 
The two adjacent cysteines in the binding motif of the PSST subunit had posed the question 
about the existence of a non-cysteine fourth ligand in this subunit (Ahlers et al., 2000b). In 
addition, some mutations affecting conserved acidic residues had been found to result in 
inhibitor resistance and to affect catalytic activity of complex I (see 1.3.4). These results 
corroborated the hypothesis that this subunit plays a role in complex I catalytic activity. In an 
effort to investigate the position of the fourth ligand and the involvement of the PSST subunit 
in complex I catalytic activity, the second goal of this work was to carry out site directed 
mutagenesis of each conserved acidic amino acid in the NUKM (PSST) subunit of Y. 
lipolytica. 
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In Vitro Characterization of Leigh Mutations 
In the nuclear coded subunits of mitochondrial complex I homologous to TYKY and PSST, 
three missense mutations had been identified as causative genetic defects of Leigh syndrome 
(see 1.4). The three point mutations were reconstituted in Y. lipolytica. The third goal of the 
present work was the characterisation of these mutants with intent to provide a first clue 
towards a molecular understanding of the aetiology of this syndrome. 
 
Characterization of Mutant Strains 
Mutant strains were characterised in terms of: 
1.  Complex I content; 
2.  Catalytic activity and inhibitors resistance; 
3.  EPR signature of cluster N2. 
 
1.  Complex I content 
NADH:HAR activity was used to estimate complex I content in mitochondrial 
membrane preparations. This activity is based on the ability of complex I to oxidize 
NADH in the presence of the electron acceptor HAR (hexammineruthenium-III). 
Being dependent only on FMN in the 51 kDa subunit, but independent of the 
ubiquinone oxidoreductase activity or of proton pumping, the NADH:HAR activity 
essentially reflects the amount of complex I in the membrane preparation. By virtue of 
these peculiarities, NADH:HAR ubiquinone oxidoreductase activity can be used to 
quantify and compare complex I contents of different membrane preparations from 
parental or mutant strains, even if the NADH:ubiquinone oxidoreductase activity of 
complex I is compromised by mutations. 
 
2.  Catalytic activity and inhibitors resistance 
The physiological activity of complex I (NADH:ubiquinone oxidoreduction) is 
measured in vitro as deamino-NADH:n-decyl-ubiquinone oxidase activity 
(dNADH:DBQ). The substrate deamino-NADH, in contrast to NADH, offers the 
advantage to react specifically with complex I and not with the alternative 
NADH:ubiquinone oxidoreductase. Decyl-ubiquinone is an artificial hydrophobic 
substrate that resembles the physiological Ubiquinone (Q9) of Y. lipolytica inner 
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mitochondrial membranes. Thus, dNADH:DBQ activity mimics the physiological 
NADH:ubiquinone oxidoreductase activity of complex I. Furthermore, investigating 
the effect of mutations on complex I sensitivity for quinone-analogous inhibitors, I50 
for rotenone and DQA have been measured. 
 
3.  EPR signature of cluster N2 
Most of the iron-sulfur clusters of complex I are detectable by Electron Paramagnetic 
Resonance spectroscopy (EPR, see appendix 9.2). The EPR signal of an iron-sulfur 
cluster depends on the geometry and on the microenvironment of the cluster. A point 
mutation can directly (in the case of a ligand) or indirectly influence this 
microenvironment. In an effort to investigate the position of cluster N2, EPR 
spectroscopy is a powerful method for analysing the effects of point mutations. 
 
 
1.6.2 Making a Substrate Inducible NDH2i 
 
The second part of this work was aimed at developing a substrate inducible version of the 
internal alternative NADH:ubiquinone oxidoreductase (NDH2i, see 1.3.2). The substrate 
inducible NDH2i is supposed to offer a mechanism for “switching” between complex I 
activity dependent (no NDH2i activity) and independent (NDH2i activity) cell growth, by 
changing between activating and non-activating substrates. This strategy would allow 
screening for mutants with and without complex I catalytic activity. Complex I deficient 
mutants could be easily identified, since Y. lipolytica mutant strains with residual complex I 
catalytic activity lower than ~ 30% are not able to survive under complex I dependent growth 
conditions (no NDH2i activity). Amino acids, which have an important role for complex I 
structure or function, could then be identified by sequence analysis. Mutant strains that 
survive under complex I dependent growth conditions could be tested for resistance to 
complex I specific inhibitors. This screening system is a prerequisite for realising a random 
PCR mutagenesis of single subunits of complex I. Random PCR mutagenesis is a technique 
that allows the production of a high number of point mutations in relatively short time. By 
contrast, the generation and analysis of a large number of site-directed mutants would be a 
very time consuming task. In an effort to study structure and function of complex I, this part 
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of the present work was directed towards developing an efficient screening system for 
selecting mutations which affect activity or inhibitor resistance of complex I. 
The promoter for the isocitrate lyase (pICL1) was used for realising a substrate inducible 
version of the NDH2i. The ICL1 gene (X72848) encodes the enzyme isocitrate lyase, which is 
one of the key enzymes of the glyoxylate pathway (Vanni et al., 1990). Yeast growth on 
acetate or ethanol as a sole carbon source requires this pathway as anaplerotic cycle for 
producing C4 compounds that are needed for the tricarboxylic acid cycle, and builds blocks 
for a large number of biosynthetic pathways. The isocitrate lyase gene is induced in the 
presence of n-alkanes, fatty acids, ethanol or acetate as carbon sources but not by glucose. 
Northern blot analysis of Saccharomyces cerevisiae cells that were grown on different carbon 
sources (ethanol and glucose) confirmed substrate dependent regulation of the isocitrate lyase 
mRNA (Fernandez E, 1993). Studies carried out with lacZ as reporter gene indicated that the 
ICL1 promoter of Y. lipolytica is up regulated by transferring cells from glucose to acetate 
media (Juretzek et al., 2001). 
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2  Materials and Methods  
 
2.1 Materials 
 
2.1.1 List of Chemicals  
 
Ethanol (J.T. Baker, Deventer-Nederland); bovine serum albumin (BSA) (Biolabs, New 
England); n-Dodecyl-β-D-maltoside (Biomol Feinchemikalien GmbH, Hamburg-Germany); 
DEAE Bio-Gel A Agarose (Biorad Laboratories GmbH, München-Germany); Chelating 
Sepharose (Pharmacia Biotech AB, Uppsala-Sweden); Agar; bacto
TM yeast extract, Trypton, 
selected peptone 140 (Gibco BRL Life Technologies, Paisley-United Kingdom); YNB (Difco 
Laboratories, Sparks, MD, USA); boric acid phenol developer, fixer and fixing buffer for X-
ray films and X-ray films X-OMAT AR (BioMax  MR (Kodak) Rochester-New York); 
acetone, ammonium peroxosulfate, chloroform acetic acid, Folin-Ciocalteus-Phenol reagent, 
isoamyl alcohol, isopropanol, MgSO4, HCl, trichlorine, acetic acid (Merck, Darmstadt-
Germany); ammonium sulfate, EDTA, glass pearls (0.25 – 0.5 mm), KCl, KOH, KH2PO4, 
sodium acetate, sodium citrate, NaCl, NaOH, NiSO4, NaH2PO4, saccharose, X-Gal (Carl Roth 
GmbH & Co, Karlsruhe-Germany); ATP, nucleotides, Ni-NTA Fast Flow Sepharose 
(Pharmacia); acrylamide, bisacrylamide, Coomassie-Blue G-250, urea, polyethylene glycol 
(PEG) 4000, dodecylsulfate N-salt (SDS), trichine, agarose, amino caproic acid, amino acids, 
ampicilline, DMSO, ethidium bromide, glucose, glycerine (Pharmacia); 
hexaminruthenuim(III) chloride (HAR), hepes, KCN, lithium acetate, mercapto ethanol, 
mops, d-NADH, NADH, NaN3, nystatine, PMSF, TEMED, tris, asolectin, oligonucleotides 
(Sigma Chemie GmbH, Deisenhofen-Germany), oligonucleotides (ARK Scientific GmbH 
Biosystems, Darmstadt-Germany) or MWG-Biotech Ebersberg-Germany). 
 
2.1.2 Inhibitors  
 
2-decyl-4-quinazolinyl amine (DQA) was a generous gift from Aventis CropScience, 
Frankfurt am Main -Germany; rotenone (Sigma Chemie GmbH, Deisenhofen -Germany). 
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2.1.3 Media and Buffers 
 
Media for Escherichia coli: 
LB-Medium: 1% NaCl, 0.5% yeast extract, 1% tryptone, pH 7.5 
 
Media for Yarrowia lipolytica: 
Sporulation-medium (CSM): 0.17% yeast nitrogen base without (NH4)2SO4 and amino 
acids, 0.5% (NH4)2SO4, 50 mM natrium citrate 
YM-medium: 0.5% Bacto™Peptone, 0.3% yeast extract, 0.3% malt extract 
YPD-medium: 2% Bacto™Peptone, 1% yeast extract, 2% glucose 
YPAc-medium: 2% Bacto™Peptone, 1% yeast extract, 0.4% acetate 
 
Glycerol stocks: YPD-medium + 40% glycerine 
Minimal synthetic medium (10 × S): 1.7% yeast nitrogen base without (NH4)2SO4 and 
amino acids plus 5% (NH4)2SO4, pH 5.0, were prepared as a 10 time stock solution (10 X 
S) and sterilefiltered. Carbon sources (0.4% acetate or 2% glucose solutions) were 
autoclaved and added to the 10  ×  S medium. Depending on the type of auxotrophie 
selection, one or several of the following components were added: 130 µM histidin, 200 
µM lysine, 460 µM leucin 180 µM uracil. 
 
Buffers and solutions:  
10 × TAE-buffer: 400 mM Tris / acetate, 10 mM EDTA, pH 8.3 
10 × TBE-buffer: 890 mM Tris / borate, 890 mM boric acid, 20 mM EDTA, pH 8.3 
20 × SSC-buffer: 3 M NaCl, 0.3 M sodium citrate, pH 7.0 
TE: 10 mM Tris / HCl, 1 mM EDTA, pH 8.0 
One step buffer (freshly prepared) 45% PEG4000, 0.1 M lithium acetate (pH 6.0), 100 
mM dithiothreitol, and 250 µg/ml salmon sperm DNA as carrier. 
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2.1.4 Strains 
 
Table 2.1  -Escherichia coli Strains- 
   
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.2  -Yarrowia lipolytica strains- 
*Kerscher et al., 2002 
 
 
Strain Genotype 
E129  MatA, lys11-23, ura3-302, leu2-270, xpr2-322 
E150  MatB, his-1, ura3-302, leu2-270, xpr2-322 
GB9  MatA, lys-1, ura3-302, leu2-270, xpr2-322, 
nugm::LEU2, NDH2i,30Htg2 in pUB4 
PIPO*  30 Htg pop-in-pop-out MatA, lys-1, ura3-302, leu2-270 
Strain Genotype 
DH5α supE44 ∆lacU169(φ80 lacI
qZ∆M15) hsdR17 recA1 endA1 
gyrA96 thi-1 relA1 
XL10-
Gold 
Tetr D(mcrA)183 D(mcrCB-hsdSMR-mrr)173 endA1 supE44 
thi-1 recA1 gyrA96 relA1 lac Hte [F’ proAB lacIqZDM15 Tn10 
(Tetr) Amy Camr]a 
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2.1.5 Plasmids 
 
Table 2.3    -E .coli and Y. lipolytica plasmids- 
 
Name Properties  Producer 
pCR2.1  see description of the product  Invitrogen Groningen 
(Netherlands) 
pBluescript 
SK
-
see description of the product  Stratagene (Heidelberg) 
pINA443  Yarrowia lipolytica Shuttle“ Vector, 
2,3 kb fragment, LEU 2 gene 
Prof. Gaillardin, Paris (France) 
P67JP  ICL1 promoter  Prof. Barth, Dresden (Germany) 
pUB4  Yarrowia lipolytica “shuttle”-vector 
containing 1.6 kb fragment with Hyg 
B
R gene 
Dr. Stefan Kerscher, 
Frankfurt/Main, Germany 
pUB26  modified pUB4 in ARS68 base 
changed (T737A) 
Dr. Stefan Kerscher, 
Frankfurt/Main, Germany 
 
 
2.1.6 Instruments 
 
Centrifugues: 
Heraeus Biofuge A 
Heraeus Labofuge 400 
Heraeus Minifuge GL 
Cryofuge 8500 Sorvall Heraeus (Osterode) -Germany 
J2-21, Beckman Instruments GmbH (München) -Germany 
Ultracentrifugues L7-65 und L8-70M, Beckman Instruments GmbH (München) -Germany. 
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Rotors: 
JA-10, JA-20, JS13.1 Beckman Instruments GmbH (München) -Germany 
Ti 45, Ti 70.1, Beckman Instruments GmbH (München) -Germany 
 
Fluorimeter:  
Hoefer
® DyNA Quant
® 200, Pharmacia Biotech 
 
Photometers: 
UV 300, Shimadzu (Düsseldorf) -Germany 
U-3210, Hitachi (Düsseldorf)–Germany 
Microplate spectrophotometer SPECTRA MAX
384 plus, Molecular Devices (Sunnyvale)-
CA-USA 
 
Thermocyclers: 
DNA Thermal Cycler 480, Perkin Elmer (Weiterstadt) –Germany 
GeneAmp
® PCR System 2400, Perkin Elmer (Weiterstadt) –Germany 
Cyclone gradient, Biotechnologir Gmbh-England 
Elektrotransformation Device: 
E. coli Pulser Bio-Rad (Hercules USA) 
 
EPR-Spectrometer: 
Bruker ESP 300E spectrometer equipped with a liquid helium continuos flow cryostat, 
ESR 900 from Oxford Instruments-United Kingdom 
EPR-tubes: 
Quarz glass Nr.: 707-SQ-250M (lenght: 250 mm, diameter: 4 mm), Spintec (Remshalden)-
Germany 
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DNA Sequencer: 
ABI PRISM
TM 310 Genetic Analyzer, Perkin-Elmer (Weiterstadt, Germany) 
 
Other instruments: 
 10 l fermenter, Biostat E; Braun (Melsungen)-Germany 
Bead-Beater, Biospec (Bartlesville)-USA 
Cell-disintegrator-C, Bernd Euler (Frankfurt am Main)-Germany 
BioSys 2000 protein-isolation-workstation
®, Beckman Instruments GmbH (München)-
Germany 
camera MP4 land camera, Polaroid 
Hybridisation-oven HB-1D, Techne (Wertheim)-Germany 
Microscope, Leitz (Wetzlar) 
TSKgel G 4000 SW column (21.5 mm × 600 mm), TosoHaas GmbH (Stuttgart)-Germany 
Ultrafree - 20 Centrifugal Filter Unit
® with Biomax
™ - 30 High Flux Polysulfone Mem-
brane, Millipore GmbH (Eschborn)-Germany 
UV-Stratalinker 1800/254 nm, Stratagene (Heidelberg) 
UV-transluminator TF 20M, 312 nm, Herolab 
 
Software: 
DNA-analysis-program: 
Mac Vector 3.5, IBI 
HIBIO DNASIS
™ for Windows
® version 2, Hitachi Software Engineering Co., Ltd. 
Sequence Navigator, Applied Biosystems 
Husar, DKFZ of Heidelberg, Germany 
Enzfitter, Biosoft, Cambrige (UK) 
PROF (Secondary Structure Prediction System), Department of Computer Science, 
Aberystwyth SY23 3DB, Copyright 2000-2003, Wales, UK. 
Swiss Pdb Viewer V3.7b2, Glaxo Wellcome Experimental Research 
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RasWin molecular Grafics, Windows Version 2.7.1, Copyright R. Sayle 1992-1999. 
 
2.2 Protocols of Molecular Biology 
 
2.2.1 DNA Gel Electrophoresis 
 
DNA was separated according to standard procedures (Sambrook et al., 1989) in the presence 
of ethidium bromide (0.5 µg/ml). The agarose concentration was 1.0% in 1×TEA buffer. A 
TEA buffer with extra additive (UV-safe TAE, MWG-Biotech, Ebersberg-Germany) was 
used for extracting DNA fragments from the gel. DNA molecular weight standards: 1 kb 
Ladder, 100 bp Ladder plus (MBI Fermentas, St. Leon-Rot). 
 
2.2.2 Fill-in Reaction of 5`-Overhang 
 
DNA blunt-ends were made with the large fragment of E. coli DNA-polymerase I (Kelenow-
polymerase, New England Biolabs GmbH, Schwalbach/Taunus) as described by (Sambrook 
et al., 1989). 
 
2.2.3 DNA-Vector Dephosphorylation 
 
To avoid self-ligation of empty vectors the DNA ends were dephosphorylated with SAP 
(Shrimp Alkaline Phosphatase, Boeringer Mannheim, Mannheim). 
 
2.2.4 Phosphorylation of PCR-Products 
 
The phosphorylation of both fragment ends of PCR products was made by T4 polynucleotide 
kinase (New England Biolabs) as described by Ausubel (2000). Alternatively, primers were 
phosphorylated before PCR. 
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2.2.5 DNA Extraction from Agarose Gels 
 
DNA extractions from agarose gels were made with the “Easy Pure Kit” (Biozym Diagnostic 
GmbH, Hess. Oldendorf) or with the QIAprep
® Gel Extraction Kit (Qiagen). 
 
2.2.6 Ligation 
 
T4 DNA-ligase and provided buffer (Gibco BRL Life Technologies) were used to ligate DNA 
fragments. Ligation was usually carried out over night at 14°C in 5µl volume. 
 
2.2.7 Preparation of Electro-Competent Escherichia coli Cells 
 
Electro competent E. coli cells were made according the procedure from Current Protocols 
(2000). Transformation efficiency was up to 2 • 10
9 colonies/µg pSK
-. 
 
2.2.8 Transformation into Escherichia coli (Electro Competent Cells) 
 
For the transformation of plasmid (with ampicillin resistance gene) into E. coli electro 
competent cells an E. coli Pulser (Biorad) was used as described in “Current Protocols In 
Molecular Biology (2000)”. Transformants were successively grown over night on LB solid 
medium with ampicillin (50 µg/ml) and clones were replated using the same ampicillin 
concentration. 
 
2.2.9 Isolation of Plasmid-DNA from Escherichia coli 
 
Plasmid-DNA was prepared according to (Zhou et al., 1990) from small amount of cultures 
(1,5-3 ml). Plasmid DNA for sequencing reaction was prepared using the QIAprep
® Spin 
Miniprep Kit (Qiagen). 
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2.2.10 DNA Sequencing 
 
Double-strand DNA was used as template for sequencing. The sequencing reaction was made 
with the “ABI Prism dye terminator cycle sequencing kit” (Perkin Elmer, Weiterstadt-
Germany). Sequencing was performed in an ABI Prism Automated Sequencer type ABI 310. 
 
2.2.11 Polymerase Chain Reaction (PCR) 
 
10 ng of plasmid-DNA or 100 ng of genomic DNA were combined in a total reaction volume 
of 50 µl with 5 µl of each oligonucleotide (6.4 pmol solution, cend = 128 pM) and 5 µl of 
provided 10x reaction buffer. To avoid dimerisation of oligonucleotides as well as non-
specific binding of oligonucleotides to matrix DNA, manual “hot-start” was applied. Used 
polymerases were: Taq DNA polymerase, Taq2000
TM DNA polymerase, Pfu DNA 
polymerase and PfuTurbo
TM DNA polymerase from Stratagene (Heidelberg-Germany) as well 
as Taq DNA polymerase from Sigma Chemie GmbH (Deisenhofen-Germany). 
 
2.2.12 Generation of Point Mutations 
 
The shuttle-vectors pINA443 or pUB4 (carrying the Hyg
R resistance gene) with a 2,3 kb insert 
(EcoRI fragment coding for the NUKM subunit and 2.8 Kb HindIII fragment coding for the 
NUIM subunit) were used as template for site directed mutagenesis. The point mutation was 
introduced by PCR with the “QuikChange
TM site-directed mutagenesis kit” (Stratagene, 
Heidelberg-Germany). Phosphorylated primers were used to amplify the plasmid carrying the 
wild type copy of the gene (isolated from E. coli). The reaction mix was digested by DpnI for 
eliminating template plasmid. Phosphorylated PCR products were ligated and the so obtained 
circular plasmids were transformed into electro-competent cells. The open reading frame 
(ORF) of mutagenised plasmids was sequenced and compared to the wild type ORF to 
confirm the sequence changes. 
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2.2.13 Southern Blot 
 
Digested DNA (genomic DNA: 500 ng; plasmid DNA: 50 ng) was separated using agarose 
gel electrophoresis. The DNA was transferred over night to Hybond N
+-membrane 
(Amersham, Braunschweig-Germany). A Stratalinker (Stratagene, Heidelberg-Germany) was 
used to crosslink DNA to the membrane by UV-light radiation. 
 
2.2.14
 32P DNA Labelling 
 
DNA fragments were labelled with [α-
32P] dCTP (25 µCi for 25 ng DNA) using the “Random 
primer labelling kit – Prime-It
® II Kit” (Stratagene, Heidelberg-Germany). Efficiency check 
of radioactive labelling was done by adding 3 µl of 1:100 diluted reaction mixtures onto two 
filter sheets (Whatman DE 81 ion exchange paper, Whatman International Ltd., Maidstone, 
England) One of the filters was washed two times for 5 minutes with 2 × SSC buffer, and 
subsequently washed for 5 minutes in cold ethanol. To estimate incorporation of the 
radioactive label, count rates of both filters were controlled after drying using a Geiger 
counter. 
 
2.2.15 Hybridisation of Radio Active Labelled DNA Probes 
 
Hybridisation took place in a glass tube in a hybridisation oven (HB-1D, Techne). A pre-
hybridisation was made for 15 minutes at 68°C and the main hybridisation for 60 minutes at 
68°C with “QuikHyb
® hybridisation solution” (Stratagene, Heidelberg-Germany). For the 
main hybridisation, 
32P-labelled DNA fragment was used in the presence of 100 µl 10 mg/ml 
salmon sperm DNA. Subsequently, blots were washed four times (2 × 15 min. with 2 × SSC, 
0.1% SDS; 2 × 15 min. with 0,1 × SSC, 0,1% SDS) to remove non-specifically bound 
radioactive probe. Blots were exposed an Kodak X-Omat AR films with an amplifier-sheet 
over night at –80°C. 
 
 2 MATERIALS AND METHODS     29 
2.2.16 Transformation of Yarrowia lipolytica 
 
Competent cells were made according to the one-step transformation protocol by Chen et al., 
1997 (Chen et al., 1997). One ml of overnight culture in YPD or YPAc was spun down and 
resuspended in 100 µl one step buffer. 200 µg of linear DNA fragment solution (1-5 µl) were 
added for each transformation. The transformation cocktail was thoroughly vortexed and 
incubated at 39°C for 60 minutes. The mixture was spread on a selective plate and incubated 
at 27°C for 48-56 h. 
 
2.2.17 Conjugation, Sporulation and Random Spore Isolation 
 
Strains of opposite mating type were separately inoculated into 10 ml of YPD and grown 
overnight. 0.1 ml of these cultures were transferred into fresh 10 ml YPD and grown for 18-
21 h. Cells were centrifuged (6000 g for 3 minutes) and resuspended in 1 ml YM (about 2-10 
• 10
8 cells/ml). Strains of opposite mating type were then mixed together with 8 ml YM in a 
flask, shaken at 28°C for 16-24 h and plated on selective medium to isolate diploid cells. A 
single colony from the plate was inoculated into 10 ml YPD and grown overnight. Cells were 
centrifuged and resuspended in CSM to a concentration of around 2-5 X 10
7 cells/ml and 
sporulated for 4 days in flasks at 220 rpm and 23°C. After 4 days the culture was stored at 
4°C for 1 day. 5 ml of the culture were centrifuged and cells resuspended in 10 ml YPD and 
shaken for 2 h at 28°C. The pH was adjusted to 4.5-5.0 and 0.25 ml of a 1 mg/ml nystatin 
solution were added. The incubation at 28°C was continued for another 1.5 h. Cells were 
washed twice with water, resuspended in SD and portioned into 6 aliquots. Aliquots were 
incubated with 0.5 ml of a 12.5% ethanol solution and incubated for a series of different times 
(0-120 minutes). After each incubation time, cells were washed and plated on selective 
medium. 
 
2.2.18 Isolation of Total DNA of Yarrowia lipolytica 
 
Total DNA isolation was carried out according to the protocol “Rapid Isolation of Yeast 
Chromosomal DNA” (2000). Plasmid DNA was obtained by transformation of 100 ng of total 
DNA into E. coli “electro competent cells”. 
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2.3 Protocols of Protein Chemistry 
 
2.3.1 Growth of Yarrowia lipolytica 
 
Yarrowia lipolytica strains were grown in YPD media at 220 rpm and 28°C in flasks. A single 
colony of Y. lipolytica from an agarose YPD plate was inoculated into a pre-culture and 
grown in a flask for 12-24 hours (depending on the strain). One ml of the pre-culture was 
inoculated into 500 - 1000 ml (also depending of the strain), shaken for 12-24 h and 
transferred into a 10 l fermenter (Biostat E; Braun, Melsungen). The fermentation lasted for 
12 - 18 hours at 28°C, 400 rpm stirring, and on air stream of 16 l/min. The yield was up to 90 
g cells/l (wet/weight) for the wild type and 30 g cells/l (wet/weight) for “complex I inactive 
strains”. 
Mutant strains (nukm/nuim subunit in pINA 443 plasmid) were grown with the same 
conditions as the wild type in a pre-culture (Synthetic Dextrose medium with lysine (30 mg 
/l)). Fermentation was throughout in YPD medium. 
Mutant strains (nukm subunit in pUB4 plasmid) were grown with the same conditions as 
described for the parental strain in a pre-culture (YPD medium with Hygromycine B
® (100 
mg /l). Fermentation was carried out in the absence of Hygromycine B
®. 
 
2.3.2 Preparation of Mitochondrial Membranes 
 
Mitochondrial membranes were prepared from freshly harvested cells or from cells that had 
been shock frozen in liquid nitrogen and kept at –80°C. To break the cell walls, 0.5 mm glass 
beads (Bend Euler Biotecnologie, Frankfurt-Germany) were used in a cell disintegrator. 300 – 
500 g of cells were suspended in the same amount of buffer (600 mM saccharose, 20 mM 
Na/MOPS, 1 mM EDTA, pH 7.2). Cell breakage was carried out for at least 2 hours in the 
presence of 2 mM PMSF (protease inhibitor). Centrifugation for 25 min. at 2000 • g was used 
to separate cell debris (pellet) from mitochondrial membranes (supernatant). To collect 
mitochondrial membranes, this supernatant was ultracentrifuged for 1 hour at 100,000 • g. The 
homogenised membranes were resuspended in the same buffer as above but without EDTA, 
shock frozen and stored at –80°C.  
Membrane quality was checked by recording absorption spectra (530-630 nm) of the reduced 
minus oxidised forms of the heme groups contained in the respiratory chain. Mitochondrial 
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membranes were reduced by addition of dithionite and oxidised by addition of ferricyanide. 
Content of heme b and a+a3 was measured at 562-575 nm (reduced minus oxidized form, 
heme b: ε562-575 28.5 mM
-1cm
-1 heme a+a3:  ε605-650 24 mM
-1cm
-1) and at 605-630 nm, 
respectively. Heme concentration was usually 1-10 µM and the ratio heme b: heme a+a3 
around 3:1. 
 
2.3.3 Preparation of Mitochondrial Membranes in Small Amounts 
 
Freshly harvested cells (4 - 8 g) were mixed at a 1:1:1 ratio of cells to buffer (same as in 
2.3.2) to glass beads. Cell breakage was carried out by vortexing the mixture in a falcon tube 
for 10 X 1 min. and intermittent cooling in ice for one minute. Centrifugations and further 
steps were the same as in 2.3.2. 
 
2.3.4 Protein Quantification 
 
Protein determination was conducted after the procedure of (Lowry et al., 1951), modified 
after (Helenius and Simons, 1972). Calibration was carried out with bovine serum albumin 
(BSA), in a dilution series from 0.1 – 2.0 mg/ml. 
 
2.3.5 Blue-Native Polyacrylamide Gel Electrophoresis (BN-PAGE) 
 
Blue-native polyacrylamide gel electrophoresis was used to separate the components of the 
mitochondrial respiratory chain in membranes of Y. lipolytica (Schägger, 2003). 500 µg of 
total protein was solubilised with 1 g/g dodecyl maltoside and 500 mM amino caproic acid 
and the resulting solubilised mitochondrial membranes were put on 4 / 4 → 13% gradient 
gels. 
 
2.3.6 SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
 
Tricine SDS-PAGE was used to check the composition and purity of complex I preparations 
(Schägger and von Jagow, 1987). 
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2.3.7 Activity Measurements 
 
Deamino-NADH:n-decyl-ubiquinone (dNADH:DBQ) oxidase activity was assayed at 30°C 
using a Shimadzu UV-300 spectrophotometer as dNADH oxidation rate (ε340-400 nm = 6.22 
mM
-1 cm
-1) in the presence of 100 µM dNADH in 50 mM Tris/HCl, pH 7.4, 2 mM KCN. The 
reaction was started by the addition of 60 µM DBQ. Inhibitors were added from stock 
solutions (10 mM in ethanol or in DMSO) prior to DBQ. Michaelis-Menten parameters were 
determined by varying the concentration of DBQ (2-100 µM) and data were analyzed with the 
Enzfitter software-package (Version 2.0.16.0, Biosoft, Cambridge). Detergent- and inhibitor-
insensitive NADH:HAR (HAR: hexaammineruthenium(III) chloride) activity was measured 
using 200 µM NADH and 2 mM HAR, 2 mM NaN3 in 20 mM Na
+/Hepes, pH 8.0 at 30°C 
(Sled and Vinogradov, 1993), and used to quantify the complex I content in the membranes. 
This activity depends only on FMN and possibly on Fe-S cluster N3 (Gavrikova et al., 1995). 
The reaction was started by the addition of 50 µg (total protein) of unsealed mitochondrial 
membranes. The complex I specific substrate dNADH was used instead of NADH for 
measuring NADH:HAR activities of cysteines-alanines mutants. Using dNADH avoids 
influence of non specific NADH oxidase activity of NDH2 of mitochondrial membranes. 
Both (d)NADH:HAR and dNADH:DBQ are expressed as specific activities in Units (U: µmol 
min
-1 mg
-1) per mg of total protein. 
To test for temperature stability, mitochondrial membranes were incubated for five minutes at 
increasing temperatures (30-35-40-45-48-50-53-55-60°C) before NADH:HAR activity was 
tested as described above. 
 
2.3.8 Determination of I50 Values for Inhibitors 
 
The I50 value is defined as the inhibitor concentration required for a 50% reduction in catalytic 
rate of complex I. 
The dNADH:DBQ activity test was done as described in 2.3.8, but mitochondrial membranes 
were incubated with different inhibitor concentrations (0-2000 µM for DQA and 0-20 µM for 
rotenone) for 10 seconds and the reaction was started by adding 60 µM DBQ. The residual 
activity, defined as the dNADH:DBQ membrane activity which is not inhibited by high 
concentrations of inhibitor (2 µM for DQA and 40 µM for rotenone) and not dependent on 
complex I, were subtracted when calculating the I50 values. For the parental strain the residual 
activity was between 0 and 5% (depending on the membrane preparation).  
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2.3.9a  Purification of Complex I (by His-Tag Affinity and Size Exclusion 
Chromatography) 
 
Unsealed mitochondrial membranes were prepared from plasmid complemented wild type 
and mutant haploid strains (nukm::LEU2, ura3, leu2, lys, pUB4-nukmmut/Hyg) as described in 
2.3.2. Complex I was purified by extraction of mitochondrial membranes with dodecyl 
maltoside (1g dodecyl maltoside per g total protein content in the mitochondrial membrane) 
according to a modified protocol described by (Kashani-Poor et al., 2001a). All procedures 
were carried out on ice or at 4°C. The protein concentration of the membranes was diluted to 
20 mg/ml and the salt concentration was adjusted to 50 mM NaCl and 20 mM Na3BO3 at pH 
7.2. After addition of PMSF (2 mM final concentration) and dodecyl maltoside (1 gram 
detergent per gram total protein) under stirring, the suspension was centrifuged at 140,000 • g 
for one hour. The supernatant was loaded on a Ni
2+-agarose column equilibrated with buffer 
A. After washing with 3 column-volumes of buffer A followed an elution step with one 
column-volume of buffer B (160 ml/h maximal velocity). The eluate was collected in 4 ml 
fractions. Fractions which showed NADH:HAR activity higher than 15 U/ml were pooled and 
concentrated down to 10 ml. This sample was loaded on a TSK-gel column (size exclusion 
chromatography using a BioSys 2000 protein-isolation-workstation
®) equilibrated with buffer 
D. The elution step was carried out with the same buffer at 120 ml/h. Fractions with higher 
activity were concentrated, shock-frozen and stored in liquid nitrogen. This protocol produces 
complex I with a purity about 95%, and a total yield of 38% for the PIPO strain. 
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Table 2.4    -Scheme of buffers used for isolation of complex I- 
* Buffer C was used for regeneration of the Ni
2+-agarose column.  
 
Buffer   A  B  C*  D 
NaCl mM  400  400  500  100 
L dodecyl-maltoside  %  0.1  0.1  0.1  0.05 
Na-phosphate mM  20  20     
Imidazol mM  55  140     
pH mM  7.2  7.2  7.2  7.2 
Na/Mops mM        25 
EDTA mM      50  1 
 
 
2.3.9b Purification of Complex I (by Ion Exchange and Size Exclusion Chromatography) 
 
Unsealed mitochondrial membranes were prepared from plasmid complemented wild type 
and mutant haploid strains (nukm::LEU2,  ura3
-, lys
-, pINA443) as described in 2.3.2. 
Complex I was purified by extraction of mitochondrial membranes with dodecyl maltoside 
according to the protocol described by (Kashani-Poor et al., 2001a) All procedures were 
carried out on ice or at 4°C. At first, membrane were diluted to a protein concentration of 20 
mg/ml with buffer A and the salt concentration was adjusted to 50 mM NaCl. After addition 
of PMSF (2 mM final concentration) and dodecyl maltoside (0.2 gram detergent per gram 
total protein) under stirring, the suspension was centrifuged at 140,000 • g for 90 minutes. The 
pellet was homogenised after dilution with puffer A to 20 mg/ml. For extracting complex I, 
the supernatant was adjusted to 75 mM NaCl and the procedure described above was repeated 
using 0.75 g LM / g total protein. The supernatant was loaded on a 200 ml DEAE Bio-Gel A 
agarose column (ion exchange chromatography) equilibrated with buffer B. After washing 
with two column-volumes of buffer C protein was eluted in two column-volumes of buffer D 
(160 ml/h maximal velocity). The eluate was collected in 4 ml fractions. Fractions which 
showed NADH:HAR activity higher than 15 U/ml were pooled and concentrated down to 10 
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ml and loaded on a TSK-gel column (size exclusion chromatography using a BioSys 2000 
protein-isolation-workstation
®) equilibrated with buffer E. The elution step was carried out 
with the same buffer at 120 ml/h. Fractions with high NADH:HAR activity were 
concentrated, shock-frozen and stored in liquid nitrogen. This protocol allows isolation of 
complex I with a purity of about 95% and a total yield of 10% for the parental strain. 
 
 
Table 2.5   -Scheme of buffer used for isolation of complex I- 
For using description of the buffers, see text. 
 
Buffer   A  B  C  D  E 
NaCl mM    75  100  200  100 
Dodecyl maltoside  %    0.05  0.1  0.25  0.1 
Na/Mops mM  20  25  25  25  25 
EDTA mM  2  1  1  1  1 
pH mM  7.0  7.0  7.0  7.0  7.0 
 
 
 
2.3.10 EPR-Spectra 
 
EPR Spectroscopy - Low temperature EPR spectra were obtained on a Bruker ESP 300E 
spectrometer equipped with a liquid helium continuos flow cryostat, ESR 900 from Oxford 
Instruments. Samples were mixed with NADH in the EPR tube and frozen in liquid nitrogen 
after 30 seconds reaction time. Spectra were recorded at 12 K or at 40 K with the following 
instrument settings: microwave frequency 9.475 GHz, microwave power 1 mW, modulation 
amplitude 0.64 millitesla. Under these conditions spectra show contributions from clusters 
N1, N2, N3 and N4 (Djafarzadeh et al., 2000). Spectra were recorded and analysed by Dr. 
Klaus Zwicker. 
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2.3.11 Redox Titrations 
 
For redox titrations mitochondrial membranes (~200 mg protein) were sedimented by 
centrifugation for 1 h at 48,000 X g. The pellet was resuspended in 30 ml of buffer containing 
30 mM each of sodium-acetate, Mes, Mops, Tris, glycine, pH 7.0, 100 mM NaCl and 1 mM 
EDTA and centrifuged as before. After one additional washing step the resulting pellet was 
suspended in 4–5 ml of the above buffer yielding a final protein concentration of 25–30 
mg/ml. The following redox mediators were added to a final concentration of 30 µM each: 
tetramethyl-phenylenediamine, phenazine-methosulfate, methylene blue, menadione, 
resorufin, indigotrisulfonate, 1,2-naphthoquinone, 2-hydroxy-1,4-naphthoquinone, 
phenosafranine, benzyl viologen, and methyl viologen. Redox titrations were performed 
anaerobically as described by (Dutton, 1978). The membrane suspension was poised at 
appropriate potential values by small additions of freshly prepared 50 mM dithionite. Aliquots 
were anaerobically transferred into an EPR tube, frozen rapidly in cold 
isopentane/methylcyclohexane (5:1), and stored in liquid nitrogen. Cluster N2 reduction rates 
in the frozen samples were then determined by recording EPR spectra at 12 K from samples 
poised at redox potentials between +100 and -500 mV. After subtraction of the oxidized 
spectrum recorded at a redox poise between +30 and -30 mV, to eliminate signal 
contributions from components with higher redox potential, the intensity of the N2 EPR 
signal was calculated by scaling it to a simulated N2 spectrum. The resulting N2 reduction 
rates were fitted to the Nernst equation using PSI Plot (Poly Software International, Salt Lake 
City, UT). Redox titrations were performed by Dr. Klaus Zwicker. 
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3 Results  
 
3.1 Site Directed Mutagenesis in the TYKY (NUIM) and PSST (NUKM) Subunits 
 
A 2.3 kb EcoRI genomic fragment from the NUKM locus and a 2.8 kb HindIII genomic 
fragment from the NUIM locus have been cloned into the replicative vector pUB4 (carrying 
the Hyg
R resistance gene) and pINA443 (carrying the URA3 resistance gene) respectively, and 
used as template for the mutagenesis (see 2.2.12). The mutagenised plasmids were used for 
transformation into the deletion strain ∆nuim, ndh2i, leu
-, lys
-, Mat A using plasmid pINA443 
and ∆nukm, ndh2i, 30Htg, leu
-, his
-, Mat A using plasmid pUB4 (Table 3.1). 
Transformants were selected on minimal media without uracil (pINA443) or on complete 
media containing Hygromycin B (pUB4). Sequencing of the entire open reading frame on the 
plasmids reconfirmed the mutations.  
 
 
 
 
TYKY PSST 
Mutation Vector Mutation  Vector 
C110A pINA443 C85A/S  pUB4 
C113A pINA443 C86A/S  pUB4 
C116A pINA443  C150A/S  pUB4 
C120A  pINA443  C180A/S  pUB4 
C149A  pINA443  S180C  pUB4 
C152A  pINA443  D99N/E/G pUB4 
C155A  pINA443  D115N/E/G  pUB4 
C159A  pINA443  D174N  pUB4 
    E185Q  pUB4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.1:     -Point mutations- 
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3.1.1 Characterisation of Mutants in the TYKY (NUIM) Subunit  
 
Strain ∆nuim 
Mitochondrial membranes were prepared as described in 2.3.3 and analysed by BNP (Blue-
Native Polyacrylamide gel electrophoresis, see 2.3.5). This method allows separation of the 
multiprotein complexes of the oxidative phosphorylation system after their solubilization by 
n-dodecyl-β-D-maltoside (Lauryl Maltoside, LM). Membranes of mutant strains were 
solubilised by 1g/g LM and loaded on the SDS-free gel. The complex I band was missing in 
the case of strain ∆nuim, whereas the bands of the complexes V and III of the respiratory 
chain were comparable to the wild type (E150) strain (Fig. 3.1). In E150 strain the complex I 
specific band (C I) is located between the complex V dimer (VDIM) and monomer (VMON.) 
bands. The presence of both VDIM. and VMON. bands indicated that the concentration of LM 
used corresponded to the opportune concentration for solubilising complex I. Data from BNP 
analysis and NADH:HAR activity measurements (see 2.3.8) reported in table 3.2 indicated 
that the mitochondrial membrane preparation of strain ∆nuim did not contain any relevant 
quantity of assembled complex I.  
 
   Parental 
Strain  ∆nuim C110A
C I 
V DIM. 
   V MON. 
II I
E150  C113A C116A C120A C149A      C152A C155AC159A 
 
 
Figure 3.1        -Blue native gel of strains E150 (wilde type), parental, and C110A, C113A, C116A, 
C120A, C149A, C152A, C155A, C159A- 
Mitochondrial membranes were loaded on a blue native gel after solubilisation with 
1 g n-dodecyl-β-D-maltoside (LM) per g total protein. The figure shows the first 
dimension of blue native page (BNP): E150 (wild type, cf. 2.1.4), Parental strain 
(∆nuim strain plasmid complemented with a wild type copy of NUIM gene), ∆nuim 
and Cys mutant strains. 
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Strain 
Complex I band in 
BN-Page 
Complex I 
content (%) 
E150 yes  110 
Parental yes  100 
∆nuim  no  20 
C110A  no  20 
C113A  no  20 
C116A  no  20 
C120A  no  20 
C149A  no  30 
C152A  no  20 
C155A  no  20 
C159A  no  30 
 
 
Table 3.2:     -Characterization of E150, parental, ∆nuim and cysteine-mutant strains in the TYKY 
homologous NUIM subunit- 
 
*  Complex I content in mitochondrial membranes was extimated by measuring the dNADH:HAR 
activity that is not affected by mutations in the NUKM subunit (cf. 2.3.7). 100% = 1.0 µmol min
-1 
mg
-1. 
 
 
Complemented NUIM Deletion Strain 
An unmodified copy of the NUIM gene was subcloned into plasmid pINA443 as described in 
2.2.12 and transformed into the ∆nuim strain. The resulting strain was defined as 
complemented  NUIM deletion and compared to the wild type (E150) strain in terms of 
complex I content and catalytic activity. Mitochondrial membranes loaded on a blue native 
gel showed almost identical patterns (Fig. 3.1) and similar complex I contents were measured 
(Table 3.2). dNADH:DBQ oxidoreductase activity (0.35 U/mg for the complemented NUIM 
deletion and 0.42 U/mg for the E150 strain) indicated that the catalytic activities of both 
complexes were comparable. 
Since both strains showed essentially the same characteristics with respect to complex I, the 
complemented NUIM deletion strain is referred to as the parental strain. 
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Cysteine Mutants 
Every single of the eight fully conserved cysteines shaded in Fig. 3.2 were mutagenized into 
alanine. As a qualitative test for complex I assembly, mitochondrial membranes from each 
mutant were tested by BNP and compared to the wild type and to the parental strain (Fig. 3.1). 
Both VDIM and VMON bands were visible in each line, but complex I band was missing in the 
case of ∆nuim and Cys mutant strains. 
Successively, bands were resolved into the individual polypeptides by a second-dimension 
SDS-PAGE (Fig. 3.3): no mutant showed the specific complex I bands. Complex I content in 
mitochondrial membranes was quantified by NADH:HAR activity (cf. 2.3.8): ∆nuim strains 
and all mutants showed comparable basal activities that are not caused by assembled complex 
I (Table 3.2). 
 
 
Y.l. RGEHALRRYP SGEERCIACK LCEAICPALA ITIDAEER-- ----IDGSRR TTKYDIDMTK
B.t. RGEHALRRYP SGEERCIACK LCEAVCPAQA ITIEAEPR-- ----ADGSRR TTRYDIDMTK
N.c. RGEHALRRYP SGEERCIACK LCEAVCPAQA ITIEAEER-- ----ADGSRR TTRYDIDMTK
P.d. RGEHALRRYP NGEERCIACK LCEAVCPAQA ITIDAERR-- ----EDGSRR TTRYDIDMTK
E.c. RGRIVLTRDP DGEERCVACN LCAVACPVGC ISLQKAETK- -----DGRWY PEFFRINFSR
T.a. HGRHVLTRHP NGLEKCIGCS LCAAACPAYA IYVEPAENDP ENPVSAGERY AKVYEINMLR
    .*...*.* *  *.*.*..*  **.. **. . *    .          .* ..    . *.. .
Y.l. CIYCGYCQES CPVDAIVETP NVEYATETRE ELLYNKEKLL ANGDKWELEL QYALDADAPY
B.t. CIYCGFCQEA CPVDAIVEGP NFEFSTETHE ELLYNKEKLL NNGDKWEAEI AANIQADYLY
N.c. CIYCGFCQES CPVDAIVESP NAEYATETRE ELLYNKEKLL SNGDKWEPEL AAAIRADSPY
P.d. CIYCGFCQEA CPVDAIVEGP NFEYATETRE ELFYDKQKLL ANGERWEAEI ARNLQLDAPY
E.c. CIFCGLCEEA CPTTAIQLTP DFEMGEYKRQ DLVYEKEDLL ISGPGKYPEY NFYRMAGMAI
T.a. CIFCGLCEEA CPTGAIVLGY DFEMADYEYS DLVYGKEDML VDVVGTKPQR REAKRTGKPV
    **.** *.*. **. **.. . . *   .    .* * *...*   .     .        .
149 155 159
113 110 116 120
152  
 
 
Figure 3.2   -Alignment of TYKY-homologous subunits of complex I-  
Identical amino acids are marked by asterisks, similar residues by dots. Cysteins that 
form the canonical binding-motifs for two Fe4S4 clusters in a ferrodoxin-like 
arrangement are shaded in grey and labelled with their number in the sequence of the Y. 
lipolytica protein. Y.l., Yarrowia lipolytica; B.t., Bos taurus; N.c., Neurospora crassa; 
E.c., Escherichia coli; P.d., Paracoccus denitrificans; T.a., Thermus aquaticus. 
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                                       Parental                C110A 
VDIM.  III VMON.  C I VDIM.  III VMON.
 
 
 
 
Figure 3.3         -Second dimension- 
Parental strain and mutant C110A are shown as examples: the other mutants, 
which exhibited the same pattern, are not shown. 
 
 
3.1.2 Characterisation of Mutants in the PSST (NUKM) Subunit  
 
∆nukm 
Similar to the ∆nuim strain, mitochondrial membranes of the ∆nukm strain were tested by 
Blue Native Polyacrylamide gel electrophoresis (BNP) for complex I assembly, after 
solubilisation with 1 g/g LM. As in the case of strain ∆nuim, a complex I specific band was 
missing and the pattern of complexes V and III of the respiratory chain were comparable to 
the pattern of the wild type (E150), as shown in Fig. 3.4a. Data from BNP analysis and 
dNADH:HAR activity measurements (Table 3.3) indicated that the mitochondrial membrane 
preparation of strain ∆nukm did not contain relevant quantities of assembled complex I.  
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COMPLEX I
COMPLEX V DIMER
COMPLEX V MONOMER
Parental
Strain ∆nukm C85A
 
 
Figure 3.4a -Blue native gel of the  parental, ∆nukm and C85A strains- 
Mitochondrial membranes were loaded on a blue native gel after solubilisation with 1 
gram n-dodecyl-β-D-maltoside (LM) per gram total protein. Parental strain (∆nukm 
strain plasmid complemented with a wild type copy of NUKM gene), ∆nukm (∆nukm 
strain), C85A (cysteine-alanine mutant strain). 
 
 
 
Complemented NUKM Deletion Strain 
An unmodified copy of the NUKM gene was subcloned into the plasmid pUB4 as described in 
2.2.12 and transformed into the ∆nukm strain. The resulting strain was defined as 
complemented  NUKM deletion strain. Mitochondrial membranes from the complemented 
NUKM deletion and the wild type (E150) strain were characterised for comparison. 
Mitochondrial membranes are loaded on a blue native gel (Fig. 3.4b), and complex I content 
(estimated by measuring the NADH:HAR activity), NADH:ubiquinone activity, Michaelis-
Menten parameters, and I50 for specific complex I inhibitor like DQA and rotenone were 
determined and are reported in table 3.3. Both strains showed, essentially, the same 
characteristics. Therefore, complemented deletion strain is referred to as the parental strain. 
 
 
Parental
Strain
Parental
Strain E150
COMPLEX  I
COMPLEX V DIMER
COMPLEX V MONOMER
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Figure 3.4b    -Blue native gel of the wild type (E150) and parental strains- 
Mitochondrial membranes were loaded on a blue native gel after solubilisation with 1 
g n-dodecyl-β-D-maltoside (LM) per g total protein. E150 (wild type, cf. 2.1.4), 
parental strain. 
 
 
 
Strain  Complex I 
content (%)
*1
Complex I band in 
BN-page 
Vmax
*3 µM 
min
-1 mg
-1
Km µM 
I50
*4 
rotenone 
nM 
I50
*4 
DQA 
nM 
E150  110  yes  0.42 ± 0.02  32 ± 6  500  20 
Parental 100  yes  0.40 ± 0.02  22 ± 2  500  20 
∆nukm  20  no        
 
 
 
Table 3.3     -Characterization of strains E150 (wild type), parental and ∆nukm- 
*1  Complex I content in mitochondrial membranes was extimated by measuring the 
dNADH:HAR activity that is not affected by mutations in the NUKM subunit (100% = 
1.0 µmol min
-1 mg
-1). 
*2 Complex I assembly was determined by Blue Native Page. 
*3 To account for variations in complex I content in different batches of mitochondrial 
membranes, dNADH:DBQ activity was normalized to complex I content expressed as 
specific NADH:HAR activity. 
*4  I50 is the inhibitor concentration required for a 50% reduction in catalytic rate 
(dNADH:DBQ µM min
-1 mg
-1) of complex I. 
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Cysteine Mutants 
Every single of the four fully conserved cysteines (Fig. 3.5) were mutagenised into alanine 
and serine.  
 
 
                        . .    .* *
99 115
     *    ***** *.* *.***.           .    .*.*   * .. .*** .**..**.   
89*
Y.l.64
B.t.70
N.c.80
E.c.62
P.d.32
T.a.24 
136* 140*
Y.l.133
B.t.139
N.c.149
E.c.112
P.d.101
T.a. 94
      ...**..*. .*.***.**. .**..   *.     .*...*  .* **.*.***** . **. ..   .**
185
 SAPRYDQDRL
 AAPRYDMDRF
 STPRYDQDRL
 FTAVHDVARF
 SMPRYDLERF
TDARNDLARF
 G-IIFRASPR QSDIMIVAGT 
 G-VVFRASPR QSDVMIVAGT 
 G-IIFRASPR QSDVMIVAGT 
 G-TAPRASPR QSDLMIVAGT 
 GSEVFRASPR QADVMIVAGR 
 GAEVLRASPR QADLMVVAGT 
168 174
85-86
  LDAVANWARQ GSFWPVTFGL ACCAVEMMHV 
  LDDLINWARR SSLWPMTFGL ACCAVEMMHM 
  LDSIVNWARQ SSLWPMTFGL ACCAVEMMHL 
  LNDMVNWGRK NSIWPYNFGL SCCYVEMVTL 
  TEDIINWARN GSLHWMTFGL ACCAVEMMQT 
 LEKLVAWGRS NSLWPATFGL ACCAIEMMAS 
 QVYDQMPEPR WVISMGSCAN GGGYYHFSYS
 KVYDQMPEPR YVVSMGSCAN GGGYYHYSYS
 QVYDQMPDPR WVISMGSCAN GGGYYHYSYS
 RLYDQMLEPK WVISMGACAN SGGMYDI-YS
 RVWEQMPDPK WVISMGACAS SGGMFNN-YA
 KVYDQMPEPR YVISMGSCAN GGGYYHYSYS
 VVRGCDRIVP VDVYVPGCPP TSEALMYGVF QLQ
 VVRGCDRIVP VDIYVPGCPP TAEALLYGIL QLQ
 VVRGCDRIVP VDIYVPGCPP TSEALMYGIF QLQ
 VVQGVDKFIP VDVYIPGCPP RPEAYMQALM LLQ
 VVRGCDRIVP VDIYVPGCPP TAEALLYGIL QLQ
 IVQNVDSVVP VDVYVPGCPP RPEALIYAVM QLQ
168* 150 180
 
 
 
Figure 3.5    -Alignment of PSST-homologous subunits of complex I- 
Identical amino acids are marked by asterisks,  similar residues by dots. Proposed 
ligands for Fe4S4 cluster N2 are shaded in dark grey and labelled with their number in 
the sequence of the Y. lipolytica protein. Conserved acidic amino acids are shaded in 
light grey and labelled with their number in the sequence of the Y. lipolytica protein. 
Y.l., Yarrowia lipolytica; B.t., Bos taurus; N.c., Neurospora crassa; E.c., Escherichia 
coli; P.d., Paracoccus denitrificans; T.a., Thermus aquaticus. 
*Mutants in positions E89, D136, E140 and D168 were analysed by (Ahlers et al., 
2000b) and results are summarised in 1.3.4. 
 
 
To verify the mutagenesis system used, mutant C180S was reverted to the original cysteine. 
The resulting strain S180C was supposed to show the same characteristics as the parental 
strain. This expectation was confirmed by dNADH:HAR activity measurement (Table 3.4). 
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Strain 
Complex I 
content (%)
*1
Complex I band in BN-
Page
 
Parental 100  yes 
∆nukm  20  no 
C85A 20  no 
C85S 20  no 
C86A 30  no 
C86S 30  no 
C150A 20  no 
C150S 20  no 
C180A 20  no 
C180S 20  no 
S180C*
2 100 yes 
 
 
Table 3.4  -Characterization of cystein-mutants in the PSST homologous NUKM subunit- 
*1  Complex I content in mitochondrial membranes was extimated by measuring the 
dNADH:HAR activity that is not affected by mutations in the NUKM subunit (100% = 
1.0 µmol min
-1 mg
-1). 
*2 Mutation nukm-C180S was changed back into the original nukm-S180C. 
 
 
Mitochondrial membranes from the parental, ∆nukm and mutant strains C-85, 86, 150, 180-A 
and C-85, 86, 150, 180–S, were solubilised with 1 g/g LM and loaded on a native gel (BNP). 
Figure 3.4 shows the native gel of the parental, ∆nukm and C85A strain. The other mutants 
had a similar pattern as the C85A strain and are not shown. A complex I specific band was 
visible only in the case of the parental strain. Similarly as for the nuim mutants, complex V 
dimer and monomer bands are visible: this was taken as an indicator that the optimal LM 
concentration needed for solubilising complex I was used. Figure 3.6 shows the second 
dimensions (SDS-PAGE) from the bands of the parental and the C85A strains: again, only the 
parental strain showed complex I bands. In addition, dNADH:HAR membrane activities of all 
cysteine mutants were comparable to the activity of the ∆nukm strain (Table 3.4). 
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              Parental              C85A 
 
 
VDIM. C I VMON. III VDIM. VMON. III
 
 
Figure 3.6      -Second dimension of Blue Native gel shown in figure 3.5- 
Parental strain and C85A mutant are shown as examples: other mutants which showed 
the same BNP pattern are not reported for brevity. VDIM., complex V in dimeric form; 
CI, complex I; VMON., complex V in monomeric form; III, complex III. 
 
 
EPR spectra from mitochondrial membranes of parental and Cys-Ala mutant strains were 
recorded. To compensate for different complex I concentrations in different batches of 
membrane preparations and to allow direct comparison of signal intensities between the 
different spectra reported in figure 3.7, spectra were normalised to the signal intensity of iron-
sulfur cluster S3 from complex II. The spectrum of the parental strain clearly showed the gz 
signal of cluster N2 and the typical signals in the middle region of the spectrum that are due to 
the contributions of clusters N1, N2, N3 and N4. None of the mutants showed any signal that 
could be assigned to a complex I cluster. The low signals visible between the dotted lines are 
most likely due to the clusters of complex II and to the Rieske protein. 
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Parental
strain
C86A
gzN2 S3
contributions from: 
N1, N2, N3, N4
C85A
10 mT
C150A
C180A
 
 
 
 
Figure 3.7     -EPR spectra of mitochondrial membranes from parental and C-85, 86, 150, 180-A 
mutant strains reduced by NADH– 
The intensities of the spectra were normalised to the signal intensity of the Fe-S 
cluster S3 from complex II. Dotted lines indicate field positions of the gz signal of 
cluster N2 (2.051) and the field region where the contributions from clusters N1, N2, 
N3, and N4 are detectable. EPR conditions: microwave frequency 9.475 GHz, 
modulation amplitude 0.63 mT, microwave power 1 mW, temperature 12 K. 
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•  Mutations of Acidic Residues  
Eight fully conserved acidic residues in PSST subunit, E89, D99, D115, D136, E140, D168, 
D174 and E185 (shaded in light grey in Fig. 3.5) were hypothetical candidates for the fourth 
ligand for N2 cluster: positions E89, D136, E140 and D168 were analysed in a previous study 
(Ahlers et al., 2000b) and results are briefly reported in 1.3.4. 
In the present work, site directed mutagenesis in positions D99, D115, E185 and D174 was 
carried out. Mutant membranes were characterised in terms of complex I assembly and 
content, catalytic activity and sensitivity toward quinone-analogous inhibitors. EPR spectra 
were recorded from isolated complex I and/or from membrane preparations. 
 
Mutant D99N, D99E and D99G 
Codon 99 in the NUKM open reading frame translates into a fully conserved aspartic acid. 
Mitochondrial membranes from mutants D99N, D99E and D99G were prepared in small 
amounts (2.3.3) from cells grown in YPD medium containing hygromycin B (Hyg). The 
complex I content of all three strains was in the same range as the parental strain (Table 3.5). 
Membranes of mutant D99N were solubilised with 1 g/g LM and loaded on a blue native gel 
(BNP). The second dimension is shown in figure 3.8: complex I bands were clearly visible 
and comparable to the complex I bands of the parental strain. 
 
 
 
 
Figure 3.8    -BNP second dimensioN– 
VDIM., complex V in dimeric form; CI, complex I; VMON., complex V in 
monomeric form; III, complex III. 
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Strain 
Complex I 
Content (%)
*1
VMax
*2 
µmol min
-1 mg
-1
KM
µM 
I50 Rotenone
*3 
nM 
I50 DQA
*3 
nM 
E150  110  0.42 ± 0.02  32 ± 6  500  20 
Parental  100  0.40 ± 0.02  22 ± 2  500  20 
D99N 90  0.02  -  -  - 
D99E 90  0.02  -  -  - 
D99G 90  0.02  -  -  - 
D115N 100  0.02  -  -  - 
D115E 100  0.02  -  -  - 
D115G 100  0.02  -  -  - 
D174N  90  0.40 ± 0.05  35 ± 5  500  20 
E185Q  110  0.14 ± 0.01  50 ± 4  500  20 
 
 
Table 3.5:     -Characterization of mutants in the PSST homologous NUKM subunit- 
Mitochondrial membranes (prepared as described in 2.3.2) from different strains were 
characterised and compared in the table. 
*1Complex I content in mitochondrial membranes was extimated by measuring the 
dNADH:HAR activity that is not affected by mutations in the NUKM subunit (100% = 
1.0 µmol min
-1 mg
-1). 
*2To account for variations in complex I content in different batches of mitochondrial 
membranes, dNADH:DBQ activity was normalized to complex I content expressed as 
specific NADH:HAR activity. Determination of VMax, KM, and I50 values for mutants in 
positions D99 and D115 was not possible. dNADH:DBQ activities of these two mutants 
were determined at 100 µM dNADH and 60 µM DBQ whereby the parental strain 
showed 0.3 µmol min
-1 mg
-1. 
*3I50 is the inhibitor concentration required for a 50% reduction of the dNADH:DBQ 
catalytic rate of complex I. 
 
 
Changing the carboxylate residue into its corresponding amide asparagine resulted in almost 
complete loss (< 5% residual activity) of dNADH:DBQ oxidoreductase activity, measured in 
the presence of saturating amounts of both substrates. Due to this very low activity, 
determination of Michaelis-Menten parameters like KM and VMax, and also the determination 
of I50 values for complex I inhibitors was not possible for this mutant. To isolate complex I, a 
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second batch of mitochondrial membranes was prepared from cells grown in 10 l of YPD 
medium (without Hygromycin) as described in 2.3.1-2. Complex I content as estimated by 
NADH:HAR activity in this second mitochondrial preparation (60%) was lower than in the 
first preparation. This phenomenon could find an explanation in plasmid loss during growth in 
media without selective pressure by the antibiotic. In fact, the mutagenised nukm copy carried 
on the plasmid, providing assembly of complex I but no NADH:ubiquinone oxidoreductase 
activity, does not constitute an advantage for cell growth. To investigate loss of plasmid in 
absence of Hyg pressure, cells were grown 12 hours in YPD and plated on YPD and YPD-
Hyg agar media. After 48 hours incubation, cells were counted and the survival ratio 
YPD/YPD-Hyg was calculated. Only cells that still have the plasmid (containing a copy of 
the gene for Hyg resistance and for the PSST subunit) are able to survive on medium with 
Hyg and to produce an assembled complex I. Consequently, the ability to survive in YPD-
Hyg medium is taken as indicator for the ability to produce an assembled complex I. The 
same experiment was carried out growing cells 12 hours in YPD-Hyg medium, to avoid loss 
of plasmid. As expected, parental strain showed essentially the same survival ratio when cells 
were incubated in the presence and in the absence of antibioticum (Table 3.6). Differently, the 
survival ratio for mutant D99N decrease significantly when cells were grown without Hyg 
(see table 3.6 for more details). This suggested that a significant portion of the cells had lost 
the plasmid (and the ability to form complex I) in the absence of Hyg selective pressure, and 
explained the observed decrease of NADH:HAR activity in the second membrane 
preparation. For strain D99N, the presence of a fully-assembled complex I, does not constitute 
an advantage. 
 
 
Cells grown in YPD  Cells grown in YPD-Hyg 
  
YPD 
Agar medium 
YPD-Hyg 
 
Survival rate (%)
 
YPD 
Agar medium 
YPD-Hyg 
 
Survival rate (%) 
Parental 93  83  89%  90  81  90% 
D99N 87  43  49%  85  70  82% 
 
 
Table 3.6    -Survival rate (YPD/YPD-Hyg agar medium) of parental and D99N strains - 
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Cells were grown for 12 hours in YPD medium (with and without Hyg). 100 cells were 
plated on YDP and YPD-Hyg agar medium and incubated for 48 hours. In the table the 
number of cells counted on the plates after 48 hours growth time are indicated. Survival 
rates (YPD/YPD-Hyg agar medium) are expressed in %. 
 
 
Affinity purification of complex I from mitochondrial membranes (see 2.3.9a) of mutant 
D99N was carried out twice: in both experiments the yield was about 8% of the complex I in 
mitochondrial membrane (about one fourth of the yield usually obtained from the parental 
strain). Table 3.7 compares the two purification experiments of complex I from D99N and 
parental strain. 
 
 
  Strain Solubilized  membranes
(1g/g LM) 
Purified enzyme 
 Units  Units  % 
D99N (I exp.) 4920  409  8 
D99N (II exp.) 5012  501  8 
Parental 7051  2115  30 
 
 
 
 
 
 
 
Table 3.7    -Complex I purification experiments- 
Two different complex I purification experiments for mutant D99N and one purification 
experiment for the parental strain are summarised. Units = µmol min
-1. 
 
 
The low purification yield suggests a somewhat lower stability of complex I in mutant D99N. 
Data obtained by comparing temperature stability of NADH:HAR oxidoreductase activity of 
mutant and parental membranes were consistent with this assumption (Fig. 3.9). Membranes 
were incubated at different temperatures for five minutes and their NADH:HAR activity was 
measured at 30°C (see 2.3.7). For this experiment mitochondrial membrane preparations from 
the parental and the D99N mutant strain with comparable specific NADH:HAR activities 
were used. 
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Figure 3.9   -NADH:HAR activity as a function of incubation temperature- 
•  Parental strain; ▲ Mutant D99N 
NADH:HAR activity at each temperature point is reported as average of eight 
measurements. 
 
 
NADH:HAR activity of the mitochondrial membranes after incubation at 30°C was taken as 
100%. The activity from both the parental and the mutant strain was quite stable up to 45°C, 
as shown in figure 3.9 (13% reduction). By contrast, at 48°C D99N showed a decrease by 
about 57%, whereas the activity of the parental strain did not change substantially up to 53°C 
(96%). Since the NADH:HAR oxidoreductase activity depends only on the FMN and the 51 
kDa subunit, the different NADH:HAR temperature dependence of mutant and parental 
strains seems to be linked to a destabilization effect on the enzyme due to the mutation, and 
not to the specific effect of the mutation on the NADH:ubiquinone activity of complex I. 
The proposed enzyme instability was also confirmed by EPR spectroscopy. In fact, in the first 
complex I preparation from this mutant, cluster N2 was not clearly detectable by EPR 
spectroscopy, whereas in the second preparation the presence of a N2 gz signal is clearly 
evident, and the spectra of all other visible clusters in both cases seemed to be essentially 
unchanged when compared to the parental strain (Fig. 3.10). In the first isolation, due to the 
low yield obtained from mutant enzyme purification, the protein concentration of the mutant 
sample (2.4 mg/ml) was considerably lower compared to the parental sample concentration 
(3.4 mg/ml). This caused the lower signal/noise ratio of the mutant spectrum. To compensate 
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for different complex I concentrations and to allow direct comparison of signal intensities 
between the different spectra reported in this figure, spectra were normalised to the N1 signal 
intensity of the parental enzyme at 40 K. At this temperature cluster N1 can be measured 
selectively avoiding background effects from other overlapping iron-sulfur clusters, like iron–
sulfur cluster S3 of complex II. The smaller peak identifiable at the N2 gz position in the first 
isolation is presumably due to a reduced amount of this cluster. 
In the second batch of complex I from mutant D99N shown in Fig 3.10 (8.5 mg/ml), the 
presence of iron-sulfur cluster N2 was clearly evident from the EPR spectrum recorded at 12 
K and the gz value for iron-sulfur cluster N2 was not shifted, indicating that the mutation had 
not influenced ligand geometry. The g values and relative intensities of the signals for clusters 
N4 and N3 were comparable to the parental signals whereas the middle region (contributions 
of all clusters to the EPR signal) showed different intensities and line shapes, and the N1 gz 
signal seemed to be sfifted. From the spectra recorded at 40 K became clear that the signal of 
the iron–sulfur cluster S3 of complex II contributed significantly to the slightly shifted peak at 
the N1 gz field position. This indicated that significant amounts of complex II were present as 
an impurity in the complex I preparations from mutant D99N. It follows that cluster N2 
remains the only possible candidate for causing the different patterns in the middle region of 
the spectra, but since signals originating from all iron-sulfur clusters overlap in this field 
position this signal could not be used for quantification. Observing the N2 gz signal it can be 
concluded that in the second batch of complex I from mutant D99N the amount of N2 was 
decreased by about 50%.  
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Figure 3.10   -EPR spectra of isolated complex I from the parental strain and the D99N mutant 
strain reduced with NADH- 
The intensities of the spectra were scaled to the signal intensity of cluster N1 recorded 
separately at 40 K for each sample. Dotted lines indicate field positions for g values of 
individual clusters: gzN4, 2.104; gzN2; 2.051; gzN1, 2.018; gxN4, 1.892; gxN3, 1.861. 
EPR conditions: microwave frequency 9.475 GHz, modulation amplitude 0.64 mT, 
microwave power 1 mW, temperature 12 K. 
 
 
On the basis of the EPR spectra the function of aspartate 99 as a direct ligand for cluster N2 
seems to be implausible but an indirect role of this amino acid in cluster binding cannot be 
excluded. In fact, cysteines ligate an iron-sulfur cluster by binding the iron ions of the cluster 
to their thiol group (1.2.3). The cysteinyl sulfur of a ligand offers two electron pairs for 
hydrogen bound. It is reasonable to suppose that the carboxylic group of the aspartate 99 may 
form a hydrogen bond to this sulfur, influencing with its charge the ability of the cluster to 
accept electrons. In this case, the elimination of the residue may still allow assembly of the 
cluster, but on the other hand its removal should result in a change of the midpoint potential 
of cluster N2. In this working hypothesis, an expected consequence of the changed midpoint 
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potential of redox centre N2 in D99N might be an incomplete reduction of N2 clusters in the 
EPR sample. The observed 50% reduction in N2 signal intensity would fit to this scenario. To 
investigate this possibility the midpoint potential of cluster N2 in D99N was determined in 
membranes (Fig. 3.11). The measured value of –125 mV for the mutant strain was not 
significantly different from that obtained for the parental strain, demonstrating that the 
reduction in N2 gz signal intensity reflects a reduction in N2 content and definitively 
excluding D99 as ligand for cluster N2.  
 
 
 
 
 
Figure 3.11    -Redox titrations of iron-sulfur cluster N2 monitored by EPR spectroscopy- 
•, parental mitochondrial membranes, Em,7 = -140 mV;  , mutant D99N, Em,7        
=-125 mV. 
 
 
To test a more conservative mutation that left intact the carboxylic acid function at position 
99, the aspartic acid residue was replaced with a glutamic acid residue. In terms of specific 
NADH:HAR activity of mitochondrial membranes, D99E did not show any significant 
difference compared to the parental strain or mutant D99N (Table 3.5). Also dNADH:DBQ 
activities of D99E and D99N were comparable (< 5% of the wild type rate). As a more drastic 
mutation aspartic acid 99 was changed into glycine. Again, specific NADH:HAR activity of 
the mutant membranes was comparable to the parental strain (Table 3.5) and the 
dNADH:DBQ specific activity was as low as for mutants D99N and D99E. Summarising, 
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mutants D99 N/E/G were indistinguishable in terms of complex I content and catalytic 
activity. 
Mutants D115N, D115E and D115G 
A second fully conserved aspartic acid residue in the PSST sequence, D115 (Fig. 3.5) was 
mutagenised to give asparagine, glutamic acid or glycine. Mitochondrial membranes from 
each mutant were prepared in small amounts (cf. 2.3.3) from cells grown in YPD medium 
with hygromycin B. The complex I content of all three mutant preparations was in the same 
range as the parental strain. Membranes were solubilized with 1g/g LM and loaded on a blue 
native gel (BNP). The second dimension of parental and D115N strains is shown in figure 
3.12: specific complex I bands were clearly visible and comparable to the complex I bands of 
the parental strain. 
 
 
 
Parental strain  D115N  Parental strain 
V  DIM.  VMON. III V  DIM.  C I  VMON. III CI III VDIM. VMON.
 
 
Figure 3.12    -BNP second dimension – 
VDIM., complex V in dimeric form; CI, complex I; VMON., complex V in monomeric 
form; III, complex III. 
 
 
 
 
dNADH:DBQ activities were found to be only ~8% of the wild type rate in all three mutant 
preparations. As for the D99 mutants, this low activity made the determination of KM , VMax 
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and I50 values for complex I inhibitors impossible. For isolating complex I, a second batch of 
mitochondrial membranes was prepared from cells grown in 10 l YPD medium (without 
hygromycine) as described in 2.3.1-2. Complex I content estimated by NADH:HAR activity 
(70%) was lower than in membranes obtained from cells grown in the presence of 
hygromycine. As in the case of the D99 mutants, the explanation of this phenomenon could 
be found in plasmid loss by growth in media without antibiotic pressure, when assembly of 
complex I does not constitute a growth advantage. Loss of plasmid in the absence of 
hygromycine (Hyg) pressure was investigated by plating cells on YPD and YPD-Hyg plates 
after 12 hours growing-time in YPD medium. This experiment was carried out for the mutant 
D115N and the parental strain as described for mutant D99 (see above). The survival rate on 
YPD-Hyg / YPD agar media for the D115N mutant strain was only around 45% (Table 3.8). 
This fact suggested that a significant portion of the cells had lost the plasmid (and the ability 
to form complex I) in the absence of Hyg selective pressure, and explained the observed 
decrease of NADH:HAR activity in two different membrane preparations. 
 
 
Cells grown in YPD  Cells grown in YPD-Hyg 
  
YPD 
Agar medium 
YPD-Hyg 
 
Survival rate (%) 
 
YPD 
Agar medium 
YPD-Hyg 
 
Survival rate (%) 
Parental 95  86  90%  95  86  91% 
D115N 91  41  45%  87  70  80% 
 
 
Table 3.8   -Survival rate (YPD/YPD-Hyg agar medium) of parental and D115N strains - 
Cells were grown for 12 hours in YPD (with and without Hyg) medium. 100 cells were 
plated on YDP and YPD-Hyg agar medium and incubated for 48 hours. In the table are 
indicated the number of colonies counted on the plates after 48 hours growth time. 
Survival rate (YPD/YPD-Hyg agar medium) are expressed in %. 
 
Purification of complex I from both mutants gave a yield of 12% for D115N and 10% for 
D115E, that is about one third of the parental strain yield (Table 3.9). 
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Solubilized membranes
(1g/g LM) 
  Purified enzyme 
  Units % Units  % 
D115N 3781 100 454  12 
D115E 4587 100 459  10 
Parental   7051 100 2115  30 
 
 
Table 3.9    -Complex I purification experiments- 
Two different complex I purification experiments for mutants at position D115 and one 
purification experiment for the parental strain are summarised. Units =  µmol min
-1. 
 
 
As in the case of mutant D99N, this low yield suggested some destabilisation of complex I. 
Membranes of both strains were incubated at different temperatures for five minutes, followed 
by NADH:HAR activity measurements. The experimental conditions were the same as for 
mutant D99N (described above) and results are shown in figure 3.13: mutant D115N showed 
different temperature stability when compared to the parental strain. 
 
 
Figure 3.13    -NADH:HAR activity as a function of incubation temperature- 
• Parental strain; ■ Mutant D115N 
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NADH:HAR activity at each temperature point is reported as average of eight 
measurements. 
 
 
Incubation at temperatures below 45°C did not change substantially the NADH:HAR 
oxidoreductase activity of both strains, whereas incubation at higher temperatures up to 53°C 
reduced the activity of mutant mitochondrial membranes, but not from the parental strain. 
EPR spectroscopy of complex I isolated from D115N (Fig. 3.14) showed that the g values and 
relative signal intensities for clusters N1, N3 and N4 were not changed and that their relative 
amplitudes were comparable to complex I from the parental strain. 
 
 
 
 
 
 
Figure 3.14    -EPR spectra of isolated complex I from the parental and the D115N mutant strains 
reduced with NADH- 
The intensities of the spectra were scaled to the signal intensity of cluster N1 recorded 
separately at 40 K for each sample. Dotted lines indicate field positions for 
characteristic g values of individual clusters: gzN4, 2.104; gzN2; 2.051; gzN1, 2.018; 
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gxN4, 1.892; gxN3, 1.861. EPR conditions: microwave frequency 9.475 GHz, 
modulation amplitude 0.64 mT, microwave power 1 mW, temperature 12 K. 
 
 
As in the case of mutant D99N, the gz signal for cluster N2 was not shifted but a reduction in 
signal intensity by about 50% was observed. As for D99, the possibility that this amino acid 
forms hydrogen bound to cluster N2, thereby influencing the redox midpoint potential, was 
checked. The determined value of –120 mV for D115N was not significantly different from 
that obtained for the parental strain (Fig. 3.15). 
 
 
 
 
 
Figure 3.15    -Redox titrations of iron-sulfur cluster N2 monitored by EPR spectroscopy- 
•, parental mitochondrial membranes, Em,7 = -140 mV;    mutant  D115N,  Em,7         
= -120 mV. 
 
 
The aspartic acid in position 115 was also changed into asparagine and glycine. Again, 
mitochondrial membranes from D115 N/E/G mutants were indistinguishable in terms of 
complex I content and catalytic activity (Table 3.5). 
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Mutant D174N 
A third fully conserved aspartate is located at position 174 (Fig. 3.5). This position was 
changed into asparagine. Complex I content in membranes from mutant D174N was within 
the range commonly observed for the parental strain (Table 3.5). For the determination of 
Michaelis-Menten parameters VMax and KM for DBQ, complex I activity of mitochondrial 
membranes was assayed as electron transfer from dNADH to DBQ and catalytic rates were 
normalized for NADH:HAR activity. VMax for DBQ and I50 values for rotenone and DQA 
were not significantly changed, whereas the KM value for ubiquinone was slightly increased 
(Table 3.5). Except for the KM value, the catalytic activity of complex I is not substantially 
modified by this mutation (Fig. 3.16). This fact allows the conclusion that the aspartate in 
position 174 does not play an important role in complex I function. This hypothesis is 
confirmed by EPR spectra of mitochondrial membranes: mutant D174N and the parental 
strain were indistinguishable, indicating that iron-sulfur cluster N2 content and line shape 
were not significantly affected by the mutation (Fig 3.17).  
 
 
 
 
 
Figure 3.16    -Kinetic characterization of dNADH:DBQ activity- 
KM and VMax values were determined by direct fit of the data to the standard 
Michaelis-Menten equation. 
The KM and VMax values were determined by direct fit of the data to the standard 
Michaelis-Menten equation. These parameters (cf. Table 3.5) were used to construct 
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the shown double-reciprocal plots of the parental strain and the mutants. ■, Wild type; 
•, Parental strain; ♦, mutant nukm E185Q; ▲ mutant nukm D174N. 
 
 
 
 
 
 
Figure 3.17    -EPR spectra of mitochondrial membranes from the parental and the D174N mutant 
strains reduced with NADH – 
The intensities of the spectra were scaled to the signal intensity of the middle field 
region of the spectra (marked as contribution from N1, N2, N3, N4). The dotted line 
indicates field positions for g values of gzN2 (2.051). EPR conditions: microwave 
frequency 9.475 GHz, modulation amplitude 0.64 mT, microwave power 1 mW, 
temperature 12 K. 
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Mutant E185Q 
Two fully conserved glutamic acid residues can be identified in the sequence of the complex I 
PSST subunit (Fig. 3.5): E89 and E185. Glutamate 89 (previously described in 1.3.4) has a 
position close to cysteine 86 and glutamate 185 is located near cysteine 180. Similarly as E89, 
E185 is candidate as ligand for cluster N2 by virtue of its position in the PSST sequence. 
Mutant E185Q exhibited a substantial decrease in dNADH:DBQ activity of up to 65%, the 
KM value for DBQ was increased about twofold whereas I50 values for rotenone and DQA 
were the same as for the parental strain (Table 3.5, Fig. 3.16). The purification of complex I 
from mutant E185Q was successful and the yield obtained from membranes of this mutant 
was comparable to the yield normally obtained for the parental strain. The EPR spectrum of 
E185Q was virtually indistinguishable from spectra of parental complex I: there were no 
effects on the positions of the gz signals of clusters N1, N2, N3, N4 and their intensities were 
also unaffected (Fig. 3.18). 
 
 
 
 
 
Figure 3.18    - EPR spectra of isolated complex I from the parental and the E185Q mutant strains 
reduced by NADH- 
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The intensities of the spectra were scaled to the signal intensity of cluster N1 recorded 
separately at 40 K for each sample. Dotted lines indicate field positions for 
characteristic g values of individual clusters: gzN4, 2.104; gzN2; 2.051; gzN1, 2.018; 
gxN4, 1.892; gxN3, 1.861. EPR conditions: microwave frequency 9.475 GHz, 
modulation amplitude 0.64 mT, microwave power 1 mW, temperature 12 K. 
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3.1.3 Characterisation of the Leigh Mutations 
 
Since researchers at the Nijmegen Center for Mitochondrial Diseases had identified point 
mutations in subunits NDUFS7 and NDUFS8 of complex I (homologous to PSST and TYKY 
from  Y. lipolytica, respectively) as the causative genetic defects in two cases of 
neuropathologically proven Leigh syndrome (cf. 1.4), the corresponding positions were 
mutagenised in Y. lipolytica in an effort to analyse in vitro the effects of these mutations on 
complex I. Mutagenesis was carried out in a previous work by transforming a modified copy 
of the nukm or nuim gene on plasmid pINA443 in ∆nukm, ndh2i (lys
- ura
- nukm::leu2 Mat A) 
and ∆nuim, ndh2i (lys
- ura
- nuim::leu2 Mat A) strains, respectively (Ahlers et al., 2000a). In 
the present work, mitochondrial membranes of the mutant strains were prepared and 
characterised in terms of complex I content and catalytic activity. 
Valine 122 in NDUFS7  corresponds to V119 in the PSST protein of Y. lipolytica. This 
position is fully conserved in the alignment of the PSST homologous subunits from different 
organisms shown in figure 3.19, and is part of a well-conserved region, even in prokaryotes 
like Paraccocus denitrificans and E. coli. 
P78 and R101 in the TYKY protein correspond to P79 and R102 in NDUFS8. In contrast to 
position 119 in NUKM, sequence homology in the region between both residues is high only 
for eucaryotes.  
 
 
Figure 3.19    -Positions of Leigh mutations in the PSST- and TYKY- homologues of Y. lipolytica- 
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The protein sequences from various organisms were aligned using the CLUSTAL 
program of the HUSAR 4.0 package, DKFZ Heidelberg, Germany. Identical amino 
acids are marked by asterisks. Residues forming the first half of the ferredoxin-type 
binding motif in TYKY and conserved cysteins in PSST are shaded in gray. Leigh 
mutations are marked with arrows and the positions of the mutated residues in the Y. 
lipolytica protein are indicated.  
 
 
Mitochondrial membranes were prepared from cells grown in minimal medium to avoid loss 
of plasmid, and NADH:HAR oxidoreductase activity was measured for each mutant. V119M 
showed an estimated complex I content of about 110% of the parental strain content, whereas 
mutants R101H and P78L showed about 80 and 60%, respectively (Table 3.10). 
 
 
Strain 
(subunit) 
Complex I 
content (%)*
1
VMax*
2 
µmol min
-1 mg
-1
VMax 
(%) 
KM (DBQ) 
µM 
I50 
Rotenone
*4 
nM 
I50 
DQA
*4 
nM 
Parental 
(PSST)
*3 100  0.40 ± 0.02  100  22 ± 2  500  20 
V119M 
(PSST) 
110  0.22 ± 0.01  55  12 ± 1  700  10 
Parental 
(TYKY)
*3
100  0.44 ± 0.02  100  23 ± 2  600  25 
P78L 
(TYKY) 
60  0.25 ± 0.01  57  12 ± 1  700  20 
R101H 
(TYKY)  80  0.20 ± 0.01  45  19 ± 2  500  10 
 
 
Table 3.10   -Characterization of the Leigh mutantions in the PSST and TYKY homologous 
subunits- 
 
Mitochondrial membranes (prepared as described in 2.3.2) from different strains were 
characterised and compared in the table. 
*1  Complex I content in mitochondrial membranes was extimated by measuring the 
dNADH:HAR activity that is not affected by mutations in the PSST and TYKY subunit 
(100% = 1.0 µmol min
-1 mg
-1). 
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*
2 
To account for variations in complex I content in different batches of 
mitochondrial membranes, dNADH:DBQ activity was normalized to complex I 
content expressed as specific NADH:HAR activity. VMax was set at 100% for 
parental strains. 
*
3   ∆nukm, ndh2i (lys
- ura
- nukm::leu2 Mat A) complemented by an unmodified 
copy of the NUKM gene carried on plasmid pINA443. 
∆nuim, ndh2i (lys
- ura
- nuim::leu2 Mat A) complemented by an unmodified copy 
of the NUIM gene carried on plasmid pINA443. 
*4  I50 is the inhibitor concentration required for a 50% reduction of the dNADH:DBQ 
catalytic rate of complex I. 
 
 
 
In all three mutants, VMax was found to be significantly reduced by about 50%. The KM for 
DBQ was unaffected in the R101H mutant (TYKY), while it was reduced from around 20 µM 
to 12 µM in the V119M (PSST) and the P78L (TYKY) mutants. These two mutants also 
exhibited a tendency to higher I50 values for inhibitor rotenone. As indicated by a somewhat 
lowered I50, the R101H and the V119M mutants exhibited a slight hypersensitivity to DQA 
(Table 3.10). Figures 3.20 and 3.21 show Lineaver-Burk representations of mutant and 
parental strains kinetic characterization. 
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Figure 3.20    - Kinetic characterization of the V119M and parental (NUKM) strains- 
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The KM and VMax values were determined by direct fit of the data to the standard 
Michaelis-Menten equation. These parameters (Table 3.10) were used to construct the 
shown double-reciprocal plots of the parental strain and the Leigh mutants. ■, Parental 
(PSST) strain; ▲, mutant V119M (PSST).  
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Figure 3.21    - Kinetic characterization of the P78L, R101H and parental (TYKY) strains - 
The KM and VMax values were determined by direct fit of the data to the standard 
Michaelis-Menten equation. These parameters (Table 3.10) were used to construct the 
shown double-reciprocal plots of the parental strain and the three Leigh mutants. ■, 
Parental (TYKY) strain; ●, mutant R101H (TYKY), ♦, mutant P78L (TYKY). 
 
 
The particular position of V119, separated by 30 and 32 amino acids from the closest 
conserved cysteine that could serve as ligands for iron-sulfur cluster N2 and located in a 
highly conserved region, posed the question about a possible interaction with cluster N2. In 
fact, the mutant had effects not only on catalytic activity (VMax and KM), but also on I50 for 
quinone analogous inhibitors like rotenone and DQA. 
For analysing possible effects of the mutation on cluster N2, complex I was isolated from 
mutant mitochondrial membranes by ion exchange and size exclusion chromatography 
(2.3.9b). Enzyme purification from the mutant strain gave a yield of 8% whereas the normal 
yield for the parental strain enzyme obtained by the same procedure was about 10%. The EPR 
spectra from mutant and parental strains are shown in figure 3.22. 
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Figure 3.22  -EPR spectra of isolated complex I from the parental (PSST) and the V119M mutant 
strains reduced by NADH- 
Dotted lines indicate field positions for characteristic g values of individual clusters: 
gzN4, 2.104; gzN2; 2.051; gzN1, 2.018; gxN4, 1.892; gxN3, 1.861. EPR conditions: 
microwave frequency 9.475 GHz, modulation amplitude 0.64 mT, microwave power 
1 mW, temperature 12 K. 
 
 
To compensate for different protein concentrations of the samples, spectra were scaled to the 
gx signals intensities of clusters N3, N4 and the gz intensity of cluster N4. The spectrum of 
V119M did not show shifts of the g values of the EPR detectable clusters. Also, the intensities 
of the signals of clusters N1, N3 and N4 were unchanged in the mutant sample. By contrast, 
the amplitude of N2 signal in V119M mutant complex I was decreased by about 40%, when 
compared to the amplitude of the gz N2 signal in complex I from the parental strain. 
Summarizing, mutation V119M showed a reduced N2 content in isolated enzyme, whereas 
the spectra of all other visible clusters were essentially unchanged compared to the parental 
strain.  
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3.2 Construction of a ∆nukm-∆nucm Strain 
 
To obtain a strain with deletions of the genes for both PSST (NUKM) and 49 kDa (NUCM) 
subunits, two haploid Y. lipolytica strains were mated: nucm::URA3, Mat A, ndh2i, 30Htg, 
lys11-23, ura3-302, xpr2-322, leu
-, his
- and nukm::LEU2, Mat B, ndh2i, 30Htg, leu2-270, 
xpr2-322, ura
-, lys
-. After sporulation haploid strains carrying the appropriate genetic markers 
were selected. 
 
 
 
Figure 3.23    –Strategy to obtain a ∆nukm-∆nucm strain- 
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Strains ∆nucm and ∆nukm were mated and sporulated. The desired double deletion 
mutant ∆nucm-∆nukm should contain both URA3 and LEU2 alleles. 
Open Reading Fream (ORF) of NUCM and NUKM genes have been partially 
substituted by URA3 and LEU2, respectively (Ahlers et al., 2000b). 
 
 
Different spores were investigated by PCR for deletion of both genes. Primers SAPA seq (5´- 
CCC TGA CCA CTC TGG ATG C -3´) and PSST mut (5´- GTT TCG CAT CTT TCG CTG G -3´) were 
used for the NUKM gene and primers 49i2 (5´- GCG TAC GTG CGA CCT GGA -3´) and 49i1 (5´- 
GCC TCC ATA TCC TCC –3´) for the NUCM gene. A 450 bp PCR product for both genes was 
visible only for the wild type strain, which was used as a control. Southern Blot confirmed 
results obtained by PCR. Genomic DNA from spores and WT was digested with HindIII. The 
Southern Blot probe used was the 3.44 kb Pst1 fragment from the NUKM locus, which gave 
two bands for the WT (2.23 kb and 1.21 kb, as shown in figure 3.23). Strains ∆nukm and the 
eight spores analysed did not shown the characteristic wild type bands. To detect the NUCM 
gene genomic DNA from spores and WT was digested with BamHI. The Southern Blot probe 
used was the 5.5 kb SphI fragment from the NUCM locus, which gave three bands for the WT 
(1.63 kb, 2.75 and 1.12 kb, Fig. 3.23). Strains ∆nucm and the eight spores analysed (AG∆KC 
1-8) did not shown the characteristic wild type bands.  
The spore AG∆KC1 was grown for preparing mitochondrial membranes: the measured 
NADH:HAR activity was 0.2 U/mg, suggesting that no assembled complex I was present. 
NADH:HAR and dNADH:DBQ activities of the plasmid complemented parental strain 
(NUCM-NUKM wild type copy carried on the pUB4 plasmid in the AG∆KC strain) were 
comparable to the wild type activities, as reported in table 3.11. 
 
 
Strain 
Complex I 
content (%)
*2
dNADH:DBQ
*1 
U/mg 
E150 100  0.35 
AG∆KC1 20 - 
Parental
* 80 0,47 
 
 
 3 RESULTS     72 
Table 3.11     -Characterization of the E150 (Wild Type), AG∆KC1 and parental (NUCM-NUKM) 
strains- 
*1To account for variations in complex I content in different batches of mitochondrial 
membranes, dNADH:DBQ activity was normalized to complex I content expressed as 
specific NADH:HAR activity.  
*2Complex I content in mitochondrial membranes was extimated by measuring the 
dNADH:HAR activity that is not affected by mutations in the NUKM subunit (100% 
= 1.0 µmol min
-1 mg
-1). 
 
 
3.3 Realisation of a pICL1-NDH2i Construct  
 
The NDH2i, oxidizing matrix NADH and transferring electrons into the respiratory chain 
quinone pool, can rescue the NADH:oxidoreductase function of complex I (see 1.3.2). In this 
part of the work, a construct in which the NDH2i open reading frame is fused with the 
promoter for the isocitrate lyase (pICL1-NDH2i) was realised as described below. The 
pICL1-NDH2i construct should allow to conveniently switch between complex I dependent 
(glucose as sole carbon source) and independent (acetate as sole carbon source) growth, for 
selecting complex I activity deficient mutants (1.6.2). 
A pBluescriptSK
- derivate, the pUB5 plasmid, was used as starting clone. It contains a 4.7 kb 
SalI fragment that consists of the NUAM (75 kDa subunit) promoter, the NUAM pre-
sequence (1-34), the truncated (101-582) version of the NDH2 open reading frame, and 
3´sequence from the NUAM locus, as shown in figure 3.24A (Kerscher et al., 2001a). The 
ATG codon underlined in figure 3.24A is the start codon for the NUAM presequence (cf. 
appendix 9.4). The promoter for the NUAM subunit was deleted by inverse PCR using 
primers 75AGf (5´-CTC TCG AGA AAC CTC AGC AAG-3´) and 75AGr (5´-CAT CAG GAA GAG GAG 
TGT CC-3´), whose position is shown in the figure. Both primers were designed for deleting 
the NUAM promoter, but not the NUAM 1-34 import-sequence, and also the Sal I site located 
upstream of the NUAM promoter was conserved. The pICL1 promoter (shown in figure 
3.24B) was amplified from plasmid pINA354b (kind gift of Prof. Barth) using primers 
pICL1f1 (5´-AAG TGC GGC CGC GGT ACC G-3´) and pICL1r (5´-CAC TGG GTT AGT ACG GGA C-
3´), whose position is shown in the figure. The intron is necessary for the functionality of this 
promoter: the first methionine of the NUAM import-sequence is coded by the triplet ATG 
(underline in Fig. 3.24A). The pICL1 intron interrupts this triplet, but still allows the 
expression of the methionine (Fig. 3.24B). Cloning the pICL1 in front of the NUAM pre-
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sequence deleting the NUAM promoter resulted in the desired regulation of the NDH2i under 
the control of the pICL1 (Fig. 3.25). 
 
Sal I Sal I
4.7 kb   I - fragment (pUB5) : Sal
NDH2i (1.4 Kb)
NUAM
1-34
NDH2
101-582
1 kb
 3’ NUAM-promoter (1.6 Kb)  5’
inverse PCR
pICL1
1.322 Kb 1.3 Kb
TG A INTRON
Sal 1
TG A
75AGf 75AGr
A
B
13 4
NUAM
 pICL1
 5’  3’
 
 
 
Figure 3.24    -Subcloning strategy for the pICL1-NDH2i construct - 
A.  SalI fragment of the replicative vector pUB5. Arrows indicate the approximate 
position and direction of the primers. 
B.  PCR product derived from plasmid pINA 354b. Arrows indicate the 
approximate position and direction of the primers used. 
 
 
Primers pICL1f1 and pICL1r were phosphorylated at the 5´ ends (see. 2.2.4) to provide a 
blunt-ends ligation between the amplified pICL1 fragment and the product of the inverse 
PCR. Figure 3.25 shows the obtained ligation product (pUB5S) in its linear form. 
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Amp
PUB26
(8.04 Kb)
Xba1 EcoR1
Sal I Sal I Sal I
5.5 kb   I - fragment (pUB5S) : Sal
ICL1-
Intron
NDH2i
NUAM
1-34
NDH2
101-582
A TG
1 kb
NUAM 3’
ICL1-promoter
NUAM 5’
ndh2rev2
3.0 Kb 0.5 Kb
MCS Sal I
pSK- pSK-
 
 
Figure 3.25       -Subcloning strategy used for making pUB26SC plasmid– 
A 7.2 kb fragment from pUB5S was cloned into pUB26. Dotted lines were not 
drawn to scale. An arrow indicates the approximate position and direction of primer 
ndh2rev2. SalI sites are indicated. 
 
 
Plasmid pUB5S contains the pICL1 sequence that is blunt-end ligated to the presequence 
(import sequence) of the NUAM subunit of complex I (amino acid 1 to 34). This is fused to 
the truncated version of the NDH2 open reading frame (from amino acid 101 to 582). 
Different clones were tested by SalI digestion for selecting the right ligation products, and the 
correct orientation of pICL1 was verified by sequencing using the primer ndh2rev2 (5´-GTG 
TCA ATG GTT CCG GTG- 3´), which position is reported in Fig. 3.25. The sequence of the shown 
5.2 kb SalI fragment is reported in the appendix 9.4. A 7.2 kb pUB5S fragment was cloned 
into plasmid pUB26 (see 2.1.5) by cutting with NheI and EcoRI. PUB26 contains the Amp
R 
gene, the HygB
R gene and a unique NheI site (compatible with XbaI site). The subcloning 
strategy is shown in figure 3.25. The resulting plasmid (pUB26SC) was amplified in E. coli 
and transformed into Y. lipolytica, as described below. 
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3.3.1 Function of the pICL1-NDH2i Construct in Vivo 
 
Plasmid pUB26SC was transformed into strain PIPO (see 2.1.4). Transformants were selected 
for growth on YPAc (see 2.1.3) agar medium with hygromycin B. Subsequently, the ability of 
NDH2i to rescue NADH oxidation in the mitochondrial matrix and electron transfer into the 
respiratory chain quinone pool was checked by inhibition of complex I with increasing 
concentrations of 2-decyl-4-quinazolinyl amine (DQA) in the presence of acetate or glucose. 
After growth in glucose or in acetate minimal media (both adjusted to pH 7.0), cells were 
plated on the appropriate agar medium. Plates were prepared with glucose or acetate as sole 
carbon source (pH 7.0) and different concentration of DQA (0-10 µM) as selective inhibitor 
for complex I. Concentrations of DQA higher than 1.5 µM inhibited growth of cells on 
glucose, but not on acetate, as shown in figure 3.26. From these data it can be concluded that 
NDH2i is under the substrate dependent control of the ICL1 promoter. 
 
 
 
 
 
 Figure 3.26     -PIPO strain complemented with pUB26SC on glucose and acetate as sole carbon 
source-  
NDH2i is under the control of pICL1. DQA concentrations > 1.5 µM inhibit 
complex I. The pICL1-NDH2i gene functionally replaces complex I activity on 
acetate, whereas on glucose complex I inhibition is not compatible with survival of 
Y. lipolytica. 
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4 DISCUSSION 
 
4.1 Site Directed Mutagenesis of Conserved Cysteines in the TYKY and PSST Subunits 
of Complex I 
 
The exact path of electron transport from NADH to ubiquinone in complex I is still unknown: 
the number and location of iron-sulfur clusters are matters of discussion. The tetranuclear 
iron-sulfur cluster N2 is considered to be one of the central players for understanding the 
complicated complex I machinery (see 1.2.3). At the beginning of this work, subunits PSST 
and TYKY were the most likely candidates for harbouring this cluster. 
In the present work, a mutagenesis study has been carried out on all the twelve conserved 
cysteines that form the three binding motifs for iron-sulfur clusters in subunits PSST and 
TYKY (see 1.2.2). Mitochondrial membranes from strains ∆nukm,  ∆nuim and cysteine 
mutants in both subunits were analysed by Blue Native Page: no complex I band was visible, 
whereas the bands of complex V and III of the OXPHOS could be identified. This result was 
also confirmed by dNADH:HAR activity measurement: only 0.2-0.3 U/mg was the observed 
activity in these strains (see 3.1), whereas the activity of the parental strain was about 1 U/mg. 
From these results it can be concluded that the deletion of subunits PSST and TYKY and the 
mutagenesis of any cysteine residue in the conserved motifs for tetranuclear iron-sulfur 
clusters affected the stability of complex I. The interpretation of the residual dNADH:HAR 
activity in the membrane preparations from these strains is unclear. From these experiments is 
not possible to establish if the residual 0.2-0.3 U/mg of activity are due to other membrane 
proteins, to complex I fragments (of the peripheral arm, containing the 51 kDa subunit and 
FMN, cf. 2.3.7), or to a small amount of assembled complex I which is not detectable by 
BNP. Consequently, failure to detect mutant complex I could be ascribed to misfolding or to 
structural destabilisation caused by the mutations. Assuming that mutations destabilise protein 
folding, one would expect a small amount of enzyme in the mutant membrane preparations. 
Along the same line, it is reasonable to consider that detergent solubilisation by 1g/g LM, 
which works efficiently for parental strain complex I, would not be gentle enough for the 
“less stable” mutant complexes. For detecting small amounts of complex I in membranes 
avoiding the solubilisation step, mitochondrial membranes from mutant and parental strains 
reduced with NADH were analysed by EPR spectroscopy. None of the cysteine-alanine 
mutants in subunit PSST showed any signal that could be assigned to a complex I cluster. It 
follows that the residual dNADH:HAR activity measured from these membranes was either 
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due to small fragments of complex I (most likely containing the FMN and the 51 kDa subunit 
and no EPR visible clusters), or is due to the activity of other membrane proteins. On the 
basis of these results it can be concluded that there is no relevant quantity of assembled 
complex I in the mitochondrial membranes of strains in which the putative ligands of cluster 
N2 were mutagenised. 
In an effort to selectively modify the microenvironment of the cluster N2, maintaining its 
structure intact, more conservative mutations have been carried out. By changing each single 
cysteine into serine, the function of the thiol group of cysteine was replaced with a hydroxyl 
group of a serine side chain, thereby providing an oxygen ligand for the iron ions of the 
cluster. Again, assembled complex I could be not detected in mitochondrial membranes of 
Cys-Ser mutants. From these data it is not possible to conclude unambiguously if the above 
mentioned amino acids are the ligands. In fact, it is plausible to reason that the mutagenised 
cysteines play an important role for complex I stability, or that formation of the affected iron-
sulfur cluster is a prerequisite for complex I assembly in Y. lipolytica.  
In the last four years, mutagenesis studies have been carried out in Rhodobacter capsulatus, 
N. crassa and E. coli (summarised in appendix 9.3). The results obtained from mutagenesis in 
N. crassa agree with the results of the present work. Three cysteines, corresponding to C113, 
C152 and C155 in the TYKY subunit from Y. lipolytica, were mutagenised into alanine or 
serine: no assembled complex I was found in membrane preparations of the mutant strains. 
The authors concluded that the TYKY subunit and most likely the iron sulfur clusters are 
important elements for assembly of complex I (Duarte and Videira, 2000). In contrast, 
mutagenesis of the same residues in the Rh. capsulatus TYKY homologous subunit 
(corresponding to C113 and C152 in Y. lipolytica) gave an assembled complex I, which 
showed altered N2 signals in EPR spectroscopy and in which content and catalytic activity 
were lower than in the parental strain. On the basis of these results, authors concluded that 
there are two N2 type clusters in TYKY (Chevallet et al., 2003). In strong contradiction to 
this work, a combination of UV/vis and EPR spectroscopy study in the TYKY homologous 
subunit detected two novel 4Fe-4S redox groups named N6a and N6b (Friedrich et al., 2000), 
which are invisible under standard EPR conditions. 
More recently, all eight conserved cysteines in the TYKY homologous subunit from E. coli 
were mutagenised into cysteines or alanines. In contrast to eucaryotic organisms like N. 
crassa and Y. lipolytica, and similar as in Rh. capsulatus, the bacterial complex I from E. coli 
was assembled but did not show any catalytic activity (for an overview about mutagenesis of 
subunits PSST and TYKY of complex I from different organisms and relative references, see 
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appendix 9.3). The complex I content in the membrane preparations from both bacterial 
organisms was significantly decreased, suggesting a somehow compromised protein stability. 
Enzyme preparation of one mutant from E. coli was unstable and aggregated upon 
concentration and could therefore not be used for EPR spectroscopy. This observation 
corroborates the theory that these cysteines, and most likely the iron-sulfur clusters, play an 
important role for complex I stability (Flemming et al., 2003). 
In the same work all four conserved cysteines in the PSST subunit were also mutagenised into 
alanine or serine. Mutants showed an assembled complex I (unable to transport electrons to 
quinone) whose EPR properties were changed. The conclusion of this work was that cluster 
N2 is located in the PSST subunit. However, it is still unclear whether both adjacent cysteines 
in PSST are ligands or if the fourth ligand has still to be identified (Flemming et al., 2003). 
These data agree with data from a previous work in N. crassa: cysteines 85 and 86 (in subunit 
PSST) were changed into serine and alanine, respectively. Mutants were assembled, complex 
I content in membranes was comparable to the parental strain and the specific EPR signal of 
cluster N2 was absent (Duarte et al., 2002). Yield and purity of these mutant complex I 
preparations were lower when compared to the parental one and no specific N2 signal, 
recorded under standard condition, was identified from these preparations. 
Thus, the stability of cysteine-mutated complex I seems to depend on the organism. The data 
obtained from the experiments presented in this work and from the literature do not allow a 
satisfactory explanation for these phenomena. Nevertheless these results stress the important 
role of TYKY and PSST subunits for folding and assembly of complex I.  
 
4.1.2 Site Directed Mutagenesis of Conserved Acidic Residues in the NUKM Subunit 
 
To obtain more information about the role of the conserved amino acid in the PSST subunit 
and to search for the still unknown fourth ligand of iron-sulfur cluster N2, mutants of the 
highly conserved acidic residues in the PSST homologous NUKM protein from Y. lipolytica 
were constructed and characterized. These results, in addition to the data of a previous work 
in Y. lipolytica (Ahlers et al., 2000b), constitute complete mutagenesis study on the conserved 
acidic residues in this subunit and led to the identification of functionally important amino 
acids.  
EPR spectra of complex I from strains mutated in positions E89, D99, D115, D136, E140, 
D168, D174 and E185 showed normal or in one case (E89) somewhat shifted gz signals of 
iron-sulfur cluster N2. The slightly shifted N2 signals in mutants E89C, E89A and E89Q were 
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interpreted as a consequence of an altered electromagnetic environment of the cluster. On the 
basis of these results, residue E89 is most likely located in the vicinity of cluster N2, but 
definitely can be excluded as a ligand (Ahlers et al., 2000b). 
Two aspartates, Asp-99 and Asp-115, were found to be essential for complex I catalytic 
activity, but in contrast to mutant E89, the N2 gz positions of D99N and D115N were not 
shifted. This indicated that the geometry of the cluster was not substantially changed. On the 
other hand, the intensity of the gz signal was reduced by about 50% in both mutants. These 
results can be explained by a decreased protein stability, which became more evident from 
lower yields during protein purification and may have resulted in a partial loss of iron-sulfur 
cluster N2, or in a modified redox midpoint potential of the cluster. A putative formation of 
hydrogen bonds by Asp-99 and/or Asp-115 to the cysteinyl sulfur of one ligand of cluster N2, 
thereby influencing the ability of the cluster to accept electrons (defined by the redox 
midpoint potential), is a possible explanation for the reduced intensity of the N2 signal 
observed in EPR spectra of both D99N and D115N mutants. The resulting shifted redox 
potential would not allow the complete reduction of clusters N2 in the EPR sample. This 
could be excluded by titrating the redox potential and monitoring the reduction of N2 by EPR 
spectroscopy. These titrations demonstrated that the redox midpoint potential of this cluster 
was unchanged when compared to membranes of the parental strain (cf. 3.1.2). This also 
indicated that the electron transfer to N2 was not blocked and implied that the loss of catalytic 
activity, as well as the reduction of the gz signal intensities, were not due to a change in the 
redox properties of the cluster. Consequently, the modified N2 signal intensity is most likely 
due to a destabilisation effect caused by the mutations. 
One explanation for the loss of dNADH:DBQ activity caused by removing the carboxylic 
groups in positions 99 and 115 could be their role as proton donor/acceptors. In fact, two 
protons are required for the reduction of ubiquinone to ubihydroquinone. Assuming the 
hypothesis that both carboxylic groups act as proton acceptor-donor in the ubiquinone 
oxidoreduction process, the carboxylic groups were conserved introducing an additional 
methylene group by changing the aspartates to glutamates. The complete loss of ubiquinone 
reductase activity in both D99E and D115E lowered this theory. Analysis of purified complex 
I from mutant and parental strains by FTIR (Fourier Transform Infrared) spectroscopy, a 
technique that can detect whether an acidic residue is in the protonated or no-protonated state 
during the oxidoreduction, are currently under way in the group of Professor Peter Rich 
(London, UK). Also removing the side chain completely by changing the aspartates into 
glycines had the same effects as the more conservative mutations. Mitochondrial membranes 
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from all six mutants contained virtually normal amounts of complex I: even the rather drastic 
exchange of each of the aspartates to glycine still allowed normal assembly of complex I and 
its residual activity was as low as for the more conservative exchanges. The very similar 
effect of rather different amino acid exchanges in these two positions makes it tempting to 
speculate that in all cases a similar local change of a structural configuration occurred and that 
the resulting fold was incompatible with ubiquinone reductase activity of complex I. Further 
experiments will be required for checking this hypothesis (see 5). From these data it can be 
concluded that D99 and D115 play a vital role for complex I NADH:ubiquinone reductase 
activity, but are not ligands for N2 cluster. In addition, their position seems to be not close 
enough to the cluster to influence directly its electromagnetic environment. 
In contrast to aspartates 99 and 115 in the PSST subunit, changing other acidic amino acids 
that are fully conserved between complex I from different organisms but not between 
complex I and [Ni-Fe] hydrogenases, had only moderate effects on NADH:ubiquinone 
oxidoreductase activity or on inhibitor resistance (Fig. 4.1A). Results from mutagenesis that 
have been carried out until now in Y. lipolytica are briefly summarised below. 
Mutations D136N and E140Q have significant effects on inhibitor binding, whereas changing 
asparagine 168 to the corresponding amide had little or no effect on inhibitor resistance 
(Ahlers et al., 2000b). Aspartate 174, when changed to its corresponding amide, had little or 
no effect on the Michaelis-Menten parameters and the N2 EPR signal from the membrane did 
not show any difference when compared to the parental strain. Mutant E185Q showed a 
significantly reduced VMax, but EPR spectra of isolated complex I showed unequivocally that 
not only the specific N2 signal, but also the signals of the other iron-sulfur clusters were not 
different from those of the parental strain. This definitely excludes a role of this residue as 
ligand of cluster N2. Both amino acid residues are located in the vicinity of C180, one of the 
candidates for ligating this cluster (Fig. 4.1A). The modification of these positions, changing 
the carboxylic groups of the side chains into amide groups, did not have any consequence on 
the micro-environment of the N2 cluster. Considering the result obtained from changing 
glutamate 89 into glutamine (see 1.3.4), it can be concluded that both residues D174 and E185 
are not ligands of cluster N2, even though their positions in the primary structure suggest 
them as possible fourth ligand. A more detailed interpretation of the observed effects of the 
mutations on complex I catalytic activity and inhibitor sensitivity is not possible without a 
high-resolution structure of complex I. Nevertheless, looking at the alignment between the 
small subunit of the [Ni-Fe] hydrogenase from D. fructosovorans and the PSST subunit from 
complex I (Fig. 4.1A), and using the X-ray structure of the [Ni-Fe] hydrogenase as a model, 
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preliminary conclusions can be drawn on the basis of the homology between the two enzyme 
classes (see below). 
 
4.1.3 The Structure of [Ni-Fe] Hydrogenases as a Model for Complex I 
 
Structures of homologous proteins can be helpful for understanding the machinery of complex 
I. In particular, the molecular structure of the water soluble [Ni-Fe] hydrogenases from D. 
fructosovorans offers a useful model for studying subunits PSST and 49 kDa. In fact, not only 
homology studies (cf. 1.2.4) but also experimental evidences (cf. 1.3.4), strongly suggest that 
both subunits are structurally and functionally connected, constituting part of the “module” 
which is responsible for the ubiquinone reductase activity and which has evolved from the 
hydrogenases structure (cf. 1.2.5). 
A sequence alignment between the [Ni-Fe] hydrogenase small subunit from D. fructosovorans 
and the PSST homologous subunit from Y. lipolytica is shown in Fig. 4.1A. Sequence 
conservation is rather weak, but three of the four cysteines that ligate the proximal cluster in 
the small hydrogenase subunit are conserved in subunit PSST, allowing a reasonable 
alignment of the sequences. Figure 4.1B shows the X-ray structure of the [Ni-Fe] hydrogenase 
of  D. fructosovorans. Subunit PSST is much smaller than the small hydrogenase subunit 
because the C-terminal half that forms the domain harbouring two of the three iron-sulfur 
clusters of the hydrogenase is missing (marked in grey) and the N-terminal part up to the first 
cysteine ligating cluster N2 is partially missing in the small subunit (marked in yellow). The 
domain marked in blue represents the region between cysteines 86 and 150: this region in 
complex I is shortened by 30 amino acids in comparison to the corresponding region of the 
small hydrogenase subunit. Changing glutamate 89 in Y. lipolytica PSST subunit has an effect 
on the N2 signal in EPR spectroscopy. In addition, the fully conserved position 99 is vital for 
complex I physiological activity. Also aspartate 115 was found to be essential for complex I 
activity, even if apparently this position is not fully conserved in the alignment in Fig. 4.1A. 
Looking at the sequence of the small subunit there is no amino acid corresponding to this 
position in the alignment, whereas the adjacent position is an aspartate. In addition, the two 
above mentioned aspartates are separated by 35 amino acids in the small subunit from D. 
fructosovorans whereas only 16 amino acids are present in PSST. It follows that the 35 amino 
acids which separate both positions form a connecting loop in the [Ni-Fe] hydrogenase of D. 
fructosovorans, which is supposed to be much smaller in complex I. The two aspartates D33 
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and D68 (supposed to be homologous to D99 and D115 in NUKM, respectively) are drawn as 
space fill models and the connecting loop in between is marked in grey (Fig. 4.1B). 
All this suggests that the position of cluster N2 and the folding of its environment are 
essentially conserved, although the sequence homology between PSST and small subunit is 
rather weak.  
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igure 4.1   -Alignment between domains of the small subunit of [NiFe] hydrogenase and 
correspondent domains of subunit PSST of complex I- 
  89         99              115    119                    136  140  86                     
yl    nukm   82  GLACCAVEMMHVSAPRYD        SPRQSD..IMIVAGSLTN   KMAPVLRQVYDQMPEPRWVIS 
human nukm   85  GLACCAVEMMHMAAPRYD        SPRQSD..VMIVAGSLTN   KMAPALRKVYDQMPEPRYVVS 
ECHC         16  SCNGCDIEVVACLTPLYD        TPKQAD..IMVVTGSVNY   KNVNVLKNIYNQIPDPKVVLA 
dfss         16  ECTGCTEAAIRTIKPKID        LEGKD.GYYLVVEGGLPT   AGHPMIETCKKAAAKAKGIIC 
                         33            68       
 
 
                                              174     185 
  17 20     
150             180   
yl    nukm  146               MGSCANGGGYYHFSYS..VVRGCDRIVPVDVY.VPGCPPTSEALMYG 
human nukm  149               MGSCANGGGYYHYSYS..VVRGCDRIVPVDIY.IPGCPPTAEALLYG 
ECHC         92               VGACASTGGIFHDCN...VIGGVDQVIPVDAY.VPGCCPRPEAILDG 
dfss        111               IGTCSAYGGVQKAKPNPSQAKGVSEALGVKTINIPGCPPNPINFVGA 
                                                                   114 147
F
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A Sequences of PSST homologous subunits of complex I from Yarrowia lipolytica 
(yl) and human (human) mitochondria have been aligned with the small subunits of 
hird cysteine of the 
 
A domain form e] hydrogenase secondary structure is shown 
 figure 4.2. Two of the three β-strands are predicted to be conserved in complex I folding 
mplex I, in terms of assembly (cysteine mutants) or catalytic 
[NiFe] hydrogenases from Methanosarcina barkeri (ECHE) and Desulfovibrio 
fructosovorans (dfss). C17, C20, C114, and C147 which ligate the proximal iron-
sulfur cluster in hydrogenase and their homologues C86, C150, and C180 in Y. 
lipolytica are marked in red, conserved residues in yellow, similar residues in grey, 
and mutagenised residues which have been characterised in pink. 
B Ribbon representation of the X-ray structure of the [Ni-Fe] hydrogenase. The 
domain marked in blue is the region between the second and t
small subunit, magenta is the region downstream of the third cysteine which is 
retained in subunit PSST of complex I, grey is the C-terminal domain of the small 
subunit that carries two iron-sulfur clusters and that is missing in subunit PSST of 
complex I. Mutations in subunit PSST of complex I that have significant effects are 
clustered in the region corresponding to the domain shown in blue. The proximal iron-
sulfur cluster is shown in yellow space fill representation. D33 and D68 
(corresponding to D99 and D115 in complex I, respectively) are represented in space 
fill. The large subunit, homologous to the 49 kDa subunit in complex I, is marked in 
red. See text for detailed discussion. 
ed by three β-strands in the [Ni-F
in
(cf. 9.7): cysteine 114 (C150 in Y.l.), V74 (V119 in Y.l.) and D68 (D115 in Y.l.) belong to this 
conserved domain (Fig. 4.2).  
With respect to this assumption, all the fully conserved residues that have been mutagenised 
showed dramatic effects on co
activity (D99-D115). Mutant V119M, which also affects a residue fully conserved in the 
alignment shown in figure 4.1A, showed 50% reduction of VMax in vitro when mitochondrial 
membranes were prepared from Y. lipolytica and had a lethal effect in two patients that were 
homozygous for this mutation.  
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Figure 4.2     -A domain in the small subunit of [Ni-Fe] hydrogenase corresponds to a functional 
relevant domain within subunit PSST- 
The shown domain formed by 3 β-strands is predicted (by the software “PROF”) to be 
partially conserved in complex I secondary structure (bottom two β-strands in the 
figure). Position corresponding to mutagenised residues in the PSST subunit of Y. 
lipolytica are indicated. 
 
Mutations at positions E89, D136, E140, D174 and E185, which are conserved between 
complex I subunits of eucaryotes but not between complex I and [Ni-Fe] hydrogenases, 
showed milder effects. 
In the 49 kDa subunit of Y. lipolytica, two strictly conserved histidines (91 and 95) have been 
mutagenised. Likely as D99 and D115, both of them were found to be essential for complex I 
NADH:oxidoreductase activity (Grgic et al., 2004), whereas they are not conserved in the 
hydrogenases from D. fructosovorans (only histidine 91 is conserved in the [Ni-Fe] 
hydrogenase from M. barkeri). Replacing each histidine by alanine causes a drastic reduction 
(~95%) of the complex I catalytic activity but had no effect on complex I content in the 
membrane and on the EPR signals of the iron-sulfur clusters. In the hydrogenase structure, 
both residues are near (10-20 Å) to the proximal iron-sulfur cluster and the prosthetic Ni. 
Histidine 228 in the large subunit of the [Ni-Fe] hydrogenase from D. fructosovorans, which 
has a position near to both Ni site and iron-sulfur cluster (~10 Å and 6 Å, respectively), is 
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conserved between complex I and [Ni-Fe] hydrogenases. Mutant H226A in Y. lipolytica 
(Kashani-Poor et al., 2001b) showed 25% of the wild type catalytic activity and no N2 signal 
in EPR spectroscopy, indicating that the mutation in the 49 kDa subunit has an effect on 
cluster N2. These results support the suggestion that the “catalytic core” (N2 cluster and 
quinone binding site) of complex I has been evolved from the electron transfer module of the 
[Ni-Fe] hydrogenases. Aspartates 99 and 115, being somehow necessary for the electron 
transport from N2 to quinone, directed the attention to a conserved region in the PSST 
subunit, which is predicted to be located at the interface of two key subunits.  
 
4.1.4 Yarrowia lipolytica as a Eucaryotic Model to Analyse Leigh Syndrome Mutations in 
the Complex I Subunits PSST and TYKY 
 
The effects of three mutations identified in the PSST and TYKY homologous subunits of 
patients affected with Leigh syndrome were reconstructed in the obligate aerobic yeast Y. 
lipolytica (cf. 1.4 and 3.1.3). This approach may help to understand the aetiology of the Leigh 
syndrome, in terms of the ability of complex I to oxidize NADH and to transport electrons (cf. 
1.6). The kinetics of mutant complexes was analysed in vitro with mitochondrial membranes 
of each mutant strain. The purpose of these experiments was to detect alterations in the 
NADH:ubiquinone oxidoreductase activity of complex I. In fact, the mutations are located in 
two subunits that belong to the “ubiquinone reduction” module of complex I. All three 
mutations showed effects on electron transport: VMax was reduced by about 50% in all three 
mutants (Table 3.6). The NADH:HAR activity of V119M and R101H was comparable to the 
parental strain implying a normal complex I content in the membranes. On the other hand, 
P78L showed a significant reduction in NADH:HAR activity (~60% of the parental strain 
activity, Table 3.10). The lower complex I content in the membrane was most likely due to a 
somehow reduced stability of the enzyme: as complex I is essential for survival of Y. 
lipolytica its expression cannot be selectively down regulated. Since the TYKY subunit is not 
directly involved in NADH oxidation, it can be also excluded that this mutation has some 
effects on the NADH:HAR activity (cf. 2.3.7). Consequently, it can be speculated that the 
proline has an important role in the secondary structure of the protein, and that a lysine is not 
able to fulfill its role. The previously described hypothesis (3.1.1) that the TYKY subunit may 
play an important structural role was supported by a reduced complex I content in the 
membrane preparation caused from the change of a single conserved residue. In addition, the 
inhibitory potency of the ubiquinone analogues DQA and rotenone was also altered in all 
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three mutant strains. These facts suggested a somehow modified interaction between the 
ubiquinone binding site and substrates and/or inhibitors of complex I. 
Residue V119 is located in a high conserved region of eucaryotic PSST subunits, which is 
also highly conserved when procaryotes are included into the alignment (Fig. 3.19). Position 
D115, which has been demonstrated to play a vital role for complex I catalytic activity, is 
only four residues away. Investigating the effect of this Leigh mutation on the 
microenvironment of the N2 cluster, complex I from mutant V119M was isolated and the 
EPR spectrum was recorded. No significant differences were noticed comparing this spectrum 
to the parental one, except for a reduction of the N2 signals (Fig. 3.22). The unshifted N2 gz 
signal excluded definitely a modification of the geometry of this cluster. The interpretation of 
the about 40% reduction of the gz signal intensity is more ambiguous. Differently to D99N 
and D115N, mutating valine 119 into methionine no carboxylic group able to form hydrogen 
bonds to the cluster had been removed. Therefore, the most plausible explanation of the 
reduced gz signal intensity in the V119M spectrum is a folding destabilization due to the 
mutation. 
 
4.2 The pICL1-NDH2i Construct Rescues Complex I Deficiency Selectively on Acetate 
(or Ethanol) Synthetic Medium 
 
Recently Y. lipolytica has been developed as a yeast genetic system to study mitochondrial 
complex I (for an overview see Kerscher et al., 2002). 
The present work introduced the promoter for the Isocitrate lyase (pICL1) as a useful tool for 
the substrate selective expression of the internal version of the alternative NADH:ubiquinone 
oxidoreductase (NDH2i under the control of the pICL1), which allows the “in vivo” rescue of 
complex I deficiency selectively on acetate (or ethanol) medium (cf. 3.3.1). 
The integration of the pICL1-NDH2i construct into the genome of Y. lipolytica deletion 
strains for nuclear-coded subunits (like ∆nukm,  ∆nucm and ∆nuim) would contribute to 
develop Y. lipolytica as a useful genetic device for studying mitochondrial complex I (cf. 5.2). 
This strategy presents the advantage to produce a high number of point mutations in a specific 
subunit, by using a “degenerate PCR” technique. Transformation of these products into the 
complex I subunit deletion strains, which carry the pICL1-NDH2i construct integrated into 
the genome, would allow the screening of the resulting transformants by simply “switching” 
between glucose and acetate as sole carbon source. In fact, mutant strains in which complex I 
activity is compromised by the mutation could be easily screened by plating mutants on 
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acetate (complex I independent growth) and on glucose (complex I dependent growth) media. 
In addition, resistance against complex I inhibitors could be screened in a similar way, by 
adding different concentrations of inhibitor to the agar media. 
In an effort to understand the complex I mechanism without an X-ray structure, and in 
particularly being interested in the “ubiquinone reduction” module (PSST, TYKY, 49 kDa), 
the possibility to screen for a large number of activity deficient or inhibitor resistant point 
mutations following region specific random mutagenesis constitutes an attractive perspective 
for complex I research. 
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5 Outlook 
 
5.1 Site Directed Mutagenesis of both 49 kDa and PSST Subunits of Complex I 
 
Results from mutagenesis studies in both PSST and 49 kDa subunits pointed out that residues 
which are conserved between hydrogenases and complex I play a important role for the 
catalytic activity of this complex protein. At the time of writing this thesis, important 
information about structure and mechanism of complex I was still missing. Therefore an 
exhaustive interpretation of the mutagenesis results would be premature. However, assuming 
that the folding of the [Ni-Fe] hydrogenase from D. fructosovorans has been partially 
conserved during evolution helped to find a reasonable interpretation for experimental data. 
Using the X-ray structure of the [Ni-Fe] hydrogenase as a model, the aspartate 99 in PSST 
and the histidines 91 or 95 in the 49 kDa subunit are predicted to be located at the interface 
between the two proteins. Consequently, they can be speculated to form a specific ionic bond 
between the two subunits, which may play an important role in protein folding or enzyme 
activity. Analysis of double PSST/49 kDa-mutants, in which an aspartate in the PSST is 
changed into histidine and the histidine in 49 kDa subunit is changed into aspartate, will test 
this hypothesis. In this respect and in an effort to investigate the interaction between the two 
subunits, a ∆nukm/nucm (PSST/49 kDa) strain has been constructed (cf. 3.2).  
 
5.2 Integration of the pICL1-NDH2i Construct into the Genome  
 
Deletion strains of the subunits that form the “ubiquinone reduction” module (∆nukm, ∆nucm 
or ∆nuim) containing a chromosomal-integrated copy of the pICL1-NDH2i construct would 
allow the analysis of plasmid encoded mutants of the corresponding deleted subunit. 
Furthermore, these strains could be used for mutant screens with complex I dependent versus 
independent growth, allowing the identification of essential amino acid residues or of 
inhibitor resistance mutations. 
Two strategies for the integration of the pICL1-NDH2i construct could be proposed: 
1.  Integration of the pICL1-NDH2i into the Y. lipolytica genome and subsequent deletion 
of the desired subunit 
2.  Changing NDH2i with the pICL1-NDH2i by POP-IN-POP-OUT in each deletion 
strain (Kerscher et al., 2002). 
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The first strategy presents the advantage to require relatively short time and to give a strain 
that can be used as starting point for creating deletion strains of all seven nuclear coded 
subunits of complex I. The disadvantage is that the pICL1-NDH2i would be randomly 
integrated into the Y. lipolytica genome and the integrity and functionality of the resulting 
strain must be checked. 
The second strategy offers the advantage to integrate the construct into the background of an 
existing and characterised locus of the NDH2i, but the entire procedure has to be repeated for 
each deletion strain. 
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6 Summary 
 
 
Proton-translocating NADH:ubiquinone oxidoreductase (complex I) transports two electrons 
from NADH to membranal ubiquinone: in this process protons are translocated across the 
membrane, producing 40% of the total proton gradient between matrix side and 
intermembrane space. Mitochondrial complex I contains at least 46 subunits in mammals, and 
has a molecular weight of around 1000 kDa. Electronic microscopy analysis showed that 
complex I has an L-form, which consists of two domains: a peripheral “arm” (hydrophilic 
domain) and a membrane “arm” (hydrophobic domain). The peripheral domain, which 
protrudes into the matrix, contains one non-covalently bound flavin mononucleotide (FMN) 
and the iron-sulfur clusters N1a, N1b, N2, N3, N4 and N5 as redox active groups. They 
transport electrons from NADH to ubiquinone. Cluster N2 is supposed to be the immediate 
electron donor to ubiquinone by virtue of its highest and pH dependent redox midpoint 
potential (Em,7 –150 mV). The exact location of the tetra-nuclear cluster N2 is still object of 
discussion. The TYKY and the PSST subunits contain three binding motifs for tetranuclear 
clusters which are formed by twelve cysteins. In an effort to investigate the “ubiquinone 
reduction module” of complex I, in the first part of this work site directed mutagenesis of the 
TYKY and PSST subunits has been carried out. Mutant strains were characterised in terms of 
complex I content, catalytic activity and EPR signature of cluster N2. The second part of this 
work was aimed at developing a substrate inducible version of the internal alternative 
NADH:ubiquinone oxidoreductase (NDH2i). A substrate inducible NDH2i is expected to 
offer a “switch” between complex I activity dependent (no NDH2i activity) and independent 
(NDH2i activity) cell growth, by changing between activating and non-activating substrates. 
This strategy would allow the screening for two types of complex I mutants, which is a 
prerequisite for realising a random PCR mutagenesis of single subunits of complex I, that 
allows the production of a high number of point mutations in relatively short time. Y. 
lipolytica complex I deficiency mutant strains could be easily identified, by virtue of their 
inability to survive under complex I dependent growth conditions (no NDH2i activity). By 
this way, amino acids that have an important role for complex I structure or function could be 
identified by subsequent sequence analysis.  
Each of the twelve cysteines that form the above mentioned three binding motifs for iron-
sulfur cluster have been mutagenised. In mutant mitochondrial membranes, no assembled 
complex I could be detected. From these data one may conclude that the mutagenised 
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cysteines play an important role for complex I stability, or that are a prerequisite for complex 
I assembly in Y. lipolytica, but there is not direct evidence indicating that any of the four 
mutagenised residues acts as a ligand. Two aspartates in the PSST subunit, Asp-99 and Asp-
115, were found to be essential for complex I catalytic activity. EPR spectroscopic analysis 
indicated that the electron transfer to N2 cluster was not blocked and implied that this was not 
the reason for the loss of catalytic activity. From these data it can be concluded that D99 and 
D115 play a vital role for complex I NADH:ubiquinone reductase activity, but are not ligands 
for cluster N2 and that their position is not close enough to the cluster to influence directly its 
electromagnetic environment. 
Three mutations, identified in the PSST and TYKY homologous subunits of patients affected 
with Leigh syndrome (V119M in PSST, P78L and R101H in TYKY) were reconstructed in 
the obligate aerobic yeast Y. lipolytica. This approach may help to understand the aetiology of 
the Leigh syndrome, in terms of the ability of complex I to oxidize NADH and to transport 
electrons. In fact, all three mutations showed effects on electron transport, reducing the VMax 
by about 50%. Mutant V119M in the PSST subunit, which had a lethal effect in two patients 
that were homozygous for this mutation, affects a fully conserved residue. Overall, the results 
from site directed mutagenesis carried out so far support the theory that the “catalytic core ” 
(N2 cluster and quinone binding site) of complex I has been evolved from the electron 
transfer module of the [Ni-Fe] hydrogenases. In fact, mutagenesis of residues that are fully 
conserved between complex I and [Ni-Fe] hydrogenases, showed dramatic effects on complex 
I in terms of assembly (cysteine mutants) or catalytic activity (D99-D115). Differently, 
changing aspartate 174 and glutamic acid 185 (not fully conserved, Fig 4.1A) had little or no 
effect on the Michaelis-Menten parameters and N2 EPR signal. 
In recent years Y. lipolytica has been developed as a yeast genetic system to study 
mitochondrial complex I. The present work introduced the promoter for the isocitrate lyase 
(pICL1) as a useful tool for the substrate selective expression of the internal version of the 
alternative NADH:ubiquinone oxidoreductase (pICL1-NDH2i). This allows to rescue 
complex I deficiencies “in vivo” selectively by growth on acetate (or ethanol) medium. The 
integration of the pICL1-NDH2i construct into the genome of Y. lipolytica and subsequent 
deletion of nuclear-coded subunits like PSST, TYKY and 49 kDa, would contribute to further 
develop this organism  as a useful genetic model for studying subunits of mitochondrial 
complex I by site directed mutagenesis.  
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8 Zusammenfassung 
 
8.1 Die Mitochondriale Atmungskette 
 
Die mitochondriale Atmungskette transportiert  Elektronen über ein Potenzialgefälle von 1,14 
V (Em,7) von NADH zum Sauerstoff und pumpt Protonen über die innere mitochondriale 
Membran in den Zwischenmembranraum. Dabei wird ein Protonengradient erzeugt. Vier 
Enzyme (Komplexe) und zwei Elektronüberträger gehören zu der Atmungskette: 
NADH:Ubichinon Oxidoreduktase (Komplex I), Succinat:Ubichinon Oxidoreductase 
(Komplex II), Ubihydrochinon:Cytochrom c-Oxidoreduktase (Komplex III), Cytochrom c-
Oxidase (Komplex IV), Ubichinon (UQ), Cytochrom c. Die ATP-Synthase (Komplex V) 
verwendet diesen Protonengradienten um ATP zu synthetisieren. 
 
8.2 Der Komplex I 
 
Die protonenpumpende NADH:Ubichinon Oxidoreduktase (Komplex I) oxidiert NADH und 
überträgt zwei Elektronen auf Ubichinon. Dabei werden zwei Protonen pro Elektron über die 
Membran transportiert. Komplex I, vorhanden in vielen Prokaryonten und Eukaryonten, trägt 
zu ca. 40% des Protonengradientes zwischen Matrix und Zwischenmembranraum bei. Das 
bakterielle Enzym besteht aus 13 Untereinheiten (in E. coli) und hat eine Masse von ca. 500 
kDa. Das mitochondriale Enzym besteht aus mindestens 46 Untereinheiten in Säugetieren und 
hat eine molekular Masse von ca. 1000 kDa. 
 
•  Komplex I Struktur 
 
Die 13 Untereinheiten, aus denen der bakterielle Komplex I aufgebaut ist, sind zu den 
mitochondrialen Untereinheiten homolog. Aus diesem Grund wird der bakterielle Komplex I 
aus E. coli als „minimale Form“ bezeichnet. Elektronmikroskopische Untersuchungen haben 
gezeigt, dass der Komplex I eine L-förmige Gestallt aufweist, wobei der sogenannte 
Membranarm (Membrandomäne) in die innere mitochondriale Membran eingebettet ist und 
der periphere Arm (Peripherendomäne) in die mitochondriale Matrix hinein ragt. In der 
hydrophilen, Peripherendomäne befinden sich 7 kernkodierte Untereinheiten: 20 kDa (oder 
TYKY), 23 kDa (oder PSST), 24 kDa, 30 kDa, 49 kDa, 51 kDa, und 75 kDa. Diese enthalten 
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alle bekannten Redoxgruppen des Komplex I: FMN und die Eisen-Schwefel Cluster N1a, N1b, 
N2, N3, N4 und N5. Die Membrandomäne enthält 7 hydrophobe Untereinheiten: ND1-6 und 
ND4L, die in Eukaryonten mitochondrial kodiert sind. 
 
•  Eisen-Schwefel Zentrum N2 
 
Das tetranukleare (4Fe-4S) Zentrum N2 wird als letztes Redox-Zentrum in einer Kette von 
Eisen-Schwefel Zentren vor dem Ubichinon vermutet. Außerdem könnte N2 wegen seines 
pH-abhängigen Mittelpunktpotenziales eine wesentliche Rolle bei der Protonentranslokation 
spielen. Drei konservierten Cystein-Bindungsmotive für tetranukleare Eisen-Schwefel Cluster 
wurden in zwei kernkodierten, hydrophilen Untereinheiten identifiziert: PSST (NUKM) und 
TYKY (NUIM).  
 
8.3 Zielsetzungen 
 
•  Mutagenese aller zwölf Cysteine, die zu den drei oben-genanten Bindungsmotiven 
gehören, um die N2 Liganden zu identifizieren. 
•  Mutagenese von konservierten sauren Resten in der PSST Untereinheit. 
•  Erzeugen einer Substrat induzierbaren Version der alternativen nicht 
protonenpumpenden NADH:Ubichinon Oxidoreduktase, um Y. lipolytica als 
hefegenetisches Modellsystem für Komplex I Untersuchungen weiter zu entwickeln. 
 
8.4 Ergebnisse 
 
•  TYKY (NUIM) 
 
Alle konservierten Cysteinreste, die zu dem Bindungsmotiv (CxxCxxCxxxCP –(x)27 – 
CxxCxxCxxxCP) für zwei tetranukleare Eisen-Schwefel Cluster gehören, wurden zu 
Alaninreste mutiert. Es wurde, weder in den Cys-Ala Mutanten noch in dem ∆NUIM 
Deletionsstamm, ein assemblierter Komplex I gefunden.  
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•  PSST (NUKM) 
 
Alle konservierten Cysteine, die zu dem Bindungsmotiv (CC(x)63 - C(x)28 – GCPP) für ein 
tetranukleares Eisen-Schwefel Cluster gehören, wurden zu Alaninresten und Serinresten 
mutiert. Auch in diesem Fall, war weder in ∆NUKM noch in den Cys-Mutanten assemblierter 
Komplex I vorhanden. 
 
•  Saure Reste 
 
Vier konservierte saure Reste in der PSST Untereinheit D99, D115, D174 und E185 könnten 
als vierter Ligand für das Cluster N2 dienen. Mutagenese dieser Reste wurde durchgeführt 
und Komplex I Assemblierung, dessen Gehalt in mitochondrialen Membranen und dessen 
katalytische Aktivität in dem Elternstamm und in den Mutanten wurden gemessen. 
Die Aspartatreste 99 und 115 wurden durch Asparaginreste, Glutaminreste und Glycinreste 
ersetzt. Alle Mutanten hatten einen assemblierten Komplex I und die Membranpräparationen 
zeigten einen normalen Gehalt an Komplex I. Die NADH:Ubichinon oxidoreductase Aktivität 
war jedoch auf 5% der wildtypischen Aktivität reduziert. Im EPR Spektren mit isoliertem 
Komplex I aus beiden Stämmen war das gz Signal nicht verschoben. Redoxtitrationen von 
Cluster N2, die mit der Hilfe der EPR Spektroskopie gemessen wurden, schlossen beiden 
Reste als vierten Liganden aus. 
Aspartat 174 wurde zu Asparagin mutiert und Glutamat 185 zu Glutamin. Der Komplex I 
Gehalt war in beiden Mutanten mit dem wildtypischen vergleichbar. Die katalytische 
Aktivität war jedoch im Stamm E185Q deutlich reduziert und in Stamm D174N unverändert. 
Auch in diesem Fall konnten die beiden sauren Reste, anhand von EPR-Spektren, als 
Liganden für Cluster N2 ausgeschlossen werden. 
 
•  Leigh Mutanten 
 
Zwei Punktmutationen in der TYKY (P78L, R101H) und PSST (V119M) homologe 
Untereinheiten wurden mit der Leigh Syndrome in Verbindung gebracht. Diese drei 
Mutationen wurden in Y. lipolytica rekonstruiert. Alle drei Mutanten zeigten ca. 50% 
reduzierte Aktivität und veränderte I50 Werte für Rotenon und DQA. 
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•  NDH2i-pICL1 
 
Das Konstrukt für die interne Version der alternativen NADH:Ubichinon Oxidoreduktase 
(NDH2i) besteht aus dem NUAM Promoter, der NUAM Pre-Sequenz, die für den Import des 
Proteins auf die innere Seite der Membran verantwortlich ist, und einer verkürzen Version des 
ORFs der NDH2. Der NUAM Promoter wurde gegen den pICL1 Promoter ausgetauscht. Das 
resultierende Konstrukt (NDH2i-pICL1) wurde in Y. lipolytica transformiert. Transformanten 
wurden auf synthetischem Glucose Medium (SD) und synthetischem Acetat Medium (SAc) 
entweder mit oder ohne den Komplex I spezifischen Hemmstoff DQA ausplattiert. Das 
Wachstum der Transformanten zeigte, dass die NDH2i selektiv unter der Kontrolle des pICL1 
Promoters nur auf SAc eprimiert wird, aber nicht auf SD. 
 
•  Erzeugung eines ∆nucm -∆nukm Stammes 
 
Zur Untersuchung von Doppel-Punktmutanten in der PSST und 49 kDa Untereinheiten, die zu 
einem besseren Verständnis von Struktur und Funktion des „Ubiquinone Oxidoreduktase“ 
Modules beitragen sollen, war es zunächst notwendig einen haploiden Stamm zu erzeugen, in 
dem die beiden Allele für die PSST (NUKM) und 49 kDa (NUCM) Untereinheiten deletiert 
sind. Die Deletion beider Allele entstand durch Kreuzung der NUCM und NUKM Stämme 
und wurde durch PCR und Southern Blot bestätigt. 
 
8.5 Fazit 
 
Die Mutation von zwei Aspartatresten in der PSST Untereinheit führte zu einen assemblierten 
Komplex I, dessen katalytische Aktivität weniger als 5% des Elternstammes betrug. EPR 
Spektroskopische Untersuchungen schlossen eine direkte Beteiligung der beiden Reste als N2 
Liganden und eine Blockierung des Elektronentransportes zu Cluster N2 durch die 
Mutationen aus. Die mögliche Rolle der beiden Reste wurde anhand der Homologie zu den 
[Ni-Fe] Hydrogenasen diskutiert. Punktmutationen zeigten, dass Aminosäuren, die zwischen 
[Ni-Fe] Hydrogenasen und Komplex I konserviert sind, eine zentrale Rolle für die Struktur 
oder die Funktion des Komplex I spielen. Trotz der niedrigen Homologie zwischen den zwei 
Enzymklassen, weisen die Ergebnisse dieser Arbeit darauf hin, dass die allgemeine Faltung 
des Komplex I und der [Ni-Fe] Hydrogenase in der Nähe des Cluster N2 im Laufe der 
Evolution konserviert geblieben ist. 
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In den letzen Jahren, wurde Y. lipolytica als hefegenetisches Modellsystem entwickelt, um 
den mitochondrialen Komplex I zu untersuchen. In dieser Arbeit wurde der Promoter für die 
Isocitrat lyase als genetisches „Werkzeug“ für die „in vivo“ Substrat-abhängige Expression 
der NDH2i eingeführt. Diese ermöglicht, für Komplex I inaktive Mutanten, das selektive 
Wachstum auf Acetat Medium. 
 
8.6 Ausblick 
 
Die Integration des pICL1-NDH2i Konstruktes in das Y. lipolytica Genom ist der nächste 
notwendige Schritt für eine Zufallsregiospezifische Mutagenese auf einzelne Untereinheiten 
von Komplex I. Der Stamm mit einer genomischen Version des pICL1-NDH2i Konstruktes 
und die genomische Deletion der gewünschten Untereinheit sollte mit der mutagenisierten 
Kopie des Genes für die deletierte Untereinheit transformiert werden. Zwei 
Integrationsstrategien wurden in dieser Arbeit vorgeschlagen: 
•  Zufalls-Integration des Konstruktes in das Y. lipolytica Genom und eine 
darauffolgende Deletion der gewünschten Untereinheit 
•  Austausch der NDH2i Version in den Delektionsstämme gegen das pICL1-NDH2i 
Konstrukt, mit der Hilfe der POP-IN-POP-OUT Strategie. 
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9     Appendix  
 
9.1 Nomenclature Comparison Between Complex I Subunits from E. coli and the 
Homologous Subunits from Different Organisms 
 
 
E. coli 
NUO 
Bos taurus  Y. lipolytica H. sapiens  N. crassa 
NUO 
P. denitrificans
Th. thermophilus
NQO 
B  20 kDa or PSST NUKM  NDUFS7  19.3 kDa.  6 
I  23 kDa or TYKY NUIM  NDUFS8  21.3c. 9 
E 24  kDa  NUHM  NDUFV2  24 kDa  2 
C* 30  kDa  NUGM  NDUFS3 31 kDa  5 
D* 49  kDa  NUCM  NDUFS2  49 kDa  4 
F 51  kDa  NUBM  NDUFV1 51 kDa  1 
G 75  kDa  NUAM  NDUFS1 78 kDa  3 
H ND1  NU1M  MTND1  ND1 8 
N ND2  NU2M  MTND2  ND2 14 
A ND3  NU3M  MTND3  ND3 7 
M ND4  NU4M  MTND4  ND4 13 
K ND4L  NULM  MTND4L  ND4L 11 
L ND5  NU5M  MTND5  ND5 12 
J ND6  NU6M  MTND6  ND6 10 
 
 
Table 9.1     -Nomenclature of complex I core subunits in different organisms- 
The different nomenclatures for the homologous subunits that constitute the “minimal 
form” of complex I are compared (life Science Division CEA, 2004) 
*Subunits C and D are fused in E. coli. 
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9.2 A brief Summary of EPR Spectroscopy of Iron-Sulfur Clusters in Complex I from Y. 
lipolytica  
 
Two forms of iron-sulfur clusters are found in complex I, [2Fe-2S]
(ox.: 2+, red.: 1+) and [4Fe-4S]   
(ox.: 2+, red.: 1+), which function as single electron transferring redox cofactors. In the oxidized 
state binuclear [2Fe-2S]
2+ clusters contain two high spin ferric ions (S=5/2 spin state), which 
are antiferromagnetically coupled resulting in a S=0 ground state. Upon electron uptake, one 
high spin ferric ion becomes antiferromagnetically coupled with one high spin ferrous ion 
(S=2) producing a S=1/2 ground state. The same assumption can be made for tetranuclear 
[4Fe-4S] clusters. In complex I these occur in two forms with the formal oxidation states of 
the irons (+3, +3, +2, +2) and (+3, +2, +2, +2). The latter, reduced state possesses an S=1/2 
ground state resulting from antiferromagnetic coupling between two pairs of iron ions. The 
S=1/2 spin state is responsible for the paramagnetism of the reduced iron sulfur clusters in 
complex I making them detectable by electron paramagnetic resonance spectroscopy (EPR).  
So far five iron-sulfur clusters have been detected in complex I from Y. lipolytica by EPR 
spectroscopy (Fig. 9.2.1). These are designated in the order of increasing spin relaxation as 
N1, N2, N3, N4, and N5. Due to its slower relaxation rate the binuclear cluster N1 is 
detectable at higher temperatures (> 30 K) than the tetranuclear clusters, which need 
temperatures below 20 K.  
Usually continuous wave X-band EPR spectra are recorded as first derivative spectra (Fig. 
9.2.1 column B), which also allow a better assignment of characteristic g-values. But it is 
worthwhile to keep in mind that the spin concentration and consequently the concentration of 
an individual specie in the sample is reflected by the area under the "absorption type" spectra 
(Fig. 9.2.1 column A). Hence the amplitude of a signal in the derivative spectrum can only 
give an estimate of the concentration of a paramagnetic species and the exact concentration 
can only be obtained by double integration of the EPR spectrum.  
 Spectrum B.1 in the figure, recorded at 12 K from isolated NADH reduced complex I from Y. 
lipolytica, shows contributions from the binuclear cluster N1 as well as from the tetranuclear 
clusters N2, N3 and N4. Under the experimental conditions used for this spectrum N5 is not 
detectable due to its very fast spin relaxation. The experimental spectrum can be simulated by 
addition of individually simulated EPR spectra for each iron sulfur cluster in an approximate 
1:1:1:1 stoichiometry (A.2 to A.6 and B.2 to B.6, respectively) The g-values which were used 
for the simulations are given in Fig. 9.2.1 B.2 - B.5.  
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Figure 9.2.1   –Experimental and simulated EPR spectra of iron-sulfur clusters from Y. lipolytica  
complex I - 
Column A: absorption spectra; Column B: Derivative spectra. For details see text. 
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For a more detailed description of EPR spectroscopy of iron sulfur clusters in complex I see: 
Ohnishi, T. (1998), "Iron-sulfur clusters / semiquinones in Complex I", Biochim. Biophys. 
Acta, 1364, 186 – 206  
and for a more general view of EPR spectroscopy with biological samples see: 
Weil, J. A., Bolton, J. R., Wertz, J. E. (1994) "Electron Paramagnetic Resonance (Elementary 
Theory and Practical Applications)", John Wiley & Sons, Inc., New York  
Smith, T. D. and Pilbrow, J. R. (1980) "ESR of Iron Proteins", in "Biological Magnetic 
Resonance", Vol. 2, Berliner, L. J., Reuben, J. (eds.), Plenum Press, New York  
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9.3    Mutagenised Cysteines which Belong to the Tetranuclear Iron-Sulfur Cluster 
Binding Motifs in TYKY and PSST Subunits 
 
 
9.3.1 Mutagenesis in TYKY Homologous Subunits from Different Organisms 
 
Organism Mutant
*1 Assembly Content
*2 
(%)
*
Activity
*3 
(%)
*
EPR 
spectroscopy 
Reference Authors 
conclusion 
N. crassa  113A-S no        Duarte 
(2000) 
TYKY is essential 
for assembly 
N. crassa  152 A-S  no        Duarte 
(2000) 
TYKY is essential 
for assembly 
N. crassa  155 S  no        Duarte 
(2000) 
TYKY is essential 
for assembly 
N. crassa  113-152 A  no        Duarte 
(2000) 
TYKY is essential 
for assembly 
R. capsulatus
1 110 S  no        Chevallet 
(2003) 
No complex I 
 
R. capsulatus
1 110 R  no        Chevallet 
(2003) 
No complex I 
 
R. capsulatus
1 113 S  yes  17  43  altered  Chevallet 
(2003) 
Two N2 cluster in TYKY 
 
R. capsulatus
1 113 R  no    n.d.  No N1-N3-N4 Chevallet 
(2003) 
No complex I 
 
R. capsulatus
1 116 S  yes  8  28  n.d.  Chevallet 
(2003) 
Two N2 cluster in TYKY 
 
R. capsulatus
1 120 S  no      No N1-N3-N4 Chevallet 
(1997-2003)
No complex I  
R. capsulatus
1 152 S  yes  34  71  altered  Chevallet 
(2003) 
Two N2 cluster in TYKY 
 
E. coli
2 110 A  yes  125  n.d.  n.d.  Flemming 
(2003) 
[Fe-S] cluster are essential 
for assembly 
E. coli
2 113 A  yes  100  n.d.  n.d.  Flemming 
(2003) 
[Fe-S] cluster are essential 
for assembly 
E. coli
2 116 A  yes  62  n.d.  n.d.  Flemming 
(2003) 
[Fe-S] cluster are essential 
for assembly 
E. coli
2 120 A  yes  100  n.d.  No N2 
(membrane) 
Flemming 
(2003) 
[Fe-S] cluster are essential 
for assembly 
E. coli
2 149 A  yes  75  n.d.  n.d.  Flemming 
(2003) 
[Fe-S] cluster are essential 
for assembly 
E. coli
2 152 A  yes  87  6  Slight shift  Flemming 
(2003) 
[Fe-S] cluster are essential 
for assembly 
E. coli
2 155 A  yes  112  n.d.  n.d.  Flemming 
(2003) 
[Fe-S] cluster are essential 
for assembly 
E. coli
2 155 S  yes  75  n.d.  n.d.  Flemming 
(2003) 
[Fe-S] cluster are essential 
for assembly 
E. coli
2 159 A  yes  112  n.d.  n.d.  Flemming 
(2003) 
[Fe-S] cluster are essential 
for assembly 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 9.2     -TYKY Subunit- 
*1 The Y. lipolytica nomenclature is used 
*2 measured as NADH:UB rate, % of parental strain activity 
*3 measured as NADH:O2 rate (piericidine sensitive), % of parental strain activity 
nd: not determined 
 9 APPENDIX    110 
9.3.2 Mutagenesis in PSST Homologous Subunits from Different Organisms  
 
 
 
 
Organism Mutant
*1 Assembly Content
*2 
(%)
*
Activity
*3 
(%)
*
EPR Reference Authors  conclusion 
N. crassa
1 85 S  Yes  100  ~10  No N2 Duarte 
(2002) 
N2 in PSST 
only 1 C is ligand 
N. crassa
1 86 A  Yes  100  ~10  No N2 Duarte 
(2002) 
N2 in PSST 
only 1 C is ligand 
E. coli
*1 85 A  Yes  37  0  No N2 Flemming 
(2003) 
N2 in PSST 
fourth ligand ? 
E. coli
*1 85 S  Yes  37  0  No N2 Flemming 
(2003) 
N2 in PSST 
fourth ligand ? 
E. coli
*1 86 A  Yes  25  0  No N2 Flemming 
(2003) 
N2 in PSST 
fourth ligand ? 
E. coli
*1 150 A  Yes  25  0  No N2 Flemming 
(2003) 
N2 in PSST 
fourth ligand ? 
E. coli
*1 180 A  Yes  25  0  No N2 Flemming 
(2003) 
N2 in PSST 
fourth ligand ? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 9.3     -PSST Subunit- 
*1 The Y. lipolytica nomenclature is used 
*2 measured as NADH:UB rate, % of parental strain activity 
*3 measured as NADH:O2 rate (piericidine sensitive), % of parental strain activity 
nd: not determined 
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9.4 Sequence of the Construct pICL1-NDH2i 
 
    Nuam                                                pICL1-intron           
       GTCGACGGTCTCTCCCAGGACACTCCTCTTCCTCATGAAGTGCGGCCGCGGTACCGGGCC       60 
       CGTCGAGATGGACATACTTGTATCGTCGCCCTATGTACTCGTAATGCAAGGGATTCCACC      120 
       AGACATTCCTGCCACAATGGCAGGGTCCGTGAAAACGCCGACCACTGACAAGATGCCTTG      180 
       TTCGTCTTGACCACGGACTAACTGGCACAAGCGAGATTAACGTCGTCGGAGACTATTCGG      240 
       CACACAAGGCCAGACTGTGTGGCACTTCTCATCTCTCGTACCGACCTCTGTCAACAGTCT      300 
       AACCGATTTTTAATGCTCGATATTACCAATGTTTCTTTGTGTCTTTTAACCAGAACAACC      360 
       GAGCAGACCCGAACAGGTGCCGAACATGTGAATAGCAGTGCTGGAGCTCCATCAGTAAGC      420 
       ATAATAACACAGCTGCCCAGCGACCTCCGCCCAGCGACCTCTACCCAGCGACCTCGGGCA      480 
       CGTGACTATCTGCTCCGTTCCTCGCGGTCGCTGGCACGCTGGCAAATCTGGGGTCTCCAC      540 
       ATTTTCCCCCGGATGTCTTGTTCCGTAGCGTGACTCATGCGGAATGACGTGAATGTAGGA      600 
       GGGGCTGAGAATGGGGTCCGCAGTTGATAACCGGGGATTATTGGCCGGCGGCATTGTCAA      660 
       CCAGGTGTTTTCACTGGCGTTCCTAGAATAAAAAGAAATAGGCGACCCCCTTGAGCGAGT      720 
       TCAGCGGCGGCAAAATGCCTGTTGAAACACCTACTTTGTTCCCAGCACCCCCATCGGATA      780 
       AATGGAGACGCATACATCGGCTATGTTTGGATACGATCTTGGGCCGGTGTGCGTGGTGTG      840 
       CGCGGTCATTTTGTTCTCCTTTTGGACCCACGCAAGGTTCAACCGAACCCCGGATTCGAC      900 
       TGTGAAAACGAACAACGGTTTAGTGCGGTTTAAAAAGTATCAAGTTCAGGGAGGGAAGCG      960 
       ATCCAGGCCAACAGCTATGACCAAGAAACCAAGCGACCAAGACATCTGAAGACCAACAAA     1020 
       ACCAATAATCGCTCACCAGATGCTCCCCAAACACTAACGGCAGACTCTACTCCAGATTTG     1080 
       CACTTGTAGGACCCCGATATCGGGTTGCAGATCATGGTGTCATAATCTCTGAACGTGAAG     1140 
       GTTAGGTGGAGGGGATGTTTTGGCCAGAAATGAGCGGTTTTGTGAGCTTGGAGACGGTAA     1200 
       ATCGGATACGCCCAGCGTGAGGATTCCATAGACCCCCTCCTTTTGCCAGTATATCCACCG     1260 
       CAACACCCACCATGAGCGACATCTGATACCGTGCCGCGACCACTACCCCAAATAAGCTCC     1320 
       AACTAATATGCCGAGGCAGGTGGGAAACTATGCACTCCAGTCGACGCTGTAGAAGCACAT     1380 
       GGAAGGTGCGGAGGCGGTGGCAACGAGGGGCATGAGCCATCAACGAGTAACCACAGACAA     1440 
       GGCAAGGGGGGAAACGCGACCGGAATCTCTCGCGGTCACGTGACCCGCCCGGGTTCCACT     1500 
       CGTCCATGTTGTGTCTCTGGTGTCTTCGGCCGACTCGCATTGGTTAAACTTCCACCACCG     1560 
       CAATCACGTCCCACTGGCCAAACTTTTTCTGCTTTCTCTGACTTTTTCTGGCCAAAAGGC     1620 
AACGTCGGAAAGGGTCGGGAGGATTCGGAACCGACGAAAATCGGCCGGCTCCAGCGGGGG     1680 
TAGTTCGGCAGTCCTGGTGGGAGCTCTAGGGGAGCTGTGGTCTGTGTAGGGCGCGGGTCC     1740 
GGGTTTGTTGGGTGTCAAATCACGTGTTTTTGCCCCCCCGCTGAGCCGGACTCCGACAAC     1800 
CGTGTCTCCAACGGCCTGACTAAGCTGCTCCCAGCACTCTGCCGTAGCGTTGGTCTGTCC     1860 
TGTCGCACTCTGTTCAAAGACAGAAGAAAGAAAAAGCTAACCTCCACGTCAGAGACAATG     1920 
GTAGAAGGCTTGTTCCTTGCAACCGAGGAGAGTGAGTGTTCTCGGCACGAGCATCATGGG     1980 
CGATCTGGAGGGTATTTTTGAGGGGAAAAAACGGGATCAGGACAAACAGAGGCCACAGAC     2060 
CGGGAATCTGGGCCCCAAAACGGCCTTTTCCCGTCGCAAAACCGGTCTACATACACCCCT     2120 
TCGGCCCGCCACAGGCCGGTGTGAAAAACCCTAAAGCTTGCTTCAAACCAGACGGACGCA     2180 
CAGCAAGACACATCATGAAGAGTCACCTGCAGTATATATAGATCTGGGGATCCCCAGTAG     2240 
ACTGACCAAGCATACAAAAAGTGAGTATCCAACAGCGACACGTGAGATGGCAGAGACACA     2240 
GAGACGTGTCTACATGGTTGGACAAGTCTCCACATTCGCCAGAGACGTATCCACATACAA     2300 
ACACAATCTCACAGCTGATCTGCTCCTGTGACAGCACAGTACATGTTAGTGGATGAGGTG     2360 
TTGTGTAGTGGGTTAAATGGGTGGACTGATTCAGTGGCATCGGTGGCGACACCCTCTACT     2420 
CTTCATGTCGTCACCTACCGTTCGGAATCCCAATTATCTGATGAACTAAACGATTTCTGG     2480 
CCAAAACACAATTTTGCCAAAGAAGTCGGTCTCACCAATGCAAGTGTCACATCAAACATC     2420 
TGTCCCGTACTAACCCAG TGCTCTCGAGAAACCTCAGCAAGTTTGCTCGAGCCGGTCTC     1619 
                  MetLeuSerArgAsnLeuSerLysPheAlaArgAlaGlyLeu       14 
 
ATCCGGCCAGCAACCACATCCACACACACCCGACTATTCAGCGTCTCCGCCCGACGTCTC  ▼  1679 
IleArgProAlaThrThrSerThrHisThrArgLeuPheSerValSerAlaArgArgLeu       34 
 
Ndh2i 
     940 GACCCCTCCGACCAGTTGCCCGCCGACCCCTCCAAGAAGACCCTGGTGGTGCTGGGTTCC     1739 
         AspProSerAspGlnLeuProAlaAspProSerLysLysThrLeuValValLeuGlySer       54 
 
         GGCTGGGGCTCCGTCTCCTTCCTCAAGAAGCTCGATACTTCTAACTACAACGTCATTGTC     1799 
         GlyTrpGlySerValSerPheLeuLysLysLeuAspThrSerAsnTyrAsnValIleVal       74 
 
         GTCTCTCCCCGAAACTACTTCCTGTTCACCCCTCTACTGCCCTCTTGTCCCACCGGAACC     1859 
         ValSerProArgAsnTyrPheLeuPheThrProLeuLeuProSerCysProThrGlyThr       94 
 
         ATTGAGCACCGATCCATTATGGAGCCCATCCGAGGCATCATTCGACACAAGCAGGCCGAA     1919 
         IleGluHisArgSerIleMetGluProIleArgGlyIleIleArgHisLysGlnAlaGlu      114 
 
         TGCCAGTACCTCGAGGCTGATGCTACCAAGATTGACCACGAGAAGCGAATTGTGACCATC     1979 
         CysGlnTyrLeuGluAlaAspAlaThrLysIleAspHisGluLysArgIleValThrIle      134 
 
         CGATCCGCCGTCTCTGAGAACTCCAAGGAGGAGGTCATCAAGGAGATCCCCTTCGACTAT     2039 
         ArgSerAlaValSerGluAsnSerLysGluGluValIleLysGluIleProPheAspTyr      154 
 
         CTTGTTGTCGGTGTTGGCGCCATGTCCTCCACCTTTGGTATCCCCGGTGTCCAGGAGAAC     2099 
         LeuValValGlyValGlyAlaMetSerSerThrPheGlyIleProGlyValGlnGluAsn      174 
 
         GCTTGCTTCCTCAAGGAGATCCCCGACGCCCAGCAGATTCGACGAACCCTCATGGATTGC     2159 
         AlaCysPheLeuLysGluIleProAspAlaGlnGlnIleArgArgThrLeuMetAspCys      194 
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         ATTGAGAAGGCCCAATTCGAGAAGGACCCTGAGGTCCGAAAGCGACTTCTGCACACTGTC     2219 
         IleGluLysAlaGlnPheGluLysAspProGluValArgLysArgLeuLeuHisThrVal      214 
 
         GTTGTTGGAGGTGGCCCTACCGGTGTCGAGTTCGCTGCCGAGCTCCAGGACTTCTTCGAG     2279 
         ValValGlyGlyGlyProThrGlyValGluPheAlaAlaGluLeuGlnAspPhePheGlu      234 
 
         GACGATCTCCGAAAGTGGATCCCCGATATCCGAGACGATTTCAAGGTTACTCTTGTCGAG     2339 
         AspAspLeuArgLysTrpIleProAspIleArgAspAspPheLysValThrLeuValGlu      254 
 
         GCTCTCCCCAACGTTCTGCCCTCTTTCTCCAAGAAGCTCATTGACTACACCGAGAAAACC     2399 
         AlaLeuProAsnValLeuProSerPheSerLysLysLeuIleAspTyrThrGluLysThr      274 
 
         TTCTCTGACGAGAAGATCTCCATTCTGACCAAGACCATGGTTAAGTCTGTTGACGAGAAT     2459 
         PheSerAspGluLysIleSerIleLeuThrLysThrMetValLysSerValAspGluAsn      294 
 
         GTGATCCGAGCCGAGCAGACCAAGGGTGACGGTACTAAGGAAACCCTTGAGATGCCTTAC     2519 
         ValIleArgAlaGluGlnThrLysGlyAspGlyThrLysGluThrLeuGluMetProTyr      314 
 
         GGAACTCTTGTGTGGGCCACCGGTAACACTGTGCGACCTGTTGTTCGAGAGCTCATGTCC     2579 
         GlyThrLeuValTrpAlaThrGlyAsnThrValArgProValValArgGluLeuMetSer      334 
 
         AAGATCCCTGCTCAGAAGGGCTCCCGACGAGGTCTTCTTGTCAACGAGTACCTTGTTGTT     2639 
         LysIleProAlaGlnLysGlySerArgArgGlyLeuLeuValAsnGluTyrLeuValVal      354 
 
         GAGGGTACCGAGGGCATCTGGGCTCTTGGTGACTGTTCTGCCACCAAGTACGCACCCACT     2699 
         GluGlyThrGluGlyIleTrpAlaLeuGlyAspCysSerAlaThrLysTyrAlaProThr      374 
 
         GCCCAGGTTGCCTCCCAGGAGGGATCCTACCTTGCTAACCTGCTCAACGGCATTGCTAAG     2759 
         AlaGlnValAlaSerGlnGluGlySerTyrLeuAlaAsnLeuLeuAsnGlyIleAlaLys      394 
 
         ACCGAGGACCTCAACAACGAGATCACCAACCTCGAGAAGCAGTCGGAGCACACCTTTGAC     2819 
         ThrGluAspLeuAsnAsnGluIleThrAsnLeuGluLysGlnSerGluHisThrPheAsp      414 
 
         GAGCAGGAGCGAAAGAACATCTTTGCTCAACTCGAGTCCAAGTCCCGAAAGCTGCGACGA     2879 
         GluGlnGluArgLysAsnIlePheAlaGlnLeuGluSerLysSerArgLysLeuArgArg      434 
 
         TCCAGAGCCATGCTGCCCTTCGAGTACTCTCACCAGGGTTCTCTGGCCTACATTGGTTCC     2939 
         SerArgAlaMetLeuProPheGluTyrSerHisGlnGlySerLeuAlaTyrIleGlySer      454 
 
         GACCGAGCCGTTGCCGACCTGTCCTTCAACTTCTGGGGTATCATGAACTGGTCTTCCGGA     2999 
         AspArgAlaValAlaAspLeuSerPheAsnPheTrpGlyIleMetAsnTrpSerSerGly      474 
 
         GGAACCATGACCTACTACTTCTGGCGATCCGCCTACGTGTCCATGTGCTTCTCCATGCGA     3059 
         GlyThrMetThrTyrTyrPheTrpArgSerAlaTyrValSerMetCysPheSerMetArg      494 
                                                           
         AACAAGATTCTTGTTTGCATTGATTGGATGAAGGTCCGAGTCTTCGGCCGTGATATCTCT     3119 
         AsnLysIleLeuValCysIleAspTrpMetLysValArgValPheGlyArgAspIleSer      514 
 
         CGAGAATAACAATTAGATGTTATATGAAAACCCGAGTACAGCATGTACTGGTAGAGGAGT     3179 
         ArgGlu***                                                             
 
AGGGATGATTCGAGGATAGTGGAGCTATTGTGAAGTGACCGGGTGGGTTAACAAAAGTAT     3239 
TGCTTTGAATTAGTTTGACGATATAGATGTATATGACTACTGTATGTACTTGTAGTTGCG     3299 
AGCTCAGAACGAATGAGACAGAGCAGCTCAGCCATTTACAGTACAGTATGTGCTTGCTCA     3359 
TGGGCAGTTACAAGTTCCTACTTGTAATACGGAGTCTGGTTTTTCAGTTGACATGGATTA     3419 
TACAACTTTAAGGCGCTCGAAAAGCGTTGTACCACTTTCTATCCACTAAGATATGTTTGA     3479 
ACCAACCAGAGCTATCTACTTGTAGCTACACGGCTGACCACCAAACTCTTGGTCAACTAA     3539 
TGTCACCAGCAACAACTGATGAACTCCAAAGGGTGAACCATAGACTCCACGCTGTGGAAG     3599 
GATATGTAAATAAAGACAACCATAAAACAGAACTTCAGACACTTGGCAAGGAAAAAGATT     3659 
ACAGCACCTAGGATTCTCGTATGGTCTCCCACTACAATACTAACTAGGCTCTCTGGTGCT     3719 
TGACTATGGCTGATCGGACGGGAAGCCGTATTTTCACCAGGATATGGCCGTAACCAAGAC     3779 
TCCGATACGGGGAATCGAACCCCGGTCTCCACGGTTCTCAACATGAGAGCGTGATGTGAT     3839 
AGCCCCTACACTATATCGGAAATGTGCAAGACACGGTGTTTTTGGCGTCACGCATCTGAT     3899 
TCGCCAAATAAGGTTTAATTAAAAAGTTAACGAATATTAAAATAGTTAGAATAAAAATAA     4059 
TTTGTCAAGCGTTTGTATCGGCTCAAGAAAAGAAAAATAAGGGAACCGGGGAGTGTGGAA     4119 
TTTTCAAACTGTTCGGAGAAAAACTATTACGGGTCTATTGCACGAGATTTCTCCCTGTTT     4179 
TATGGTCGTTTAGTTGCTGAGATGCATTGGGCAAGAATCACAAAATAAAATGACTCGTGA     4239 
AATGCGCACAATGCGACCTTAATGCACGTTTAGCCAGTAGTGTGCATGATAATCCACATA     4299 
CAAAGTTAAGATCCGATGTTAGCCTACGTGTATTTACTATAGCTGAAATGTCTACCTGTA     4359 
CTCATTTAGTGCGAAAAAATTTAACCACCTCTAGCGCCCGGTCTTGTCATGTCTTGGCTC     4419 
ATGTACATGAGATGAGAGTGTATGTGATCTGACGGAAGTGGGCACATACACGCTGATAAC     4579 
ATTTCAGGTGCGTTCCTGCGGTTGATATCACAAGCATCTCCGAGCACACGAAAATGAGAT     4539 
GGTATGCTGAAGTCTCCACCTTTAGTCGAC 
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Figure 9.4    -Amino acids sequence of pICL1-NDH2i- 
GTCGAC: SalI restriction site 
ATG : Start codon 
*** : Stop codon 
▼: Processing site 
 
Color code 
Green: nuam sequence 
Orange: pICL1 sequence 
Cyan: intron sequence
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9.5 Sequence of the EcoRI NUKM (PSST) Gene Fragment of Complex I in Y. lipolytica 
 
 
 
                                                  GAATTCCCAGAGA     13 
   CAGTTCTTCTCTGCGAAAACTGATATCCGAGCTGGGCTTTCTGCGGGCTCTGGACACGAG     73 
   AAACAACCCCGAGACGGAGGAGTTCTATCCGGATCTCATGTCTGTTATGGGCACTCAGGC    133 
   CGTGAACGGCAAGAGCATCTCGATCCAGTACACCAACACTCAGACGGCCGAGTTTGAGCG    193 
   GGCATGGCAGGGTACAGACACCAAGTTTGTGCGCAACCTCAAGGCACACAATCGAGAGAC    253 
   GTACGAGGACAGAATCCTGTACCAGACTCAGGCCATGCTTCGAGTGCATAACAAGGGCGG    313 
   TCTGCTGTATTGGATGGACGGTGTGTTGCTTGGTAAGGACCCCAAGTACATTGAGTCGTA    373 
   CAAGAAGCACGCTGCCAAGTGCTGGGCTGCTCGGGAGAAGCGACGCAAGCAGCAAGATGC    433 
   TGAGGAGAGAGTTGCAGGGCTGTCGAAGGATGTTAACGATACCGCTATGGCTAGTGGAGA    493 
   AGAGGCTTATGGATTCATTTAATGCTATATTTATTGTATTTTTACCCAAACGAATGAGAG    553 
   AGCTGAGCTCGAAATGAAAATGAGAATACTGGTACGAGTAACTACAATTACTCGTACCGG    613 
   TACTTGTGTGTAATTGGAATACTGAGCCAGTGGAGAGTGCGATTCTCCCGTTTTTGTACA    673 
   TTATCTAGTGGATATAACTAACATTCGAATCAAAAAGCTATCTTGGTTCTGATTTTATAC    733 
   TGTTTGACACCCCTGTCCATAGTAATATCTTAAGCAGTGGATGGAATCATGATCACTGTA    793 
   TACTGTATACACCTTCATGATGTTTACAAGCGCTATACTGGTGATGTTGTCCCAACAGGT    853 
   TAGGGTTTGATCCCTCCTCAGTGTGTTTGCACGTGATCTGGCGTCCAGCCAATAACAGCA    913 
   ATCACAAGTGGTATTACCAAGAAGCGTGATTTTCGCGCGGTGGCGGTTTTCCCTCGTTGT    973 
   TGCCGTCGGTTGGCAGTCTCGTTCTCTTCACACCAGGCCAACATTTCTTCAATTGCAACA   1033 
   TTTTTCTACACTTGTAGGTGCATGTTTGGTGTTTGTCTGAGACGAGGGAGTGAGTCGGAG   1093 
   ATGTGTTTTTTTTTAGCGAGGAGTGCTCGGAATTGGATATTTAAACACACAAAAACGGTA   1153 
   ATTTCCGGTGGCTGGTGCGATTAAACACGTCGTCCTGTCACCAGCTTGTCTCGTACGCCC   1213 
   CTTATATCTCTTCTTACCCCCAAACCACCTCCTCCATTAAGCTTCTGCATTGGCCAATCA   1273 
   GGGCTTCCCATATTTGGGTAACGAAATTATGGTTGGAGGCTTCCACTATCGTATATTTGC   1333 
   ACCAGCCAGCAGAGCACCTCACGCTTGTTGTATCGTCACAAAACCACACATCCCTACAGC   1393 
 
   ATGCTCAGATCACAGATTGGCCGACTGGCTCTGCGACCGACGCTGGTCCCCGCCACTGTC   1453 
    M  L  R  S  Q  I  G  R  L  A  L  R  P  T  L  V  P  A  T  V      20 
 
   ATCCCCCAGACCCGAGCATACTCCGCTCCCGCTGGAACCCCCCGAGTGTCGTCCTCCTCC   1513 
    I  P  Q  T  R  A  Y  S  A  P  A  G  T  P  R  V  S  S  S  S      40 
 
   ATGCCCACCGACTTCCCTCTCCCCTCACAGCAGAAGCCCAACAGCGCCGTCGACTACACC   1573 
    M  P  T  D  F  P  L  P  S  Q  Q  K  P  N  S  A  V  D  Y  T      60 
 
   CTGACCACTCTGGATGCCGTGGCCAACTGGGCTCGACAGGGCTCTTTCTGGCCCGTGACC   1633 
    L  T  T  L  D  A  V  A  N  W  A  R  Q  G  S  F  W  P  V  T      80 
 
   TTCGGTCTGGCGTGCTGTGCCGTCGAAATGATGCACGTGTCTGCCCCCCGGTACGATCAG   1693 
    F  G  L  A  C  C  A  V  E  M  M  H  V  S  A  P  R  Y  D  Q     100 
 
   GATCGTCTGGGTATCATTTTCCGAGCCTCCCCTCGACAGTCCGATATCATGATTGTGGCC   1753 
    D  R  L  G  I  I  F  R  A  S  P  R  Q  S  D  I  M  I  V  A     120 
 
   GGAACCCTCACAAACAAAATGGCCCCCGTGCTGCGTCAGGTGTACGACCAGATGCCCGAG   1813 
    G  T  L  T  N  K  M  A  P  V  L  R  Q  V  Y  D  Q  M  P  E     140 
 
   CCCCGATGGGTCATCTCCATGGGCTCCTGCGCTAACGGTGGTGGATACTACCACTTCTCC   1873 
    P  R  W  V  I  S  M  G  S  C  A  N  G  G  G  Y  Y  H  F  S     160 
 
   TACTCGGTGGTGCGAGGCTGCGACCGAATCGTGCCTGTGGACGTCTACGTTCCCGGATGT   1933 
    Y  S  V  V  R  G  C  D  R  I  V  P  V  D  V  Y  V  P  G  C     180 
 
   CCCCCCACCTCCGAGGCCCTCATGTACGGCGTCTTCCAGCTCCAGCGAAAGATGCGAAAC   1993 
    P  P  T  S  E  A  L  M  Y  G  V  F  Q  L  Q  R  K  M  R  N     200 
 
   ACAAAGATTACCCGAATGTGGTACCGAAAGTAAGCATAATAAACGTTTAGATAGTGAGTC   2053 
    T  K  I  T  R  M  W  Y  R  K  *                                210 
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   GGCTGTGTGTAGCCAAAGCTCATCAACGCAGGTCCATTGGTCCGTGTGAGGTACATGTAG   2113 
   ATCTTTTTACCATGCACCAGGTAGGTCTACGCACCCTCAATTCTGGATGGAGTGATGGTT   2173 
   ATTGGTACTTCAAGACGCAGTATATTAGCTGTTGATGTTCGTTGTGTTATTCAATCACCT   2233 
   GTCTACTAGTATCAAATACCGTACTTGTAGTAGAGGAATTC                      2274 
 
 
GAATTC: EcoRI resriction site 
 
    : processing site 
 
* : STOP-codon 
 
 
Primers used for site directed mutagenesis 
 
 
Direction  Name        Sequence  Binding site 
C85S 5’-CTTCGGTCTGGCGTCCTGTGCCGTCGAAATG-3’  1633-1663 
C86S  5’-GGTCTGGCGTGCTCTGCCGTCGAAATG-3’  1636-1666 
C150S  5’-CTCCATGGGCTCCTCCGCTAACGGTGG-3’  1828-1855 
C180S 5’-CTACGTTCCCGGATCTCCCCCCACCTCC-3’  1917-1945 
D99N 5’-GCCCCCCGGTACAATCAGGATCGTCTG-3’  1666-1672 
D99E 5’-CTGCCCCCCGGTACGAGCAGGATCGTCTGGG-3’  1664-1674 
D99G 5’-CTGCCCCCCGGTACGGTCAGGATCGTCTGGG-3’  1664-1674 
D115N 5’-CCTCGACAGTCCAATATCATCATCATTGTGGCC-3’ 1054-1073 
D115E 5’-CCTCGACAGTCCGAGATCATGATTGTG-3’  1054-1073 
D115G 5’-CCTCGACAGTCCGGTATCATGATTGTG-3’  1054-1073 
C85S 5’-CATTTCGACGGCACAGGACGCCAGACCGAAG-3’ 1663-1633 
C86S 5’-CATTTCGACGGCAGAGCACGCCAGACC-3’  1666-1636 
C150S 5’-CCACCGTTAGCGGAGGAGCCCATGGAG-3’  1855-1828 
C180S 5’-GGAGGTGGGGGGAGATCCGGGAACGTAG-3’  1945-1917 
D174N 5’-GAATCGTGCCTGTGAACGTCTACGTTCCC-3’  1899-1927 
E185Q 5’-CCCCCCACCTCCCAGGCCCTCATGTAC-3’  1994-2021 
    
D99N 5’-CCCAGACGATCCTGCTCGTACCGGGGGGCAG-3’  1674-1664 
Forwards 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reverse 
D99E 5’-CCCAGACGATCCTGACCGTACCGGGGGGCAG-3’  1674-1664 
 D99G  5’-CCCAGACGATCCTGCTCGTACCGGGGGGCAG-3’  1674-1664 
 D115N  5’-GGCCACAATCATGATATTGGACTGTCGAGG-3’  1073-1054 
 D115E  5’-CCTCGACAGTCCGAGATCATGATTGTG-3’ 1073-1054 
 D115G  5’-CACAATCATGATACCGGACTGTCGAGG-3’ 1073-1054 
 D174N  5’-GGGAACGTAGACGTTCACAGGCACGATTC-3’  1927-1899 
 E185Q  5’-GTACATGAGGGGCTGGGAGGTGGGGGG-3’  2021-1994 
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9.6 Sequence of the NUIM (TYKY) Gene of Complex I in Y. lipolytica 
 
 
 
                                                    TACAGCAGACG     11 
   GGAGAGGCAAGACAGAGGAATGGATTGAAATGTCCGAGTAACGAAATGAAATAATGTCAG     71 
   TGACATGTCCGAAAGAAGAGTATAAATACAAATACAAGTACAAGTACAAGTACAGTAGTA    131 
   ATCTGTCGCCAATATGTCGATCAAATGGCCGTTCGTAGAGCCGTGTTTTAGGATAGCTAA    191 
   TTACTATTTTATTCGTACTTCTATCATATATTTCTTTATATCCCGAATGACTCAAACTCC    251 
   CAACCTGAATGCACTGTTGGTACAGTATCACCAAACTCTACTCACAATATCCCCCTTTTC    311 
   AACCCGCGCCAAACTCGAACCCACACCTTTTCGTCTCCCCATATGCAAACAAAATTTGCG    371 
   GGGGGGGTGGAATTCCCACCAATAACCTCAGTTACAATCAGCATTCGCTAATGGGGGGTT    431 
   GTCCGGAGGTTGCAACAAGTAGGTCGAGGGGTGGATAATGTGCAATTTTTGAAATAAATA    491 
   TATACTAATTTACATGCGGCCAATCATATGCCACGTCTAAAACGAAAATTCACCCACCAA    551 
   TACACCCACTGTAGACCATTCGTGGCCTGCGGCCACTCATTTCAAGGAACCCTAACCTCG    611 
   TCCCTCCCAACCGTCAGCCAATGAAAGCAAGCAAAATTACGTGACAAGCTTAAAGGTGTA    671 
   ATACTGCTTGGAGAGGGTACAACACCACACACATCACCACCACACACAAACCAAAAAAAA    731 
 
   ATGTTGAGTCTGGTCCGACCCGCTGTCACCCGATCGATTCTGCGAGGCGCTCCCGGATCC    791 
    M  L  S  L  V  R  P  A  V  T  R  S  I  L  R  G  A  P  G  S      20 
 
   ATGCGGCTGCTGTCCTCCACAGCCCGGCTCCACGCCCCCGCCACAGACTCCGCCATCAAC    851 
    M  R  L  L  S  S  T  A  R  L  H  A  P  A  T  D  S  A  I  N      40 
 
   ATCTACGCCGGAGGATCTGCCGCTGCTGCTCCCCCAGCAGGCTTCCGAATTCACAGACCC    911 
    I  Y  A  G  G  S  A  A  A  A  P  P  A  G  F  R  I  H  R  P      60 
 
   GCCACCTGGGAGGAGAGCGAAGAGGGCGCTCTTTCCAAGGCCACCAAGTACTTTTTGCTG    971 
    A  T  W  E  E  S  E  E  G  A  L  S  K  A  T  K  Y  F  L  L      80 
 
   GCCGAGATGTTCCGTGGCCTGTACGTTGTGCTGGAACAGTTTTTCCGAGCTCCTTACACC   1031 
    A  E  M  F  R  G  L  Y  V  V  L  E  Q  F  F  R  A  P  Y  T     100 
 
   ATCTACTACCCGTTCGAGAAGGGACCCGTCTCTCCTCGATTCCGAGGCGAGCACGCCCTG   1091 
    I  Y  Y  P  F  E  K  G  P  V  S  P  R  F  R  G  E  H  A  L     120 
 
   CGACGTTACCCCAGTGGTGAGGAGCGATGCATTGCCTGCAAGCTGTGTGAGGCCATCTGC   1151 
    R  R  Y  P  S  G  E  E  R  C  I  A  C  K  L  C  E  A  I  C     140 
 
   CCCGCTCTGGCAATTACCATCGACGCTGAGGAGCGAATCGACGGATCGCGACGAACCACC   1211 
    P  A  L  A  I  T  I  D  A  E  E  R  I  D  G  S  R  R  T  T     160 
 
   AAGTACGATATCGACATGACCAAGTGCATCTACTGCGGCTACTGCCAGGAGTCGTGCCCC   1271 
    K  Y  D  I  D  M  T  K  C  I  Y  C  G  Y  C  Q  E  S  C  P     180 
 
   GTGGACGCCATTGTCGAGACTCCCAACGTGGAGTACGCCACCGAGACTCGAGAAGAGCTG   1331 
    V  D  A  I  V  E  T  P  N  V  E  Y  A  T  E  T  R  E  E  L     200 
 
   CTGTACAACAAGGAAAAGCTGCTTGCTAACGGAGACAAGTGGGAGCTCGAGCTGCAGTAC   1391 
    L  Y  N  K  E  K  L  L  A  N  G  D  K  W  E  L  E  L  Q  Y     220 
 
   GCTCTGGACGCTGATGCTCCTTACAGATAGAGAGGGGAAATGCATTTTTATTAGGAAAGC   1451 
    A  L  D  A  D  A  P  Y  R  *                                   229 
 
   GAGCAGTTGGGGTTGCGGAAAATAACAGGACTGTAGCGACTGTTGTTTTACGGCTCCATC   1511 
   TGCGAACGAGTGTAGCTATCAGTGTCGTAATAAGAGCCAAGCACTACAACCGGAGAGCGC   1571 
   ATGTGTTGTAGAAAAACACTTTCTTATTATCCGCCCATCTGAGTGTTGTAGGCGCTCTCT   1631 
   TTACGGTCAATTCAGTTGTAGTGCTTATTGGCGAGCCACATTATGTACGAGTAATGTGCT   1691 
   CGAGCGAATACATAAATAACTGTGCGGAGACAGTATTCATCATATTAGCACCTTGTACAG   1751 
   TACAAGTAAAGTCTTGTCCATCCTTTGAGATTGCTTTTGTCGATTCAAGATGGATATTGT   1811 
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   ATAAGTACTCGCGCAATTGTACACACAGTATTGTAGATCTGCAGGATATGAGTGGATGCA   1871 
   GTATGTTACGTGTGCTACACATTACCACGTAAATCACGATAATACGGAATCTAAATGGTT   1931 
   CTGCGGCTCAATAACACTCAATAACGGACAGATTCTGGACGGATTCTGAACACATGTCTT   1991 
   GCCACATGTCTCTCTTCCCTAGCCTAAGACAACCTCCTGACCTTCAAGTAGAGTGTATAT   2051 
   CTCATCATCTCAGCATCAAAGTGTAGTATCAACAAGTGGTCTCGATATATTTGCAGCTGT   2111 
   AGACTTTTGGGCATCTTTGTAATGTCGATTTAAAGCCCCAGATTAGCGAAATCCAATGAT   2171 
   GTATTTTTCATGTCATTGGACGTTGTATTCGTTGTTCTAGGTCGACGCTGGTTGTGATTA   2231 
   CTGTAGTCTCTAGTCGACATTTTAGTTGACAACTTGTTGAGGCAAAAATACACCTGGGAG   2291 
   TTCGTTTGTAGTGTTCCCGCAGGGATGGAGAGCTAATATTTATATTTATAGATACAAAAT   2351 
   CATCTAAATAAAAGACTTATCTCGGTTCAAATGATCTACATCAAGATCATGGATGAATAT   2411 
   GTGCACTTCCATGTGTATTCAACCTCCATAGTTAGTTGACAAATTAGTGAAATTGGAATA   2471 
   CACTTTTTTGGATC                                                 2485 
 
 
AAGCTT: HindIII resriction site 
 
    : processing site 
 
* : STOP-codon 
 
 
Primers used for site directed mutagenesis 
 
Direction  Name        Sequence  Binding site 
C110A 5’-GTGGTGAGGAGCGAGCCATTGCCTGCAAGCTG-3’ 1005-1035 
C113A  5’-GAGCGATGCATTGCCGCCAAGCTGTGTGAG-3’  1013-1041 
C116A  5’-GCCTGCAAGCTGGCTGAGGCCATCTGC-3’  1024-1151 
C120A 5’-GTGTGAGGCCATCGCCCCCGCTCTGGC-3’  1134-1161 
C149A 5’-GACATGACCAAGGCCATCTACTGCGGC-3’  1229-1248 
C152A 5’-CCAAGTGCA  CTACGCCGGCTACTGCCAG-3’  1231-1259 
C155A 5’-CTACTGCGGCTACGCCCAGGAGTCGTGC-3’  1240-1268 
C159A 5’-CTGCCAGGAGTCGGCCCCGTGGACGCC-3’  1252-1280 
C110A 5’-GTGGTGAGGAGCGAGCCATTGCCTGCAAGCTG-3’ 1035-1005 
Forwards 
 
 
 
 
 
 
Reverse 
C113A  5’-GAGCGATGCATTGCCGCCAAGCTGTGTGAG-3’  1041-1013 
 C116A  5’-GCCTGCAAGCTGGCTGAGGCCATCTGC-3’  1151-1024 
 C120A  5’-GTGTGAGGCCATCGCCCCCGCTCTGGC-3’ 1161-1134 
 C149A  5’-GACATGACCAAGGCCATCTACTGCGGC-3’  1248-1229 
 C152A  5’-CCAAGTGCA  CTACGCCGGCTACTGCCAG-3’  1259-1231 
 C155A  5’-CTACTGCGGCTACGCCCAGGAGTCGTGC-3’  1268-1240 
 C159A  5’-CTGCCAGGAGTCGGCCCCGTGGACGCC-3’  1280-1252 
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9.7 PROF (Secondary Structure Prediction System) of the PSST (NUKM) Subunit of 
Complex I from Y. lipolytica 
 
 
 
----| ----------------------------- 
|AA |     pH      pE     pC   PRED  Nr. 
|___|_____________________________| 
|   ||                             | 
|M  ||   0.072   0.009   0.918  C  |1 
|L  ||   0.340   0.016   0.644  C  |2 
|R  ||   0.533   0.015   0.451  H  |3 
|S  ||   0.606   0.023   0.370  H  |4 
|Q  ||   0.549   0.034   0.418  H  |5 
|I  ||   0.427   0.084   0.488  C  |6 
|G  ||   0.339   0.143   0.518  C  |7 
|R  ||   0.315   0.275   0.410  C  |8 
|L  ||   0.309   0.322   0.369  C  |9 
|A  ||   0.346   0.308   0.346  C  |10 
|L  ||   0.267   0.271   0.463  C  |11 
|R  ||   0.170   0.240   0.590  C  |12 
|P  ||   0.124   0.241   0.635  C  |13 
|T  ||   0.163   0.265   0.572  C  |14 
|L  ||   0.181   0.281   0.539  C  |15 
|V  ||   0.152   0.222   0.627  C  |16 
|P  ||   0.156   0.186   0.659  C  |17 
|A  ||   0.204   0.241   0.554  C  |18 
|T  ||   0.220   0.272   0.507  C  |19 
|V  ||   0.201   0.292   0.507  C  |20 
|I  ||   0.172   0.234   0.594  C  |21 
|P  ||   0.171   0.194   0.635  C  |22 
|Q  ||   0.187   0.192   0.620  C  |23 
|T  ||   0.194   0.189   0.617  C  |24 
|R  ||   0.199   0.184   0.617  C  |25 
|A  ||   0.203   0.209   0.589  C  |26 
|Y  ||   0.128   0.170   0.702  C  |27 
|S  ||   0.076   0.112   0.812  C  |28 
|A  ||   0.071   0.075   0.854  C  |29 
|P  ||   0.089   0.054   0.858  C  |30 
|A  ||   0.080   0.045   0.875  C  |31 
|G  ||   0.074   0.039   0.888  C  |32 
|T  ||   0.061   0.047   0.892  C  |33 
|P  ||   0.060   0.069   0.872  C  |34 
|R  ||   0.062   0.100   0.838  C  |35 
|V  ||   0.058   0.111   0.832  C  |36 
|S  ||   0.057   0.084   0.859  C  |37 
|S  ||   0.069   0.056   0.876  C  |38 
|S  ||   0.074   0.044   0.882  C  |39 
|S  ||   0.071   0.038   0.892  C  |40 
|M  ||   0.066   0.043   0.891  C  |41 
|P  ||   0.056   0.046   0.898  C  |42 
|T  ||   0.054   0.049   0.897  C  |43 
|D  ||   0.053   0.048   0.898  C  |44 
|F  ||   0.058   0.041   0.901  C  |45 
|P  ||   0.067   0.032   0.901  C  |46 
|L  ||   0.077   0.029   0.893  C  |47 
|P  ||   0.060   0.025   0.915  C  |48 
|S  ||   0.054   0.029   0.917  C  |49 
|Q  ||   0.050   0.028   0.922  C  |50 
|Q  ||   0.063   0.026   0.911  C  |51 
|K  ||   0.098   0.019   0.883  C  |52 
|P  ||   0.204   0.016   0.780  C  |53 
|N  ||   0.423   0.015   0.562  C  |54 
|S  ||   0.370   0.041   0.588  C  |55 
|A  ||   0.361   0.165   0.474  C  |56 
|V  ||   0.324   0.330   0.346  C  |57 
|D  ||   0.290   0.422   0.288  E  |58 
|Y  ||   0.333   0.469   0.197  E  |59 
|T  ||   0.288   0.591   0.121  E  |60 
|L  ||   0.256   0.564   0.181  E  |61 
|T  ||   0.190   0.400   0.409  C  |62 
|T  ||   0.099   0.224   0.677  C  |63 
|L  ||   0.587   0.059   0.354  H  |64 
|D  ||   0.691   0.030   0.279  H  |65 
|A  ||   0.683   0.027   0.289  H  |66 
|V  ||   0.731   0.023   0.246  H  |67 
|A  ||   0.676   0.024   0.300  H  |68 
|N  ||   0.561   0.027   0.412  H  |69 
|W  ||   0.582   0.032   0.386  H  |70 
|A  ||   0.545   0.053   0.402  H  |71 
|R  ||   0.487   0.073   0.440  H  |72 
|Q  ||   0.335   0.089   0.576  C  |73 
|G  ||   0.188   0.081   0.732  C  |74 
|S  ||   0.122   0.082   0.797  C  |75 
|F  ||   0.120   0.121   0.760  C  |76 
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|W  ||   0.106   0.212   0.682  C  |77 
|P  ||   0.116   0.290   0.594  C  |78 
|V  ||   0.149   0.344   0.507  C  |79 
|T  ||   0.162   0.286   0.552  C  |80 
|F  ||   0.159   0.145   0.696  C  |81 
|G  ||   0.182   0.064   0.754  C  |82 
|L  ||   0.296   0.095   0.609  C  |83 
|A  ||   0.368   0.160   0.472  C  |84 
|C  ||   0.383   0.211   0.406  C  |85 
|C  ||   0.365   0.216   0.419  C  |86 
|A  ||   0.665   0.127   0.208  H  |87 
|V  ||   0.730   0.130   0.140  H  |88 
|E  ||   0.717   0.148   0.135  H  |89 
|M  ||   0.784   0.122   0.093  H  |90 
|M  ||   0.820   0.055   0.125  H  |91 
|H  ||   0.764   0.026   0.209  H  |92 
|V  ||   0.625   0.031   0.343  H  |93 
|S  ||   0.378   0.032   0.590  C  |94 
|A  ||   0.186   0.043   0.770  C  |95 
|P  ||   0.152   0.068   0.781  C  |96 
|R  ||   0.219   0.099   0.683  C  |97 
|Y  ||   0.185   0.082   0.733  C  |98 
|D  ||   0.185   0.069   0.746  C  |99 
|Q  ||   0.443   0.059   0.498  C  |100 
|D  ||   0.447   0.062   0.491  C  |101 
|R  ||   0.366   0.133   0.502  C  |102 
|L  ||   0.227   0.232   0.541  C  |103 
|G  ||   0.082   0.331   0.588  C  |104 
|I  ||   0.053   0.458   0.489  C  |105 
|I  ||   0.047   0.540   0.413  E  |106 
|F  ||   0.056   0.463   0.481  C  |107 
|R  ||   0.048   0.325   0.627  C  |108 
|A  ||   0.050   0.154   0.796  C  |109 
|S  ||   0.060   0.064   0.875  C  |110 
|P  ||   0.113   0.051   0.836  C  |111 
|R  ||   0.136   0.074   0.791  C  |112 
|Q  ||   0.095   0.150   0.756  C  |113 
|S  ||   0.047   0.331   0.623  C  |114 
|D  ||   0.026   0.663   0.310  E  |115 
|I  ||   0.016   0.909   0.075  E  |116 
|M  ||   0.017   0.947   0.036  E  |117 
|I  ||   0.023   0.944   0.033  E  |118 
|V  ||   0.023   0.917   0.060  E  |119 
|A  ||   0.042   0.622   0.336  E  |120 
|G  ||   0.042   0.303   0.655  C  |121 
|T  ||   0.129   0.150   0.721  C  |122 
|L  ||   0.266   0.077   0.657  C  |123 
|T  ||   0.338   0.043   0.619  C  |124 
|N  ||   0.791   0.008   0.201  H  |125 
|K  ||   0.843   0.004   0.153  H  |126 
|M  ||   0.869   0.003   0.128  H  |127 
|A  ||   0.897   0.003   0.100  H  |128 
|P  ||   0.939   0.002   0.059  H  |129 
|V  ||   0.947   0.002   0.051  H  |130 
|L  ||   0.953   0.002   0.045  H  |131 
|R  ||   0.959   0.002   0.039  H  |132 
|Q  ||   0.944   0.004   0.052  H  |133 
|V  ||   0.931   0.006   0.063  H  |134 
|Y  ||   0.903   0.010   0.087  H  |135 
|D  ||   0.810   0.012   0.178  H  |136 
|Q  ||   0.632   0.018   0.350  H  |137 
|M  ||   0.228   0.013   0.760  C  |138 
|P  ||   0.052   0.020   0.928  C  |139 
|E  ||   0.031   0.029   0.940  C  |140 
|P  ||   0.021   0.076   0.903  C  |141 
|R  ||   0.021   0.389   0.591  C  |142 
|W  ||   0.014   0.866   0.120  E  |143 
|V  ||   0.013   0.930   0.056  E  |144 
|I  ||   0.018   0.930   0.052  E  |145 
|S  ||   0.028   0.867   0.104  E  |146 
|M  ||   0.043   0.619   0.338  E  |147 
|G  ||   0.064   0.406   0.530  C  |148 
|S  ||   0.190   0.279   0.531  C  |149 
|C  ||   0.324   0.216   0.460  C  |150 
|A  ||   0.299   0.161   0.540  C  |151 
|N  ||   0.185   0.100   0.715  C  |152 
|G  ||   0.122   0.082   0.796  C  |153 
|G  ||   0.084   0.058   0.858  C  |154 
|G  ||   0.074   0.101   0.825  C  |155 
|Y  ||   0.103   0.237   0.660  C  |156 
|Y  ||   0.114   0.362   0.524  C  |157 
|H  ||   0.137   0.455   0.408  E  |158 
|F  ||   0.148   0.396   0.456  C  |159 
|S  ||   0.203   0.307   0.490  C  |160 
|Y  ||   0.230   0.316   0.454  C  |161 
|S  ||   0.284   0.278   0.438  C  |162 
|V  ||   0.312   0.278   0.410  C  |163 
|V  ||   0.270   0.278   0.452  C  |164 
|R  ||   0.159   0.187   0.654  C  |165 
|G  ||   0.071   0.117   0.812  C  |166 
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|C  ||   0.076   0.123   0.801  C  |167 
|D  ||   0.060   0.136   0.804  C  |168 
|R  ||   0.041   0.261   0.698  C  |169 
|I  ||   0.025   0.507   0.467  E  |170 
|V  ||   0.021   0.625   0.354  E  |171 
|P  ||   0.015   0.563   0.421  E  |172 
|V  ||   0.016   0.677   0.307  E  |173 
|D  ||   0.017   0.721   0.262  E  |174 
|V  ||   0.023   0.758   0.219  E  |175 
|Y  ||   0.030   0.711   0.259  E  |176 
|V  ||   0.037   0.469   0.494  C  |177 
|P  ||   0.035   0.159   0.806  C  |178 
|G  ||   0.047   0.054   0.899  C  |179 
|C  ||   0.049   0.043   0.908  C  |180 
|P  ||   0.034   0.035   0.930  C  |181 
|P  ||   0.051   0.020   0.929  C  |182 
|T  ||   0.098   0.011   0.891  C  |183 
|S  ||   0.804   0.005   0.191  H  |184 
|E  ||   0.869   0.004   0.128  H  |185 
|A  ||   0.919   0.003   0.078  H  |186 
|L  ||   0.950   0.002   0.049  H  |187 
|M  ||   0.956   0.001   0.043  H  |188 
|Y  ||   0.958   0.001   0.042  H  |189 
|G  ||   0.952   0.001   0.047  H  |190 
|V  ||   0.952   0.001   0.047  H  |191 
|F  ||   0.955   0.001   0.043  H  |192 
|Q  ||   0.959   0.001   0.040  H  |193 
|L  ||   0.960   0.002   0.038  H  |194 
|Q  ||   0.939   0.004   0.057  H  |195 
|R  ||   0.886   0.010   0.104  H  |196 
|K  ||   0.854   0.012   0.134  H  |197 
|M  ||   0.717   0.013   0.269  H  |198 
|R  ||   0.626   0.016   0.357  H  |199 
|N  ||   0.426   0.027   0.547  C  |200 
|T  ||   0.214   0.046   0.740  C  |201 
|K  ||   0.143   0.069   0.788  C  |202 
|I  ||   0.163   0.156   0.681  C  |203 
|T  ||   0.244   0.289   0.468  C  |204 
|R  ||   0.232   0.369   0.400  C  |205 
|M  ||   0.276   0.287   0.437  C  |206 
|W  ||   0.249   0.312   0.439  C  |207 
|Y  ||   0.179   0.320   0.501  C  |208 
|R  ||   0.095   0.295   0.610  C  |209 
|K  ||   0.020   0.065   0.915  C  |210 
 
 
Table 9.4     -A prediction and a confidence value between 0 and 1 for each position in the amino 
acid sequence is given below- 
AA: amino acids in the NUKM sequence  
PRED: Prediction 
H: alpha helix, E: beta strand, C: coil.  
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10 Abbreviations 
 
 
 
 
Ala Alanine 
Asp Asparagine 
ATP Adenosine  Triphosphate 
BN-PAGE  Blue-Native Polyacryl Amide Gel Electrophoresis 
bp base  pair 
BSA  Bovine Serum Albumin 
Cys Cysteine 
DBQ n-Decyl-Benzoquinone 
dNADH  deamino Hydronicotineamide Adenine Dinucleotide (reduced form)
DQA 2-decyl-4-quinazolinyl  amine 
EPR  Electron Paramagnetic Resonance 
FAD  Flavin Adenine Dinucleotide 
FADH2 Flavin Adenine Dinucleotide reduced form 
FeS Iron-Sulphur  Cluster 
FMN Flavin  Mononucleotide 
Glu Glutamate 
HAR  Hexaammine ruthenuim(III) chloride 
Hyg Hygromicine 
kb kilobase 
LM  Lauryl Maltoside (n-dodecyl-β-D-maltoside) 
NAD
+ Nicotinamide Adenine Dinucleotide 
NADH  Hydronicotineamide Adenine Dinucleotide ( NAD
+ reduced form) 
NDH2(i)  (internal) version of the alternative NADH Dehydrogenase  
OXPHOS Oxidative  Phosphorylation 
PCR  Polymerase Chain Reaction 
SDS dodecylsulphate  Na-salt 
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